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I f  only there were occasion f o r  repose 
I f  only th is  long road h ad  an  end  
A nd in  the track, o f a  hundred thousand years, out o f
the h e a rt o f  dust 
Hope sprang again , lik e  greenness.
Khayyam*
* Persian poet and astronomer (1048-1131)
The Ruba'yyat of Khayyam. Translated by P. Avery & J. 
Heath-Stubbs, Penguin Books, London, England, 1979.
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SUMMARY
Proteinases have long been implicated in the pathogenesis 
of periodontal disease. Matrix metalloproteinases (MMPs) 
are a family of enzymes thought to be involved in 
periodontal tissue breakdown as well as tissue remodelling. 
MMPs are capable of degrading a variety of extracellular 
matrix components. Among these enzymes polymorphonuclear 
leucocyte derived collagenase (PMN-CL) and fibroblast 
derived collagenases (FIB-CL) have the unique ability to 
degrade type I, II and III collagens across the triple 
helix of the collagen fibre. Tissue inhibitor of 
metalloproteinases (TIMP), which are locally produced by 
host cells, inhibit these proteinases. TIMP appears to 
preferentially inhibit FIB-CL and stromelysin (SL). Most 
of the cells which produced FIB-CL and SL, also produce 
TIMP. No studies have so far been conducted on fibroblast 
derived MMPs and TIMP in gingival crevicular fluid (GCF). 
These experiments were carried out to investigate the GCF 
levels of FIB-CL, SL and TIMP in relation to periodontal 
disease status.
GCF samples were collected by means of sterile paper strips 
inserted into the crevice until mild resistance was felt 
and left for 30 seconds. GCF volume was assessed using the 
Periotron 6000. The enzymes and inhibitor levels were 
assayed using modifications of sandwich ELISAs described by
XXI
Cooksley et al. (1990). Antibodies detected both active 
and latent MMPs and the free form of TIMP. The results 
were expressed as absolute amounts i.e. pg/30 seconds of 
sample collection. Using these methods, it was possible to 
assess all three GCF proteins in the same sample (paper 
strip).
The clinical studies conducted in this thesis are: a) a 
cross-sectional study of matrix metalloproteinases and 
their inhibitor and b) a longitudinal study of matrix 
metalloproteinases and their inhibitor before and after 
treatment.
The cross-sectional study was carried out to test the 
ability of GCF levels of FIB-CL, SL and TIMP to distinguish 
healthy, gingivitis and periodontitis sites. GCF samples 
were collected from forty patients, each provided three 
samples from healthy, gingivitis and periodontitis sites. 
The mean GCF levels (pg/30s) of SL and TIMP were 
significantly higher in diseased (gingivitis and 
periodontitis) when compared to healthy sites. Both the 
enzyme and inhibitor failed to differentiate gingivitis 
from periodontitis. SL and TIMP demonstrated moderate 
correlation with clinical parameters when pooled data from 
three categories of sites were used. FIB-CL reached the 
detectable level of the assay in only 20.8% of the sites 
and did not demonstrate association with disease status.
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The aim of the longitudinal study was to investigate the 
effects of periodontal therapy on the GCF levels of FIB-CL, 
SL and TIMP as well as the ability of the baseline levels 
of these proteins to predict the outcome of treatment. 
Twenty one patients with advanced periodontal disease, each 
providing 8 GCF samples, comprised the study population. 
GCF sampling and clinical recordings were performed at 
three time points namely, baseline (before treatment), 
reassessment (after hygiene phase therapy (HPT)) and at the 
follow-up (after additional therapy) examinations. 
Attachment level (AL) and pocket depth (PD) were measured 
using the "Florida probe". All patients received oral 
hygiene instruction, scaling and root planing. Further 
treatment needs were determined based on the pocket depths 
and the state of bleeding on probing (BOP) six weeks after 
HPT, at the reassessment visit. Follow-up examination was 
performed at least six weeks after additional therapy.
Clinical parameters were reduced at both post therapy 
visits, while the mean level of SL decreased after HPT, 
TIMP level increased at this visit. Both proteins showed 
significant reduction at the follow-up visit. When sites 
were grouped according to their response to treatment, 
using different criteria i.e. PD, BOP and AL, this pattern 
of change was observed in all groups of sites which did or 
did not respond to treatment. The percentage of sites with 
detectable amounts of FIB-CL was 26.8%, 17.4% and 12% at 
three successive visits respectively. Baseline GCF levels
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of MMPs and TIMP failed to predict the outcome of 
treatment. The association between clinical and
biochemical parameters were investigated in several 
situations. Of these, SL and TIMP demonstrated significant 
and positive correlation with GCF volume only in the group 
of sites which gained attachment after therapy. As FIB-CL 
was detected in very small number of sites, no attempt was 
made to correlate its level with the clinical parameters.
The failure of SL and TIMP to distinguish gingivitis from 
periodontitis sites could be due to the fact that probing 
depths served as a differentiating factor between these 
groups of sites, keeping in mind that probing depth 
measurements taken at one point in time do not necessarily 
reflect active periodontal destruction. Moreover, the fact 
that our antibodies detected total enzyme together with the 
observation that periodontitis sites had more active enzyme 
whereas gingivitis sites harboured more latent enzyme 
(Kryshtalskyj et al. 1986) could also explain the inability 
of SL in discriminating gingivitis from periodontitis 
sites.
The failure of enzymes, at baseline, to predict the outcome 
of treatment could have resulted from different destructive 
potential (different proportion of active and latent 
enzyme) in different sites with comparable pocket depths. 
The increase of TIMP after HPT may reflect its involvement 
in the healing process whereas its decrease at the follow-
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up visit may be due to the further improvement in clinical 
conditions. However, in this study, the GCF levels of SL 
and TIMP in sites which did or did not respond to treatment 
demonstrated the same pattern of change at both post 
therapy visits. This could be explained by the followings: 
a) overall improvement in the clinical conditions of the 
entire dentition; b) the possibility that the level of 
active enzyme has been lower in sites which responded to 
treatment; and that the overall improved clinical 
condition, in an individual, may exert an indirect 
influence on the levels of MMPs and TIMP in sites which did 
not respond to treatment. Association between GCF 
constituents and clinical parameters has been established 
in some previous studies while this has not been the case 
in others. This discrepancy may be due to the different 
methods of GCF collection and reporting data as well as 
various laboratory techniques. Moreover, as different 
results were obtained when association between clinical and 
biochemical parameters were investigated in different 
groups of sites in theses studies, it seems that identical 
clinical conditions are also necessary for reproducibility 
of relationships between clinical and biochemical 
parameter.
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CHAPTER 1 
INTRODUCTION
1.1 The anatomy of the periodontium
The periodontium consists of supporting tissues of the 
tooth, including gingiva, periodontal ligament, root 
cementum and alveolar bone. The main functions of the 
periodontium, also called the attachment apparatus, are to 
attach the teeth to the jaw bones and to resolve the forces 
generated by the mastication (Lindhe & Karring, 1989).
1.1.1 The oral mucosa
The oral mucosa can be divided into three zones; a) the 
masticatory mucosa i.e. the gingiva and the covering of the 
hard palate, b) the specialised mucosa i.e. the mucosa 
covering the dorsum of the tongue, and c) the oral mucous 
membrane, lining the remaining of the oral cavity.
1.1.2 The gingiva
The gingiva is the part of the oral mucosa that covers the 
alveolar processes of the jaws and the cervical portions of 
the teeth. The gingiva is anatomically divided into 
marginal, attached, and interdental areas. The marginal 
gingiva is demarcated from the adjacent attached gingiva by 
a shallow linear depression, the free gingival groove, in 
about 50% of cases (Ainamo & Loe,1966). The free gingival 
groove is positioned at a level corresponding to the level
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of cemento-enamel junction (CEJ). In fully erupted teeth 
the free gingival margin is located on the enamel 
approximately 0.5 to 2mm coronal to the CEJ.
In human teeth the gingival margin, also known as marginal 
gingiva and free gingiva) seldom forms a knife-edged 
termination against the tooth, but it is rounded, this is 
the orifice of the gingival sulcus. The gingival sulcus is 
a shallow crevice around the tooth bounded by the tooth 
surface on one side and the epithelium lining of the 
marginal gingiva on the other side. In the presence of 
absolute normal conditions, the depth of gingival sulcus is 
0 or about 0 (Gottlieb & Orban, 1933). In fully developed 
teeth the coronal aspect of gingival sulcus is lined with 
sulcular epithelium, the nonkeratinised extension of the 
oral epithelium, and the bottom of the sulcus is formed by 
the coronal surface of the junctional epithelium. The 
junctional epithelium unites the gingival connective tissue 
with the enamel surface of the tooth, its length ranges 
from 0.25 to 1.35mm. The attached gingiva continues with 
the marginal gingiva and extends in apical direction to the 
mucogingival junction, where it becomes continuous with 
the, relatively loose and movable, alveolar mucosa. It has 
a firm texture and pink colour which is tightly bound to 
the underlying alveolar bone and therefore, is 
comparatively immobile in relation to the underlying 
tissue. The width of the attached gingiva differs in the 
different areas of the mouth (Bowers, 1963). It is greater
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in the incisors region and less in the posterior segments; 
attached gingiva in the first premolar area shows the least 
width (Ainamo & Loe, 1966), The interdental gingiva 
occupies the interproximal space beneath the areas of tooth 
contact. The interdental gingiva can be 'pyramidal' or a 
'col' shape. In the pyramidal form there is one papilla 
with its tip immediately beneath the contact point/ whereas 
the col shape presents a valley-like depression which 
connects a facial and lingual papilla and conforms to the 
shape of interproximal contact (Cohen, 1959).
1.1.2.1 Gingival epithelium
The gingiva is covered by three areas of epithelium, the 
oral epithelium which faces the oral cavity, the sulcular 
epithelium which faces the tooth without any contact with 
its surface, and the junctional epithelium which is in 
contact with tooth surface. The principal cell type of 
oral and gingival epithelium is the keratinocyte. Other 
cell types found in the epithelium are non-keratiocytes 
(clear cells), including the Langerhans cells which are 
believed to play a role in the defence mechanism of oral 
mucosa (DiFranco et al., 1985); Merkel cells which are 
terminals of nerve fibres (Ness, Morton & Dale, 1987) and 
melanocytes which synthesize melanin (Schroeder, 1969). The 
keratinocytes constitute about more than 90% of gingival 
epithelium. The process of keratinisation involves a 
sequence of biochemical and morphologic events that occur
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in the cell as it migrates from the basal layer towards the 
surface. Gingival epithelium can express three types of 
surface differentiation; a) keratinisation in which the 
cells on the surface form scales of keratin and lose their 
nuclei; b) parakeratinisation in which the cells of the 
superficial layers show some signs of keratinisation and 
retain their nuclei, although pyknotic; the granular layer 
is absent; c) non-keratinisation in which the cells of the 
surface layers have their nuclei and no signs of 
keratinisation are present.
1.1.2.2 The oral epithelium
The oral epithelium covers the crest and outer surface of 
the marginal gingiva as well as the surface of the attached 
gingiva. The stratified squamous epithelium covering these 
areas is keratinized or parakeratinised or a combination of 
both and is joined to the underlying connective tissue by 
a basal lamina (Stern, 1965). The border between oral 
epithelium an underlying connective tissue is uneven and 
characterised by deep epithelial ridges (rete pegs) that 
surround finger-like connective tissue papillae.
1.1.2.3 The sulcular epithelium
The sulcular epithelium which lines the gingival sulcus, is 
a thin, nonkeratinised stratified squamous epithelium. It 
extends from the coronal limit of the junctional epithelium
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to the crest of the gingival margin and like the oral 
epithelium possesses the rete pegs. The sulcular 
epithelium has the potential to keratinize if it is 
reflected and exposed to the oral cavity (Caffesse, Karring 
& Nasjleti, 1977) or if bacterial flora of the sulcus is 
totally eliminated (Caffesse, Kornman & Nasjleti, 1980).
1.1.2.4 The junctional epithelium
The junctional epithelium, also known as dento-gingival 
epithelium, consists of a collar-like band of stratified 
squamous nonkeratinised epithelium. It is three to four 
layers thick in early life, but the number of layers 
increases with age to 10 or even 20 and its length ranges 
from 0.25 to 1.35mm. The reduced enamel epithelium (the 
remnants of enamel producing apparatus which covers the 
crown of the unerupted tooth) is gradually transformed 
during tooth eruption into the junctional epithelium 
(Listgarten, 1966a). The junctional epithelium is attached 
to the tooth surface (epithelial attachment) by means of a 
basal lamina (Listgarten, 1966b). The basal lamina 
consists of a lamina densa (adjacent to the tooth surface) 
and a lamina lucida to which hemidesmosomes are attached. 
Unlike the oral and sulcular epithelium, junctional 
epithelium in normal, non-inflamed gingiva lacks rete pegs 
and connective tissue papillae at its boundary with 
underlying connective tissue (Lindhe & Karring, 1989).
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1.1.2.5 The gingival connective tissue
The connective tissue of the gingiva, which is known as 
lamina propria, consists of cells, fibres, nerve processes 
and blood vessels embedded in a dense collagenous 
environment. This densely collagenous connective tissue 
contains a prominent system of collagen fibre bundles, the 
gingival fibres, which are mostly arranged in four groups; 
circular, dentogingival, dentoperiosteal and transseptal 
(Arnim & Hagerman, 1953, Lindhe & Karring, 1989). The main 
cell is the fibroblast (65% of the total population), which 
synthesises and secretes the basic elements of the 
connective tissue, the collagen fibres. There are other 
cells including mast cells (Shelton & Hall, 1968), 
undifferentiated mesenchymal cells, and macrophages.
Leucocytes have been found in clinically healthy gingival 
sulci in human and experimental animals. The main 
leucocytes found are the PMNs which appear in small numbers 
in the extravascular area in the connective tissue adjacent 
to the bottom of the sulcus. In a recent study, it was 
shown that 18% of the connective tissue adjacent to the 
apical portion of the junctional epithelium were PMNs after 
6 months of optimal plaque control (Brecx et al., 1987). 
It is from there that they travel across the epithelium 
(Cattoni, 1951; Grant & Orban, 1960) to the gingival sulcus 
where they accumulate and are eventually lost to the oral 
cavity.
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1.1.3 The periodontal ligament
Periodontal ligaments are connective tissue structures 
which surround the root and connect it with the alveolar 
bone. The most important part of the periodontal ligament 
is the principal fibres, which were first described by 
Black in 1887. These are collagenous fibres, arranged in 
bundles, and follow a wavy course with their terminal 
portions inserted into the root cementum and alveolar bone 
(Sharpey's fibres). The collagen of the periodontal 
ligament is mostly of Type I, though some Type III collagen 
is present as well (Butler et al., 1975). The turnover 
rate of periodontal ligament collagen is estimated to be 
two to three times faster than of gingival collagen 
(Rippin, 1978). The principal fibres are arranged in the 
following groups: a) transseptal group which extend
interproximally over the alveolar crest inserting into the 
cementum of adjacent teeth; b) alveolar crest group which 
extend obliquely from the cementum, just beneath the 
junctional epithelium, to the alveolar crest; c) horizontal 
group which extend at right angle to the long axis of the 
tooth from the cementum to the alveolar bone; d) oblique 
group which are the largest group in the periodontal 
ligament and extend from the cementum in a coronal 
direction obliquely to the bone; and finally e) apical 
group which radiate from cementum to the bone at the fundus 
of the socket. Other fibres in periodontal ligament are 
the relatively few elastic fibres (Thomas,1927); and the
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oxytalan fibres (Goggins, 1966) which are distributed 
around the blood vessels.
1.1.4 The cementum
Cementum is a specialised calcified tissue of mesodermal 
origin which forms the outer covering of the anatomic root 
and, occasionally, small portions of the crown of the 
teeth. Cementum does not undergo physiological resorption 
and remodelling. Two different types of cementum exist, 
acellular (primary) and cellular (secondary), both consist 
of a calcified interfibrillar matrix and collagen fibres. 
There are two sources of collagen fibres in cementum: a) 
Sharpey's fibres (extrinsic fibre system) which are the 
embedded portion of the principal fibres of the periodontal 
ligament (Romaniuk, 1967); and b) another group of fibres 
(intrinsic fibre system), belonging to the cementum matrix 
per se, produced by cementoblasts (Selvig, 1965). The 
intrinsic fibre system is composed of fibres oriented more 
or less parallel to the long axis of the root which cross 
the extrinsic fibres (Sharpey' fibre) at right angles 
(Lindhe & Karring, 1989). The cemento-enamel junction 
(CEJ) is the point at which enamel (outer layer of the
anatomic crown) meets the cementum. Three types of
relationship, at the CEJ, exist between enamel and
cementum. Cementum overlaps the enamel in 60% of the
cases; there is an edge to edge joint in 30% of the cases; 
and in 10% the enamel and the cementum fail to meet.
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1.1.5 The alveolar bone
The alveolar process is the part of maxilla and mandible 
that forms and supports the tooth sockets (alveoli). It 
develops when the tooth development and eruption takes 
place and gradually disappears when the tooth is lost. The 
alveolar process consists of a) the alveolar bone proper, 
a thin and compact layer of bone also called the cribriform 
plate, where the Sharpy's fibres are inserted into the bone 
(Selvig, 1965); b) the supporting alveolar bone including 
cancellous trabeculae, the pattern of which is affected by 
occlusal forces (Parfitt, 1962); and c) the facial and 
lingual/palatal plates of compact bone. The interdental 
septum consists of cancellous bone enclosed within a 
compact border. The periodontal ligament and the root 
cementum together with the alveolar bone form the 
attachment apparatus for the teeth. The fundamental 
function of this apparatus is to distribute and resorb 
forces applied to the teeth by mastication and other tooth 
contacts (Lindhe & Karring, 1989).
1.1.5.1 Alveolar bone remodelling
Alveolar bone remodelling is an ongoing process in which 
two types of cells are involved; a) osteoblasts which 
produce osteoid consisting of collagen fibres and matrix. 
The latter undergoes calcification by the deposition of the 
minerals which are subsequently transformed to
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hydroxyapatite; and b) osteoclasts which are responsible 
for osteolysis by resorbing the mineral as well as organic 
bone materials (Lindhe & Karring, 1989).
1.2 Definitions
1.2.1 Clinical and histological appearance of 
'normal' periodontium
In the normal periodontium, the gingiva is clinically 
characterised by its pale pink colour, firm consistency, 
scalloped outline, which does not bleed on probing and 
fills the entire space between adjacent teeth (Ainamo & 
Loe, 1966, Wennstrom, 1988); the gingival sulcus is rarely 
present; histologically, no inflammatory exudate is present 
and only a few polymorphonuclear leucocytes are seen 
traversing the connective tissue and junctional epithelium; 
(Lindhe, 1989); alveolar bone is located 1mm apical to the 
cemento-enamel junction (Eliasson et al., 1986). Normal 
gingiva is, therefore, free from inflammation at both the 
clinical and microscopical level which can be found in 
humans who, daily, exercise meticulous supervised plaque 
control for several weeks. These conditions are, however, 
rarely met in average human subjects (Taichman & Lindhe, 
1989). In the light of this fact and the findings of 
(Seymour, Powell & Aitken, 1983; Brecx et al., 1987) that 
an inflammatory infiltrate, comprising of polymorphonuclear 
leucocytes and small round mononuclear cells is always
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present in gingival biopsies from clinically healthy 
gingivae, it seems that normal gingiva should be
distinguished from clinically healthy gingiva.
1.2.2 Definition and classification of periodontal 
disease
The periodontium comprises diverse tissues of different 
origin; therefore, the term periodontal disease, if used in 
the general sense, would include a range of diseases
affecting various elements of the periodontium (Kinane & 
Davies, 1990). However, in this thesis, the term
periodontal disease will refer to gingivitis and
periodontitis, the inflammatory processes associated with 
the presence of dental plaque.
In the World Workshop in Clinical Periodontics (1989) 
different forms of periodontitis were classified as 
follows s
I. Adult periodontitis
II. Early-onset periodontitis
A. Prepubertal periodontitis (localised, generalised)
B. Juvenile periodontitis (localised, generalised)
C. Rapidly progressive periodontitis
III. Periodontitis associated with systemic disease
IV. Necrotizing ulcerative periodontitis
V. Refractory periodontitis
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However, there is a considerable overlapping between the 
different categories.
1.2.2.1 Clinical features of gingivitis and 
periodontitis
In gingivitis, which is the most common form of gingival 
disease, pathological changes are confined to the gingiva. 
Gingivitis is clinically manifested by gingival redness and 
swelling and increased tendency of soft tissue to bleed on 
gentle probing (Taichman & Lindhe, 1989). In
periodontitis, the deeper structures such as alveolar bone, 
periodontal ligament and root cementum are affected by 
pathological changes. In general, periodontitis is 
clinically manifested by pocket formation, open interdental 
contacts, and loosening and migration of the teeth.
Prepubertal periodontitis (PP) is a very rare condition 
with its onset during or immediately following eruption of 
the primary teeth. In the generalized form all the primary 
teeth are affected and severe bone loss is evident 
radiographically, whereas in the localized form some of the 
teeth are involved to a lesser extent (Page & Schroeder, 
1982) .
Juvenile periodontitis (JP), with its onset thought to be 
at puberty, may be diagnosed at any age beyond puberty. JP 
is characterized by deep pockets and bone loss associated
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with the permanent first molars and/or incisors, with 
usually a symmetrical distribution of lesions (Baer et al., 
1971).
Rapidly progressive periodontitis's (RPP) onset occurs 
between puberty and 30-35 years of age (Page et al,, 1983) 
and is characterized by severe bone loss affecting most 
teeth, without any consistent pattern of distribution. In 
both JP and RPP the amount of bone loss is not commensurate 
with the amount of plaque (Page & Schroeder, 1982). Early 
onset forms of periodontitis in general and prepubertal 
periodontitis in particular are rare and most, if not all, 
of the cases have a genetic basis.
Adult periodontitis (AP) is the most common form of the 
disease, with its onset beyond the age of 30-35 years. The 
lesions are not confined to any certain teeth and the 
amount of microbial deposits (dental plaque) are consistent 
with the severity of lesions (Page et al., 1983).
Periodontitis associated with systemic disease. Different 
forms of periodontitis described above exhibit pathologic 
changes in the periodontium without any accompanying or 
underlying systemic disease, whereas systemic conditions 
may modify the normal defence, thus predisposing individual 
to specific forms of periodontitis. Reduction in number or 
function of PMNs results in increase rate and severity of 
periodontal breakdown (Kinane & Davies, 1990). In these
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cases periodontitis could be considered as a symptom of the 
underlying disorder.
Acute necrotizing ulcerative gingivitis (ANUG) is a rapidly 
progressive inflammation of the gingiva which may enter a 
chronic stage. ANUG rarely occurs in a generalized form 
and may be very advanced in anterior teeth whereas the rest 
of the teeth may not be involved. Disease is caused by a 
fusospirochetal complex of micro-organisms in the presence 
of a number of predisposing factors such as poor oral 
hygiene, smoking and stress (Sabiston 1986). When the 
infection reaches the alveolar bone and periodontal fibres, 
the disease is termed Necrotizing ulcerative periodontitis 
(Proceeding of the World Workshop in Clinical 
Periodontology, 1989).
Refractory periodontitis (RP) is seen as an enigma in 
clinical periodontology. According to the World Workshop 
in Clinical Periodontics (1989), this condition has been 
described as cases with multiple sites which continue to 
lose attachment despite appropriate management. However, 
whether a particular site is truly refractory or whether 
refractory periodontitis is a separate disease entity is a 
critical question. It is quite clear that several forms of 
periodontal disease can become resistant to treatment. 
Therefore it seems more realistic to refer the term 
refractory to sites which do not respond to treatment 
rather than the diagnosis of periodontitis (Adams, 1992).
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1.3 Epidemiology of periodontal disease
Epidemiological studies performed over the past half a 
century have employed the radiographic evidence of alveolar 
bone resorption, periodontal pocket depth /attachment level 
and the degree of gingival inflammation to assess the 
prevalence of periodontal disease (Marshall-Day & Shourie, 
1949; Schour & Massler, 1947; Russell, 1956; Ramfjord, 
1959). The prevalence of gingivitis, in early
epidemiological studies, approached approximately 100% for 
children and young adolescents. Marshall-Day and Shourie 
(1949) reported that 73% to 97% of Indian children aged 9- 
17 and 81.2% of those aged 5-10 years had gingivitis. 
Similarly, a prevalence of 99% was reported for 13-year old 
children in postwar Italy by Schour & Massler (1947). 
Marshall-Day, Stephen & Quigley (1955) reported that with 
increasing age, a concomitant decrease in the prevalence of 
gingivitis with no bone involvement and an increase in 
prevalence of periodontitis, as indicated by radiographic 
bone loss, was evident; and at the age of 40 years, 
approximately 100% of the subjects were affected by 
destructive periodontitis. Using the Periodontal Index 
(PI) of Russell (1956), extensive data has been collected 
from different populations all around the world. Analyses 
of these observations have revealed that variation in 
prevalence and severity of periodontal disease is 
associated with race, geographic area, sex, socioeconomic 
status and education level. Using a better known Oral
15
Hygiene Index (OHI) of Greene and Vermillion (1960), it has 
been shown that the evident racial, geographic, 
socioeconomic, gender and level of education disappear when 
disease severity is directly related to the oral hygiene 
level (Schrep, 1964). This point has been suggested by 
Russell (1963) that more than 90% of the variance of the 
periodontal disease experience in the population can be 
explained by age and oral hygiene. Although, different 
indices and various thresholds for detection of gingivitis 
and periodontitis have been employed, the results of these 
studies led to the concept that; a) periodontitis is a 
global disease affecting high proportions of the 
population; b) the disease starts as gingivitis at an early 
age which if left untreated will develop to periodontitis; 
c) most of the variance of the periodontal disease in the 
population can be explained by age and oral hygiene. These 
concepts dominated periodontal literature until recently 
when a more appropriate analyses of epidemiological data 
was made. Data collected by the PI of Russell (1956) and 
the Periodontal Disease Index (PDI) of Ramfjord (1959) have 
been expressed as mean values for gingivitis scores as well 
as pocket depths and attachment loss. However, it has been 
recognised that reporting data as mean values could result 
in data smoothing which may obscure the differences within 
and between individuals with respect to extent and severity 
of periodontal disease (Papapanou, Wennstrom & Grondahl, 
1989). When the extent and severity of periodontal 
involvement were taken into consideration a different
16
overall picture of the prevalence and progression of 
periodontal disease became evident. Recent cross-sectional 
studies have shown that although a periodontium of reduced 
height is common with increasing age, relatively few 
individuals in each age group suffer from advanced 
periodontal destruction. These subjects account for most 
of the sites which express severe periodontal breakdown. 
Papapanou, Wennstrom & Grodahl (1988) reported that 23% of 
subjects accounted for 75% of the total number of the sites 
showing advanced bone loss (^6mm). Jenkins and Kinane 
(1989) pointed out that 14.4% of patient who had been 
referred to the Glasgow Dental Hospital for a variety of 
dental complaints, showed advanced bone loss. Longitudinal 
studies have in addition shown that few sites undergo 
extensive periodontal destruction within a given 
observation period. Lindhe, Haffajee and Socransky (1983) 
reported that during a six year follow up of Swedish 
periodontally affected subjects, who were not receiving 
active treatment, only 3.9% and 11.6% of their sites had 
lost attachment >2mm at 3 and 6 years respectively. 
Similar percentage (3.2%) of sites exhibiting attachment 
loss were reported in the same study for a group of 
American who were followed for one year. However, a higher 
percentage (7%) of sites which lost attachment over a 1 
year period has been reported by Haffajee, Socransky and 
Goodson (1983a). Loe et al. (1986), who conducted a 15 
year long study of the natural history of periodontal 
disease in Sri Lanka, reported that only 8% of the total
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sample showed rapid progression of periodontal disease, as 
defined by tooth mortality rates and interproximal 
attachment levels, whereas in 11% of the subjects 
gingivitis never converted to periodontitis. Jenkins, 
MacFarlane and Gilmour (1988) reported that in a one year 
longitudinal study of untreated periodontitis patients only 
1.9% of sites exhibited attachment loss of more than 2mm. 
In a two year follow up of a group of untreated subjects, 
it was shown that only 0.7% of sites had lost attachment of 
>2mm, however, 70% of the sites that experienced further 
attachment loss belonged to 12% of the subjects (Lindhe et 
al., 1989). In a 10-year retrospective study, Papapanou et 
al. (1989) demonstrated that only 7% of subjects 
experienced bone loss of ^3mm and 10 sites or more with 
bone loss of s6mm were found in 4% of the subjects over a 
10 year period.
The current view, therefore, is that: a) periodontal
disease is subject related; b) a small subset of 
individuals within a given population suffer from advanced 
periodontal destruction; c) relatively few subjects and 
sites undergo active periodontal destruction within a given 
period of time; and d) in the absence of treatment, 
gingival inflammatory lesion does not necessarily convert 
to destructive periodontal disease (Papapanou, 1989).
18
1.4 Gingival crevicular fluid
1.4.1 Production
Gingival crevicular fluid is an inflammatory exudate or a 
pre-inf lammatory transudate present in the gingival crevice 
which contains several components of different origin. GCF 
components are mainly derived from: a) interstitial fluid 
and locally produced factors from migrating or resident 
host cells; b) serum; c) tissue degradation/turnover 
products; and d) microbial sources (Cimasoni, 1983). 
Production of GCF in the presence of inflammation was shown 
to be due to an increase in the vascular permeability of 
the subepithelial vasculature in inflamed gingiva (Brill & 
Bjorn, 1959; Egelberg 1966). Either chemical (topical 
application of histamine) or mechanical (massage of the 
marginal gingiva with a ball burnisher or scraping with a 
blunt probe) stimuli to the gingiva resulted in an 
increased vascular permeability which in turn increased the 
GCF flow (Egelberg, 1966). Loe and Holm-Pedersen (1965) 
reported an increasing level of GCF as the severity of 
gingival inflammation increased. However, they failed to 
show the presence of GCF in healthy gingiva with or without 
the mechanical stimulation. Although, when paper strips 
were deeply inserted into the crevice substantial amounts 
of GCF were collected. Brill (1960) in his clinical and 
histological study observed that sites with histological 
signs of inflammation had, significantly more GCF than
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sites without inflammation at a histological level. It 
seems that GCF in clinically healthy gingiva is produced 
under different mechanism. In his hypothesis, Alfano 
(1970) suggested that pre-inf leaned flow of GCF may be 
osmotically mediated in the following way: In clinically
healthy gingiva during initial plaque accumulation 
macromolecules derived from subgingival plaque can diffuse 
intercellularly to the basement membrane, where due to its 
relative impermeability in health, they will accumulate. 
An osmotic gradient can then be created and a flow of GCF 
generated. Pashley (1976) described a model which can be 
applied to the situation in both health and disease. He 
suggested that GCF production is governed by relative 
differences in: a) passage of fluid from capillaries into 
the tissues (capillary filtrate); b) removal of this fluid 
by lymphatics of the gingiva (lymphatic uptake) and c) 
filtration through the junctional epithelium into the 
gingival crevice (GCF production). When the rate of 
capillary filtrates exceeds that of lymphatic uptake, fluid 
will leave the area. Factors modulating these processes 
include the filtration coefficient of the capillary and 
lymphatic endothelium as well as the osmotic pressure 
within the different compartments. Thus, even in health, 
if the osmotic pressure of the sulcular compartment, due to 
the plaque derived products, exceeds that of tissue fluid, 
there will be a net increase in the flow of GCF. In an 
attempt to verify the model described by Alfano (1970), 
Bickle, Cimasoni and Anderson (1986) studied the
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contribution of serum in GCF production during early (pre- 
inf lammatory) plaque accumulation by measuring albumin 
concentration in GCF and its ratio to that of the serum. 
They recovered no fluid from healthy gingiva and low 
concentrations of albumin during pre-inflammatory plaque 
accumulation. These observations supported the osmotic 
gradient model of Alfano (1970). With increasing plaque 
accumulation, both the GCF albumin concentration and its 
ratio to that of the serum increased. Chronically inflamed 
sites showed a GCF:serum albumin ratio of approximately 1. 
However, Stoller, Karras and Johnson (1990) concluded that 
the increase of GCF volume in the presence of dental plaque 
is due to the presence of significant quantities of water 
in dental plaque. They have not discussed the other 
possibilities, such as osmotic pressure, in GCF production. 
As the GCF traverses the inflamed tissue, on its way, picks 
up enzymes and other molecules that participate in the 
destruction process, as well as products of cell and tissue 
degradation. Therefore, GCF offers a great potential as a 
source of factors that may be associated with active tissue 
destruction (Page, 1992).
1.4.2 Methods of collection and volume determination
A variety of methods have been used for the collection of 
GCF which can reflect the type of analysis to be performed 
on the samples and the amount of fluid required. They 
include, absorbent precut paper strips/paper points placed
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at the orifice, partly into or to the bottom of the pocket 
or sulcus, the capillary tubes or micropipettes and the 
gingival washing (Golub et al., 1976; Villela et al., 1987; 
Adonogianaki, Moughal & Kinane, 1993). When large volumes 
of GCF are required capillary tubes (Ishikawa et al., 1972; 
Larivee, Sodek & Ferrier, 1986) or micropipettes 
(Eisenhauer et al., 1983) are used. When cell types and 
numbers in the fluid are required gingival crevicular 
washings (Salonen & Paunio, 1991; Adonogianaki et al., 
1993) are employed.
Exact placement of the sampling device is important. It 
has been shown (Mann, 1963; Loe & Holm-Pedersen, 1965) that 
the insertion of the paper strips in the crevice will 
irritate the gingival tissue and induce vascular 
permeability which in turn gives cause to increased GCF 
production.
The effects of repeated sampling on GCF flow when using 
paper strips have been the focus of several studies which 
have shown that GCF volume tends to decrease by repeated 
sampling (Binder, Goodson & Socransky, 1987; Curtis et al., 
1988; Lamster et al., 1989; Persson & Page, 1990). 
Although in most cases repeated sampling resulted in a 
reduction in total amounts of GCF components (Lamster et 
al., 1989; Persson & Page, 1990) some investigators 
reported an increase or steady flow rate (Binder et al., 
1987; Villela et al., 1987). This discrepancy could have
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resulted from lengthy sampling periods (Villela et al.,
1987) or deep intercrevicular sampling (Binder et al.,
1987). Lamster et al. (1989) employed repeated sampling 
for 30 seconds and observed that GCF constituents did not 
return to baseline level even after 60 minutes. They also 
found that the fluid volume in the crevice recovers more 
rapidly than constituents derived from host cells.
Sampling time is also of great importance. Persson and 
Page (1990) employed four sampling times (5, 10, 20 and 30 
seconds) and four different sampling sequences, alternating 
the order by which samples of different time periods were 
taken. They suggested that 5s or 10s first time sampling 
of GCF is adequate whereas lengthier sampling periods (20s 
or 30s) tend to dilute aspartate aminotransferase activity. 
However, Cao and Smith (1989) have reported that 
myeloperoxidase activity is higher in 30s compared to 5s 
samples from the same site when the samples are taken one 
week apart.
In general, it can be concluded that while the same 
sampling technique, sampling time and sampling sequence 
may not be the best for all studies the procedure of choice 
should have the following features: a) causes the least 
interference with gingival tissues; b) is the shortest in 
time and provides enough sample for subsequent analysis; 
and c) collects fluid present at the site prior to 
sampling. Thus, it seems that sampling for 30s or less
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with a paper strip would be ideal as it provides a sample 
of GCF of sufficient size for subsequent analysis while 
minimising irritation of the gingival tissues.
GCF volume collected on paper strips has been measured by 
assessing the wetted area of the strip, by weighing of 
paper strip before and after sample collection or by the 
use of the Periotron (Harco Electronics, Winnipeg, 
Manitoba, Canada). The wetted area of the strip can be 
assessed directly using a microscope fitted with a 
graticule (Egelberg & Attstrom, 1973) or after staining 
with ninhydrin (Egelberg, 1964). Although staining 
facilitates viewing and assessment of the wetted area, the 
sample is not of any use for GCF analysis afterwards. 
Weighing prior to and after GCF sampling of paper strips 
has been performed for assessing the volumes beyond the 
measuring range of the Periotron (Cimasoni & Giannopoulou,
1988). Assessing the GCF volume by weighing of the strip 
and the use of the Periotron make the subsequent analysis 
of the biochemical components of GCF possible. The 
Periotron 6000 has been extensively used by investigators 
in periodontal field and it has proven satisfactory for the 
assessment of GCF volume (Cimasoni, 1983).
However, assessing minute amounts of GCF by any of the 
above methods (volumes of 0.01-0.2 pil) is demanding and 
could be subject to uncontrollable errors (Lamster et al,,
1988) .
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1.5 Clinical assessment of the periodontium
1.5.1 Introduction
The periodontium is clinically evaluated by means of 
different indices which distinguish between healthy 
tissues, gingival inflammation and destructive periodontal 
disease. These clinical indices are based on visual 
observation, palpation/percussion of the teeth, the use of 
the periodontal probe and radiographic examination. The 
use of GCF flow has also been suggested to supplement other 
clinical findings. Subject's oral hygiene performance and 
plaque accumulation are assessed using plaque indices. 
Generally accepted criteria for an index include 
simplicity, validity, sensitivity, reproducibility and 
amenability to statistical analysis (Hazen, 1974).
1.5.2 Assessment of oral hygiene
The assessment of oral hygiene dates back to the 1930s 
(Ainamo & Bay 1975). Oral hygiene indices are based on the 
measurement of the tooth surface area covered by dental 
plaque and/or thickness of the material in the gingival 
margin. In 1959 Ramfjord introduced his Periodontal 
Disease Index (PDI) with different components for assessing 
the gingival condition and plaque accumulation on the tooth 
surfaces as well as an index for calculus assessment. 
Quigley and Hein (1962) published their plaque index which
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is graded according to the coronal extension of plaque on 
the tooth surface. In 1964 Greene and Vermillion 
introduced their Simplified Oral Hygiene Index (OHI-S) 
including calculus index and debris index of which dental 
plaque is one component. Since then numerous indices have 
been developed to assess plaque accumulation (reviewed by 
Fischman, 1986). In 1964 Silness and Loe described their 
plaque index which is one of the most widely used plaque 
indices in periodontal trials. This index was fully 
described by Loe (1967) and scores plaque accumulation from 
0 to 3. This plaque index is based on the different amount 
of plaque present on the tooth surface/gingival margin and 
can be used to score individual sites, as single site 
score, teeth as average of four sites per tooth (buccal, 
lingual and interproximal) and individuals or groups of 
teeth. The last two scores are based on site scores 
divided by the number of sites assessed. To this date oral 
hygiene indices have been calculated by adding up the 
plaque and calculus scores. Silness and Loe (1964) stated 
that the presence and amount of plaque alone gives an 
adequate expression of the state of oral hygiene. They 
also stated that running an explorer along the tooth 
surface both supra and subgingivally gives better results 
than the use of disclosing solutions. The plaque index 
(Silness and Loe, 1964) remains one of the most widely used 
indices although it has been criticised for its subjective 
nature and disruptive character when distinguishing between 
scores 0 and 1, especially when it is used for within and
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between examiner calibration. The plaque index has the 
advantage of having the ability to assess very subtle 
changes in plaque accumulation (Lindhe, 1989). It has also 
been suggested that the plaque index is suitable when the 
plaque/gingivitis cause and effect relationship is to be 
considered (Fischman, 1988).
1.5.3 Assessment of gingival inflammation
Assessment of gingival inflammation is performed by the use 
of gingivitis indices as well as GCF flow. These indices 
rely on one or more of the following parameters: gingival 
colour, gingival contour, gingival bleeding and the extent 
of gingival involvement. Such indices were initially 
developed for use in epidemiological surveys (Ciancio, 
1986). One of the first gingival indices (PMA) was 
described by Schour and Massler (1947) which evaluates the 
condition of papillary (P), marginal (M) and attached (A) 
gingiva with varying degrees of inflammation. Later, Russel 
(1956) introduced the Periodontitis Index (PI) and Ramfjord 
(1959) published the Periodontal Disease Index (PDI). Both 
indices as well as the Navy Periodontal Disease Index 
(Elliott et al., 1972) incorporated the assessment of 
gingival inflammation at the lower parts of their scales, 
which reflects the notion dominated at the time, that 
gingivitis precedes periodontal destruction. However, Loe 
(1967) has given two reasons for not including a gingival 
index into a complex system, which also assesses the amount
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of periodontal breakdown. The first reason is, that 
gingival inf lamination and periodontal breakdown are two 
different incomparable parameters and should not be put 
into one index; the second reason is, that there is no need 
for transforming pocket depth or attachment loss as based 
on measurement in millimetre to a different system of 
figures (index). He, therefore, suggested that the quality 
of gingiva should be scored according to the Gingival Index 
(Loe & Silness, 1963) and the quantity of periodontal 
destruction measured in millimetre. More recent indices 
for the assessment of gingival inflammation are based on 
visual changes and/or bleeding on probing of the gingival 
unit. Among these are: the Gingival Index (GI)(Loe &
Silness, 1963; Loe, 1967), the Sulcular Bleeding Index 
(SBI)(Muhlemann & Mazor, 1958; Muhlemann & Son, 1971), the 
Gingival Bleeding Index (GBI)(Ainamo & Bay, 1975) and the 
Papillary Bleeding Index (PBI)(Muhlemann, 1977; Barnett, 
Ciancio & Mather, 1980). The Gingival Index of Loe and 
Silness (1963), has been widely accepted and provided a 
conceptual change in the assessment of gingival 
inflammation as it scores both its severity and location. 
The GI scores inflammation from 0 to 3. Scores 2 and 3 
incorporate the bleeding on gentle pressure component which 
was later modified to bleeding on probing (Loe, 1967). The 
invasive nature of GI is a disadvantage for this index when 
it is used in longitudinal studies of gingivitis where 
trauma to the gingival tissues could yield an altered 
response. In addition, a non-invasive index facilitates
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the use of other clinical examinations during the same 
appointment such as GCF sampling which is influenced by the 
irritation of the gingival tissues. To address this 
problem Lobene and co-workers (1986) made some 
modifications to the GI of Loe and Silness (1963) by 
eliminating its bleeding on probing/pressure component 
yielding a completely non-invasive index. They also 
expanded the lower part of the scales resulting in a 
scoring system of 0-4 which gives the index greater 
sensitivity to the earliest changes of gingival tissues. 
Although, the Modified Gingival Index (MGI) (Lobene, et 
al., 1986) lacks the bleeding component it showed a great 
correlation with the Gingival Index of Loe and Silness 
(1963) and could be equally used in clinical trials. 
However, it should be kept in mind that the bleeding 
component in the GI is only present in the higher part of 
the scale (GI=2 or 3) and, therefore, the differentiation 
between clinically healthy gingiva and mild inflammation 
(GI= 0 and 1, respectively) is still dependent on visual 
criteria alone (Lobene et al., 1989).
By incorporating the bleeding on probing component in some 
indices, they have the ability to assess the presence of 
inflammation at the depth of the pocket in case of 
periodontitis. Therefore, the use of another index, where 
it is desired, to determine the presence or absence of 
bleeding is recommended (Lobene et al., 1989). When 
bleeding upon probing is assessed the use of pressure
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sensitive probes is recommended as they allow a 
standardised force to be applied in order to test for 
bleeding.
As late as I960, it has been suggested that GCF flow could 
offer some abilities in the assessment of the gingival 
inflammation (Brill, 1960). Since then both cross- 
sectional (Mann, 1963; Egelberg, 1964? Loe and Holm- 
Pedersen, 1965? Borden, Golub & Kleinberg,1977) and 
experimental gingivitis studies (Loe & Holm-Pedersen, 1965? 
Egelberg and Attstrom, 1973) have been conducted in order 
to assess the correlation between GCF flow and gingival 
inflammation, and a positive relationship has been 
obtained. The same kind of trials have also been conducted 
to establish the relationship between Periotron units and 
gingival inflammation (Suppipat, Johansen & Gjermo, 1977; 
Garnick, Pearson & Harrell, 1979) from which positive 
associations with clinical signs of gingival inflammation 
were reported. The Periotron was initially introduced, for 
chairside use, for exactly this purpose. The manufacturer 
assigned different degrees of disease severity (from health 
or mild gingivitis to periodontitis) to increasing 
Periotron units which could be called the GCF flow index. 
In conclusion, it is the type and purpose of study which 
determines the type of indices to be used (Ainamo & Bay, 
1975; Ciancio, 1986? Fischman, 1986).
1.5.4 Assessment of probing pocket depth and 
attachment level
Over the years periodontal probing has been and continues 
to be one of the more useful diagnostic tools to determine 
the presence and severity of periodontal disease; it also 
serves to evaluate the outcome of periodontal therapy; and 
more recently, is being used to record the disease 
activity/progression via changes occurring in attachment 
level (Armitage, Svanberg and Loe, 1977; Van der Velden, 
1978; Listgarten, 1980; Fowler et al., 1982, Haffajee et 
al., 1983a). These measurements are based on the 
identification of the most apical extent of the periodontal 
pocket, which is measured either from the gingival margin 
(pocket depth) or a fixed reference point, usually the 
cementoenamel junction (attachment level). There are 
several problems associated with pocket depth/attachment 
level measurement which could give cause to erroneous 
results. These problems include: a) variations in probing 
force; b) variations in the diameter of the probe tip; c) 
errors in the graduation of the probes; d) errors in probe 
placement; e) errors in reading the probe and data 
recording and f) errors in the precision of measurement 
(Jeffcoat et al., 1986). Additional to these physical 
factors influencing the measurement, biological variations 
such as transient fluctuation in gingival margin location 
over time, could further complicate the pocket depth 
measurement. The location of cementoenamel junction, when
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used as a fixed point in the measurement of attachment 
level, may introduce another source of error (Badersten, 
Nilveus & Egelberg, 1984; Clark et al., 1987). It has been 
reported (Van der Velden, 1979) that variations of the 
probing force as well as variations in the probe's tip 
diameter will influence the penetration of the probe 
through the junctional epithelium and gingival tissues. By 
using higher forces deeper probing depth recordings were 
obtained and a plateau was reached at a probing force of 
1.25 N, using a probe with a tip diameter of 0.63mm. 
Freed, Gapper and Kalkwarf (1983) have also reported that 
probing force applied by different operators could vary 
from 5g to 135g. They also found that, as a mean, probing 
forces applied in the posterior areas were significantly 
higher than probing force used in anterior segments. Van 
der Velden (1978) pointed out that variation in the 
graduation of the probe may also be a source of error. It 
has been shown (Armitage et al., 1977; Caton, Greenstein & 
Poison, 1981) that deeper probe penetration was obtained in 
areas demonstrating signs of increased inflammation, 
indicating that probe penetration could be influenced by 
the degree of inflammation of the area. In the measurement 
of attachment level at single rooted teeth, using a 
conventional periodontal probe and an occlusal stent, inter 
and intra examiner agreement was within 1mm at 
approximately 90% of the duplicate measurements, while it 
was found to be the case in 73% to 84% of duplicate 
measurements when cementoenamel junction served as a
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!reference point (Badersten et al., 1984). Clark et al. 
(1987) reported that the cementoenamel junction was found 
to be masked by its subgingival location or the presence of 
the calculus in 17% of the sites. In an attempt to control 
probing force, pressure control probes were introduced (Van 
der Velden & de Vries, 1978; Poison et al., 1980), and in 
order to reduce errors originating from location and 
relocation of the probe as well as identification of the 
cementoenamel junction occlusal stents have been used 
(Isidor, Karring & Attstrom, 1984; Badersten et al., 1984; 
Clark et al., 1987). In recent years, by advancing 
technology in construction of pressure sensitive probes 
some other aspects of the methodological problems 
associated with measurement of probing depth and attachment 
level have been addressed. A new pressure sensitive probe 
which automatically detects the cementoenamel junction was 
introduced by Jeffcoat et al. (1986). An electronic 
pressure sensitive probe, the Florida Probe, which measures 
pocket depth and attachment level to the nearest 0.2mm was 
developed by Gibbs et al. (1988). The Florida Probe is 
equipped with different handpieces which allow pocket depth 
measurement as well as the measurement of the attachment 
level both from custom-made stent and the occlusal surface 
(Magnusson et al., 1988; Osborn et al., 1990). Another 
electronic pressure sensitive probe, first described by 
Birek, McGulloch and Hardly (1987) and was later modified 
by Karim, Birek and Mcgulloch (1990), the Toronto Probe, 
measures attachment level to the nearest 0.1mm under
33
controlled angulation.
However, the attention has recently been given to the 
pressure sensitive probes over their relatively lack of 
tactile sensation when facing subgingival deposits during 
the probing procedure (Griffiths et al., 1988). Mullally 
and Linden (1994) reported a significant bias towards 
shallower pocket depths with electronic pressure sensitive 
probe compared to hand probing.
1.5.4.1 Detection of attachment level change
The response to the treatment is conventionally evaluated 
by change in pocket depth and the state of bleeding on 
probing. The change in pocket depth reflects attachment 
gain, shrinkage in inflamed marginal gingiva as well as 
recession resulting from instrumentation. In order to 
assess the response to treatment at a specific site, 
particularly in a study setting, longitudinal measurements 
of attachment level taken before and after treatment, would 
therefore provide a more accurate measure. The variable of 
interest is then the change in attachment level which has 
occurred between two time points. It is of great 
importance, therefore, to employ methods that allow 
clinician/ researcher to define the change in attachment 
level that safely exceeds measurement error and could 
provide a threshold for disease activity. Several studies 
have been carried out, in an attempt to define measurement
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error when using a conventional periodontal probe to 
measure probing attachment level with or without an 
occlusal stent (Haffajee et al., 1983b; Badersten et al., 
1984; Isdor et al., 1984; Clark et al., 1987; Best et al.,
1990). In order to reduce the number of false positively 
detected sites as loosing attachment, Haffajee et al. 
(1983b) suggested a criterion of 3 standard deviations of 
the differences of replicate measurements. This figure in 
their study was 2.46mm (SD:0.82mm), which was further 
rounded up to 3mm. The 3mm threshold was subsequently 
applied in several studies. Fleiss et al. (1991) pointed 
out the variances for replicate measurements differed from 
patient to patient and even from site to site and, 
therefore criticised the application of a threshold derived 
from one population to another. Using pressure sensitive 
probes with high resolution provides a more accurate and 
reproducible assessment of probing attachment level than 
manual conventional probing (Jeffcoat & Reddy, 1991b; 
Mullally & Linden, 1994). This would reduce variability 
between replicate or sequential measurements resulting in 
smaller threshold for attachment level changes to be 
declared. Three more sophisticated methods for detecting 
significant attachment level changes namely: regression, 
the running medians and the tolerance method have been 
described by Haffajee et al. (1983b). In the regression 
method the slope and y intercept of a regression line are 
computed from a linear least squares fit of attachment 
level measurements as a function of time and the slope is
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tested for a significant departure from 0. A threshold of 
projected attachment level change per unit time has also to 
be exceeded. In the running medians method attachment 
level measurements are plotted against time and systematic 
variations can be differentiated from minor changes by 
considering the medians of three successive data points and 
setting an arbitrary threshold based on the variability of 
replicate measurements. Finally, the tolerance method is 
based on standard deviations of replicates, usually 2, 
measurements at each time point. For a pair of attachment 
level measurements to be considered different from the 
preceding pair, attachment level change has to exceed three 
different thresholds which are derived from population, 
subject and site standard deviations of replicate 
measurements. Badersten et al. (1987) used the regression 
analysis for the identification of attachment level change. 
She also developed an end point analysis method, in order 
to compensate for the insensitivity of the former to detect 
abrupt changes at the early/late phases of the study. In 
the end-point analysis method, the deeper of the pair of 
the initial measurements is compared against the shallower 
of the final pair of the measurements. When the change
exceeds a specified threshold, attachment level change is 
declared. Another method has been developed on the 
cumulative sum of successive measurements (cumsum)(Aeppli 
& Pihlstrom, 1989; Jeffcoat & Reddy, 1991a). In this 
method differences from baseline are computed for each 
observation, which are subsequently added to obtain a
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sequence of sums which increase or decrease with the number 
of positive and negative changes. If the rate of change 
exceeds a predetermined critical value, a significant 
change in attachment is declared.
The regression and the tolerance methods are the most 
commonly used methods for detecting the attachment changes 
in clinical studies. The regression method is most 
suitable for assessing gradual linear changes in attachment 
over a long period of time. The tolerance method requires 
measurements at as few as two points in time, therefore is 
more suitable for detecting abrupt differences in 
attachment level in short periods in time and has the 
advantage of considering patient and population variances 
in addition to site variance (Haffajee et al., 1983b; 
Aeppli & Pihlstrom, 1989) as it has been reported by Fleiss 
et al. (1991) that variances for replicate measurements 
differs from patient to patient and even from site to site.
1.5.4.2 Identification of active and inactive sites 
based on change in attachment levels
Detection of periodontally active sites/patient by the use 
of clinical indices, introduced in previous sections, which 
are conventionally performed in almost all of the 
periodontal clinics, seems to be of little value. Gingival 
and bleeding indices as well as GCF flow represent measures
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of transient inflammatory status of the superficial 
structures of the periodontium, whereas plaque and calculus 
indices reflect the oral hygiene status of the sites/ 
patients and can also provide a measure for the assessment 
of patient cooperation and motivation. Recording pocket 
depth alone does not take into account the presence of 
gingival enlargement or recession, while attachment level 
measurement, by using a fixed landmark on the tooth 
(cementoenamel junction), overcomes this problem. But, at 
best, probing depth and attachment level measurements, at 
any given time, could provide a history of past disease 
experience in a site/patient rather than disease activity 
(Griffiths et al., 1988).
1.5.4.3 The use of clinical parameters in prediction of
disease behaviour and response to treatment: 
Evaluation by change in attachment levels
Distinguishing between disease-active and disease-inactive 
sites is a central problem to periodontal treatment planing 
as well as evaluating the efficacy of the therapy. At 
present, the presence of the active sites is determined by 
longitudinal observations of attachment level or alveolar 
bone status. Several attempts have been made to correlate 
clinical parameters, traditionally used in clinical 
diagnosis of periodontitis, with periodontal disease 
activity as assessed by longitudinal probing attachment 
level measurements (Greenstein & Caton, 1990). Several
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studies have shown poor correlations between plaque 
accumulation and destructive periodontal disease in 
untreated as well as patients on maintenance care, which 
could be attributed to the transient nature of this 
parameter (Haffajee et al., 1983a; Badersten et al., 1985; 
Jenkins et al., 1988; Lindhe et al., 1989; Badersten et 
al., 1990; Kaldahl et al., 1990). In one of the earliest 
reports on the ability of clinical parameters in predicting 
periodontal disease activity, Haffajee et al. (1983a) 
reported a specificity of 0.71 and a sensitivity of 0.42 
for presence of plaque, just prior to the monitoring 
session, at specific sites which had lost attachment. 
Badersten et al. (1985) in a two year monitoring of 
periodontally treated patients at three monthly intervals, 
demonstrated that dental plaque, when present in all nine 
occasions , has a predictability of 25% for attachment loss 
at a threshold of ^1.5mm. When dental plaque was present 
in 8 and 6 examination times, its predictability for 
attachment loss dropped to 12% and 4% respectively. 
Jenkins and coworkers (1988) attempted to investigate the 
use of clinical and microbiological parameters as 
predictors of periodontal destruction and pointed out that 
presence of dental plaque cannot predict attachment loss. 
Badersten et al. (1990) pointed out that, during a 6 year 
monitoring period, only 30% of the sites which exhibited 
plaque in ^75% of occasions they were examined actually 
demonstrated attachment loss. In another attempt, during 
a one year study on untreated patients, Haffajee et al.
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(1991) reported positive associations between percentage of 
sites with visible plaque accumulation and the number of 
subjects exhibiting attachment loss over 3mm. Thus, the 
higher the percentage of sites harbouring plaque within a 
subject the more likely the subsequent attachment loss. 
The authors however suggested that the association observed 
between plaque and further attachment loss could have been 
due to the strong association of plaque and attachment 
level at baseline which in turn was strongly related to 
subsequent attachment loss. Bleeding on probing has long 
been considered as an important part of diagnostic 
procedure in periodontal practice. Some studies have 
evaluated the possible correlation between bleeding upon 
probing and gingival inflammation with active tissue 
destruction in periodontal disease. Badersten et al. 
(1985), monitoring periodontally treated patients for a 24 
months period, reported 17% predictability for bleeding on 
probing in all the three monthly intervals to be associated 
with attachment loss as defined by 2:1.5mm change in 
attachment level. Lang et al. (1986) and Badersten et al. 
(1990) reported a diagnostic predictability for accumulated 
bleeding scores of 30% and 23% respectively. Jenkins et 
al. (1988) from their one year study of untreated 
periodontal patients reported that gingival inflammation 
cannot be used as a predictor of further attachment loss. 
Lang et al. (1990) suggested that absence of bleeding on 
probing is a good indicator for the maintenance of 
periodontal health while, its presence could not be used as
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an effective indicator/predictor of periodontal 
destruction. When the study (Joss, Adler & Lang, 1994) 
continued for another 2 years, the authors concluded that 
patients with higher prevalences of bleeding on probing are 
at higher risk of experiencing further attachment loss. 
However it has also been demonstrated that there is a 
positive association between percentage of sites within a 
patient that demonstrate bleeding on probing at baseline, 
and risk of further attachment loss (Haffajee et al., 
1991). As it was described for plaque scores, the authors, 
however, suggested that association of bleeding on probing 
with subjects' baseline attachment level may, in large 
part, explain its association with subsequent attachment 
loss. It was revealed, in the same study (Haffajee et al.,
1991), that there was no significant difference in 
additional attachment loss between groups of patients with 
different percentages of sites exhibiting overt gingivitis 
at baseline.
Suppuration has also shown to be a rather poor predictor of 
periodontal disease activity. Its predictive value ranged 
from 17% to 30% for single and accumulated suppuration 
observations respectively (Haffajee et al., 1983a; 
Badersten et al., 1985; Haffajee et al., 1991).
Deeper probing depths at specific sites cannot necessarily 
diagnose/predict ongoing periodontal disease activity 
(Haffajee et al., 1983a; Jenkins et al., 1988). Residual
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probing depths ^7mm showed 20%, 27%, 40% and 52% diagnostic 
predictability respectively in a 1, 2, 4 and 5 year
longitudinal study of periodontitis patients on maintenance 
care (Badersten et al., 1985; Badersten et al., 1990). 
These results indicate that long monitoring periods may be 
required to improve the diagnostic value of clinical 
parameters at specific sites. Increasing individual mean 
levels of pocket depth or attachment level above certain 
thresholds as well as increasing percentages of sites 
within a patient demonstrating probing depth or attachment 
level measurement >3mm were, however, risk indicators for 
further attachment loss suggesting that previous 
periodontal destruction predisposes the site/patient to 
future periodontal breakdown (Haffajee et al., 1991).
The predictive value of a multitude of subjective clinical 
observations, employed by experienced clinicians, for 
predicting the response to treatment was evaluated by 
Vanooteghem et al. (1990). Three independent clinicians 
examined patients with adult periodontitis, prior to the 
commencement of treatment, and identified sites that in 
their opinion would continue to lose attachment after 
initial nonsurgical therapy. The patients were monitored 
for a period ranging between 24 and 36 months. The results 
demonstrated a limited agreement between probing attachment 
loss determined by linear regression and the clinicians' 
prediction of attachment loss.
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Although , in the above studies, different methods have been 
employed in order to detect attachment level changes, their 
results showed that clinical assessment of the 
periodontium, particularly in one single visit, cannot 
predict disease behaviour and response to the treatment, or 
diagnose active periodontal destruction. However, this is 
not surprising as the parameters involved in the assessment 
of the periodontal disease are static measurements of a 
dynamic process. This information could quite rightly 
confuse the clinician who had long learnt to rely on 
clinical diagnostic criteria in prognosis of periodontal 
disease. Pathogenesis of periodontal disease has received 
great attention; and numerous studies aiming to elucidate 
possible mechanisms of periodontal destruction have been 
conducted in recent years. These efforts could perhaps 
lead to the development of laboratory based diagnostic 
tests which are hopped to provide more sensitive 
diagnostic/prognostic tools to supplement, currently used, 
clinical parameters.
1.6 Aetiology and pathogenesis of periodontal
disease
Destructive periodontal disease, as evidenced by bone loss, 
has afflicted mankind since the beginning of history. In 
the early writings, the relationship of calculus to 
periodontal disease has been considered, a notion 
dominating the history of dentistry until the present
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century. John W. Riggs (1811-1885) believed when tooth is 
covered by hard deposits (calculus) it will be considered 
as a foreign body and an inflammatory reaction is followed. 
John Hunter (1728-1793), offered a clear illustrations of 
the anatomy of the teeth and their supporting structures 
(periodontium). Before the concept of periodontium (the 
relationship between soft and hard supporting tissues of 
the teeth) was evolved, periodontal disease was believed to 
affect either the gums or the alveolar bone, but not both 
structures. Since then the understanding of periodontal 
disease has greatly developed. Much of this progress has 
been achieved during the past three decades. New findings 
answer some questions and bring up other questions in the 
investigators' mind, which lead them to undertake more 
sophisticated studies and explore in the new fields. In 
this way the knowledge of periodontology makes its way 
toward further refinement and deeper understanding of the 
field, although still many questions concerning the 
aetiology, pathogenesis and progression of periodontal 
disease remain to be answered.
Chronic inflammation is the backbone of periodontal disease 
and it is well established that accumulation of dental 
plaque (bacteria) is the aetiological agent responsible for 
initiation and maintenance of the inflammatory process 
(Loe, Theilade & Jensen, 1965; Theilade et al., 1966;
Zachrisson, 1968; Hellden & Lindhe, 1973; Axelsson & Lindhe 
1978). The clinical trials by Loe et al, (1965) and
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Theilade et al. (1966), entitled "Experimental gingivitis 
in man" clearly demonstrated that there is a causal 
relationship between dental plaque formation and 
development of inflammation in the gingival tissues. In 
these studies, after an initial baseline examination 
subjects were instructed to refrain from all oral hygiene 
measures for 21 days. All the subjects participated in 
these studies developed gingivitis in the course of no 
brushing ranging from 9 to 21 days. When oral hygiene 
procedures were reinstituted gingival inflammation 
resolved, in all subjects, within a period varying from 
seven to eleven days. The histological changes in gingival 
tissues during experimental gingivitis have also been 
studied by Zachrisson (1968). After 15-17 days of 
withdrawal of oral hygiene , when clinical gingivitis 
developed, histological examination revealed inflammatory 
infiltrates confined to the connective tissue adjacent to 
the pocket epithelium. The predominating cells in the 
infiltrate were medium-large and small lymphocytes, 
macrophages and fibroblasts. The experimental design of 
these studies could, however, be criticised, as subjects 
stopped oral hygiene procedures for different time periods 
and therefore no statistical analysis of the data could be 
performed. In addition, some of participants in the Loe et 
al. (1965) and Zachrisson (1968) studies exhibited an 
initial degree of gingival inflammation and therefore 
baseline gingival conditions were not standardised. This 
point was, however, taken into consideration by Theilade
45
et al. (1966). These investigators were the first to
unequivocally show that plaque accumulation causes gingival 
inf lamination.
In order to have a better understanding of histopathologic 
changes during the development of gingival and periodontal 
inflammation, Page and Schroeder (1976) have described the 
progression of gingival and periodontal lesion into four 
phases namely: initial, early, established and advanced. 
The initial and early lesions represent rather 'acute' 
stages of gingivitis whereas the established lesion depicts 
more 'chronic' gingivitis. The advanced lesion describes 
the progression of gingivitis into periodontitis.
The initial lesion is localised around the gingival sulcus 
and usually develops after 2-4 days of plaque accumulation, 
but the vascular changes beneath the junctional epithelium 
can be seen within 24 hours of plaque accumulation. The 
increased vascular permeability leads to the migration of 
polymorphonuclear leucocytes (PMN) from the vessels into 
the connective tissue and eventually into the gingival 
crevice. Destruction of perivascular collagen is seen at 
this stage.
The early lesion develops within 4-7 days of plaque 
accumulation. At this stage, the vessels of the coronal 
portion of the dentogingival plexus remain dilated while 
the number of functioning vessels increase. With
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additional plaque accumulation there is more pronounced 
infiltration of PMNs and monocytes/ macrophages within the 
dentogingival epithelium as well as loss of perivascular 
collagen. Some fibroblasts within the inflammatory cell 
infiltrate exhibit signs of degeneration and a slight 
lateral proliferation of the junctional epithelium at its 
coronal portion is evident at this stage.
For the established lesion, according to this model, to 
occur two to three weeks of plaque accumulation are 
required. Large numbers of mature plasma cells are seen at 
this stage of inflammatory process. The shift to plasma 
cell dominated lesion is the pathognomonic feature of the 
established lesion. As gingivitis develops severe 
degeneration of gingival fibroblasts is maintained, 
collagen continues to be lost in the perivascular areas, 
vascular permeability and exudation increase and 
proliferation of the junctional epithelium, now referred to 
as pocket epithelium, continues with rete pegs extending 
into the connective tissue infiltrate. The pocket 
epithelium is not attached to the tooth surface. At 
approximately one month of plaque accumulation, the 
cellular as well as permeability response appear to 
plateau. It seems that a balance has been achieved which 
may last for extended periods of time without the 
established lesion progressing into the advanced lesion. 
The last stage of the inflammatory process is known as the 
advanced lesion. As plaque continues its apical downgrowth
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along the crown and cementum of the root surface there is 
a deepening of the periodontal pocket which is accompanied 
by the proliferation of junctional epithelium over the 
detached root surface. The characteristic features of 
advanced stage are the loss of connective tissue attachment 
(Sharpey's fibres) as well as alveolar bone loss. 
Ulceration of the pocket epithelium may also be present and 
osteoclasts can be found in the areas of bone resorption. 
The advanced lesion is synonymous with periodontitis.
Although this model has mainly evolved through early animal 
studies (Garant & Mulvihil, 1972; Attstrom, Graf-de Beerand 
& Schroeder, 1975; Schroeder & Lindhe, 1975), it has 
provided a temporal framework for both clinicians and 
scientists and is helpful for descriptive purposes. Since 
the above model was first introduced it has dominated 
descriptions of gingival and periodontal pathology. It 
should always be remembered that there is no clear cut 
division in different phases of inflammatory process, when 
it is considered in vivo, and all the above changes could 
occur simultaneously, with the more chronic features being 
superimposed on the more acute. Moreover, it has been 
reported that a much longer period than two or three weeks 
is required for a plasma cell dominated lesion to appear 
(Brecx et al., 1988). These authors conducted a six month 
experimental gingivitis in human in which they observed a 
continuous increase in the plasma cell fraction of the 
inflammatory infiltrate with time; but, even after 4-6
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months of no oral hygiene, the gingival lesions were not 
dominated by plasma cells. Thus, the investigators
concluded that a period of neglected oral hygiene of more 
than 6 months may be required to lead to a plasma cell 
dominated lesion. In their study, PMNs and lymphocytes 
were the dominant cells in the connective tissue infiltrate 
even 6 months after oral hygiene measures were abolished. 
Furthermore, there are always some PMNs and lymphoid cells 
in gingival connective tissue infiltrate even after 
extended periods of supervised oral hygiene leading to 
clinically healthy gingivae (Brecx et al., 1987) suggesting 
that this may be necessary for the maintenance of gingival 
health. However, the percentage of PMNs in the gingival 
connective tissue, in their study, was higher than what was 
reported by Page and Schroeder (1976) in clinically healthy 
conditions. Thus, the author did not rule out the 
possibility that this may be due to continuous mechanical 
injury caused by meticulous oral hygiene practices.
1.7 Pathogenesis of periodontal disease
Microorganisms that colonize the cementum/enamel or 
epithelial walls of sulcus/pocket could cause injury to the 
periodontal tissues in both direct and indirect ways.
1.7.1 Direct injury
In a classical infection, damage to the host is initiated
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by microorganisms adhering and invading the involved 
tissues. This phenomenon has been shown in cases of acute 
ulcerative gingivitis where the presence of spirochetes has 
been documented in the dentogingival epithelium 
(Listgarten, 1965). The bacterial invasion of gingival 
tissues in some cases of advanced periodontitis has been 
reported (Frank, 1980; Saglie et al., 1982). It has 
recently been shown that Porphyromonas gingivalis is able 
to invade epithelial cell layers and multiply 
intercellularly in an in vitro system (Papapanou et al., 
1994). However, the presence of bacteria within the 
gingival tissues has been challenged by other investigators 
(Liakoni, Barber & Newman, 1987; Newman 1990), as whether 
this indicates active invasion of the tissues by the 
microorganisms or represent, their passive translocation 
during the late stages of disease. Further studies are 
needed to resolve this controversial issue. Even if true 
invasion of gingival tissues by microorganisms does not 
occur, they may still cause tissue damages in two different 
ways (Birkedal-Hansen, 1993); a) periodontal pathogens 
elaborate proteolytic enzymes capable of degrading stromal 
structures (Robertson et al., 1982; Birkedal-Hansen et al., 
1988); b) microorganisms produce a variety of substances 
which may directly trigger resident and immigrant cells for 
the release or secretion of degenerative enzymes. Such 
substances include the leucotoxin produced by 
Actinobacillus actinomycetemcomitans which can cause 
release of collagenase from PMNs (Baehni et al., 1979).
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Proteinases of Porphyromonas gingivalis can cause tissue 
destruction by inducing expression of matrix 
metalloproteinases (MMPs) by mucosal keratinocytes and 
fibroblasts (Birkedal-Hansen et al., 1984).
1.7.2 Indirect injury
Antigenic, chemotactic and toxic factors, derived from 
dental plaque, indirectly damage the periodontal tissues. 
It has been reported that bacterial endotoxin can penetrate 
into the gingival tissues in dogs through intact crevicular 
epithelium (Schwartz, Stinson & Parker, 1972). Indirect 
injury to the host tissues occurs via provocation of an 
inflammatory response that induces cytokine release from 
host cells, which in turn activate one or more of the 
following degradative pathways (Birkedal-Hansen, 1993).
Plasminogen-dependent pathway- Plasmin (Pin) is a serine 
proteinase that is converted from its inactive circulating 
precursor form, plasminogen (Pig), by specific activating 
enzymes, plasminogen activators. The activating
proteinases are expressed by a wide range of stromal, 
epithelial and endothelial cell types in response to growth 
factors and cytokines. The activated enzyme, plasmin, 
cleaves a range of extracellular matrix substrates, but not 
interstitial collagen fibres (Birkedal-Hansen et al., 
1993).
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PMN-serine proteinase pathway- PMN leucocytes, when are 
triggered, may mediate the degradation of extracellular 
matrix macromolecules by releasing two serine proteinases, 
neutrophil elastase and cathepsin G. These enzymes have 
some level of activity against several extracellular matrix 
proteins but do not cleave interstitial collagens 
(Birkedal-Hansen et al., 1993).
Phagocytic pathway- Fibroblasts, macrophages and 
epithelial cells, under certain circumstances, possess the 
capability of phagocytosing fragments of collagen fibrils 
which are subsequently degraded in their phagosomes. This 
process is performed by thiol proteinases. However, it is 
difficult to reconcile the intracellular and extracellular 
pathways. One possibility is that the fragments of fibrils 
may be excised by a collagenase-dependent reaction and are 
subsequently internalised by the cells for digestion in 
phagosomes (Birkedal-Hansen et al., 1993).
Osteoclastic hone resorption- The enzymatic mechanisms of 
organic matrix removal from bones and teeth is not 
completely understood. However, according to a proposed 
hypothesis, osteoblasts initiate the resorptive process by 
dissolution of the layer of osteoid using a collagenase- 
dependent proteolytic process which leads to the exposure 
of the of the underlying mineralized bone surface. The 
vacating osteoblasts or the dissolving bone surface release 
some signals which, perhaps, attract osteoclast precursors
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to the denuded mineral surface, where they differentiate to 
osteoclasts. It is thought that osteoclasts release acidic 
thiol-proteinases into the sealed microenvironment between 
the undulating osteoclast plasma membrane and the bone 
surface which are capable of degrading the collagenous 
matrix at low pH (Birkedal-Hansen et al., 1993).
M a t r i x  m e t a l l o p r o t e  inases p a t h w a y - Matrix 
metalloproteinases (MMPs) are a family of 9 or more metal- 
dependent homologous enzymes which are able to degrade 
almost all extracellular matrix macromolecules. MMPs are 
involved in the extracellular matrix destruction and 
remodelling in both physiological and pathological 
conditions. These proteinases are released/produced by 
immigrant/resident host cells (Birkedal-Hansen et al., 
1993; Birkedal-Hansen, 1993). The role of MMPs in the 
pathogenesis of periodontal disease, their structure, 
cellular sources, regulation and ways of activation will be 
explained in section 1.7.6.1.
ripart from the above pathways, depression of the host 
immune response during the initial stages of exposure to 
dental plaque has been suggested to lead to periodontal 
destruction (Shenker, 1987). Autoimmunity to collagen 
components has also been suggested to contribute to the 
pathogenesis of periodontal disease (Hirsch, 1988). 
Anusaksathien and Dolby (1991) have suggested that 
autoantibodies detected in periodontal disease are derived
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from natural antibodies and their role is the elimination 
of dead cells and damaged tissue constituents which appear 
in the disease process. However, they did not rule out the 
possibility that this procedure which deals with the 
consequences of tissue damage, may in certain circumstances 
become excessive and contribute to the progress of disease.
1.7.3 The role of inflammatory mediators in the 
pathogenesis of periodontal disease (indirect 
injury by bacteria)
As has been discussed in the previous section, bacteria 
induce periodontal tissue destruction indirectly by 
activating host defense cells. The activated cells 
including infiltrated leucocytes and plasma cells, resident 
fibroblasts and other connective tissue cells, in turn 
produce or release mediators that stimulate the effectors 
of connective tissue breakdown. Interleukin 1 (IL-1) and 
tumour-necrosis factor a (TNF-a) have an important role in 
this process (Birkedal-Hansen et al., 1993). Two distinct 
forms of IL-1 exist designated as IL-la and IL-1J3. This 
cytokine is produced predominantly by macrophages, 
lymphocytes and PMNs following activation by 
lipopolysaccharide (LPS); it can also be released from 
fibroblasts, keratinocytes and endothelial cells. IL-1 has 
a variety of activities including: a) inducing formation of 
new osteoclasts and causing bone resorption by activating 
osteoclasts; b) inducing fibroblasts and macrophages for
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production of MMPs and urokinase type plasminogen 
activator; c) induction of prostaglandin E2 (PGE2) synthesis 
by macrophages and fibroblasts? and d) attraction of the 
inflammatory cells into the sites of inflammation (reviewed 
by Page, 1991). IL-la and IL-1B has been detected in GCF 
from patients with periodontitis (Masada et al., 1990). 
Moreover, IL-1 activity in GCF, measured by a bioassay in 
an experimental gingivitis study, peaked prior to the 
development of clinically detectable inflammation (Kinane 
et al., 1992). The levels of IL-la and IL-1J3 were found 
to be significantly higher in periodontitis sites than in 
clinically healthy sites (Stashenko, et al., 1991). 
Comparing GCF levels of IL-1J3 from healthy, gingivitis and 
periodontitis sites within and between different groups of 
subjects, it has been shown that the level of IL-lil was 
significantly higher in diseased sites than healthy sites. 
However, there was no significant difference between GCF 
levels of IL-1J3 from gingivitis and periodontitis sites 
(Ebersole et al., 1993). TNF-a is produced by macrophages 
activated by LPS. Although not as potent as IL-1, TNF-a 
shares its properties. Stashenko et al. (1991) reported 
that periodontally affected sites demonstrated higher 
levels of TNF-a compared to healthy sites. Prostaglandins, 
the metabolites of arachidonic acid, are also implicated in 
the inflammatory process. The concentration of PGE2 in GCF 
above certain thresholds may be used as an indicator of 
increased patient susceptibility to future periodontal 
breakdown (Offenbacher et al., 1986). It has also been
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shown that topical application of PGE2 to the gingival 
sulcus in rats resulted in increased bone resorption by- 
activation and increase of osteoclasts (Miyauchi et al,,
1992). It has recently been reported that PGE2 levels were 
significantly higher in GCF samples from gingivitis and 
periodontitis sites than those from healthy sites (Ebersole 
et al,, 1993). The role of these mediators in regulation 
of MMPs and TIMP will be discussed in sections 1.7.6.4 and
1.7.7.4 respectively.
However, the exact mechanisms leading to periodontal 
destruction, are interwoven, extremely complex and in a 
constant state of reevaluation.
1.7.4 The role of polymorphonuclear leucocytes in the 
pathogenesis of periodontal disease
The polymorphonuclear leucocyte (PMN) is a short lived 
white blood cell with a lobulated nucleus and numerous 
granules within its cytoplasm. PMN granules mainly contain 
microbicidal enzymes, lactoferrin, collagenase, gelatinase, 
neutral proteases and lysozyme (Bainton, Ullyot & Farquhar, 
1971) .
The PMNs are the predominant leucocytes within the gingival 
crevice in both healthy and diseased sites which are 
attracted, from circulation, to the area via chemotactic 
stimuli elicited from dental plaque (Hellden & Lindhe,
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1973). They can also be seen traversing the inflamed 
gingival connective tissue (Seymour et al., 1983; Brecx et 
al,, 1988; Moughal et al,, 1992). In an experiment on dogs, 
Attstrom & Egelberg (1970) have shown that carbon labelled 
peripheral blood neutrophils from the circulation migrate 
into the gingival crevice and their migration rate appears 
to be higher in inflamed crevices. Using experimental 
gingivitis model, it has been reported that the PMN numbers 
increase in the gingival crevice with the development of 
experimental gingivitis (Kowashi, Jaccard & Cimasoni,1980; 
Thurre et al,, 1984). The number of PMNs was found to be 
significantly higher in periodontitis sites than in control 
sites (healthy and gingivitis), although their viability 
and phagocytosis ability were lower in the periodontitis 
sites (Thurre et al,, 1984). Adhesion molecules on 
leucocytes are essential in their migration from the 
vessels into the gingival tissue, and through the 
junctional epithelium into the gingival crevice. Moughal 
et al. (1992), in an experimental gingivitis study, showed 
that the connective tissue vessels express ELAM-1 and ICAM- 
1 in clinically healthy as well as in inflamed gingivae and 
PMNs were found in greater concentration in areas 
expressing intense ELAM-1 and ICAM-1 staining. 
Furthermore, junctional epithelium and its adjacent 
connective tissue as well as sulcular epithelium stained 
strongly positive for ICAM-1, suggesting the importance of 
this adhesion molecule in PMN migration into the gingival 
crevice.
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PMNs play an important role in host defence and form the 
first line of defence in the gingival sulcus against 
periodontal bacteria. These are evidenced by the 
observations that quantitative (neutropenia) and 
qualitative (chemotactic or phagocytic) PMN deficiencies 
result in severe periodontal destruction (Wilton et al., 
1988; Kinane & Davies, 1990). There are also evidences 
suggesting that PMNs may damage periodontal tissues by 
releasing their lysosomal contents into the extracellular 
environment. Several factors, including bacterial toxins, 
regurgitation during feeding and phagocytosis, attachment 
to surface-bound immune complexes, adherence to the 
surfaces during in vivo and in vitro migration and cell 
death and subsequent lysis, could stimulate PMN leading to 
its degranulation (Wilton, 1986). PMNs, therefore, release 
the contents of their granules as they emigrate towards the 
gingival crevice as well as during phagocytosis or 
encounter of antigen antibody complexes and bacterial 
toxins. Henson (1971a), in an in vitro study, reported 
that neutrophils when adhered to antigen-antibody complexes 
or phagocytosed particles coated with antibody or 
complement released their granular contents. In a 
successive report, Henson (1971b) has described the 
mechanisms by which the release of PMN granular constituent 
occurred. The author has stated that neutrophils adherent 
to immune complexes released their enzymes by direct 
extrusion, whereas in the case of PMNs phagocytosing 
particles, degranulation was into the phagocytic vacuole
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which was subsequently opened to the outside of the cells. 
It has been shown that PMNs interact with oral bacteria and 
release their lysosomal contents into the extracellular 
milieu (Taichman et al., 1977; Tsai et al., 1978). It has 
been reported that PMNs incubated with serum have increased 
the lysosomal release indicating that bacterial 
opsonization by complement components and immunoglobulins 
could enhance the process (Baehni et al., 1977; Taichman et 
al., 1977; Baehni et al., 1978). It appears, therefore, 
that although PMNs play a protective role in the gingival 
crevice, the interplay between microbial plaque components, 
complement components, immune complexes and PMNs, initiates 
the release of PMN granular contents which could cause 
damage to the periodontal tissues (Ishikawa et al., 1982; 
Wilton, 1986; Deguchi et al., 1990; Altman et al., 1992). 
Thus, the PMN appears to have both a protective and 
potentially destructive role in the pathogenesis of 
periodontal disease and should be viewed as a double edged 
sword. Two models have been suggested to explain this 
rather contradictory issue.
The first model, in chronological order, proposed by Page 
and Schroeder (1982) involves gingival connective tissue 
PMNs. In this model two compartments have been suggested 
for PMN function, namely the gingival connective tissue and 
the crevice/pocket. Under normal conditions, a constant 
stream of PMNs leaving the gingival blood vessels is guided 
across the connective tissue and junctional epithelium into
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the gingival crevice by a gradient of chemotactic agents 
produced by most of the bacteria present in dental plaque. 
In a clinically healthy situation, the transforming 
neutrophils leave no trace of their passage and cause no 
tissue damage. These PMNs form the first line of defence 
against dental plaque around the teeth. If the epithelial 
barrier is disrupted, perhaps by the increasing numbers of 
PMNs passing through the junctional and pocket epithelium 
as a result of subgingival plaque extension, then an open 
entrance for bacterial component and metabolites which 
flood the connective tissue is established and the 
chemotactic gradient, driving neutrophils towards the 
gingival crevice/pocket, is disrupted. As a consequence, 
PMNs consequently remain in connective tissue and randomly 
move, where they encounter bacteria and their substances 
which flooded the connective tissue because of the rupture 
of the epithelial barrier. Thus, PMNs become activated 
inside the connective tissue and undertake phagocytosis, 
resulting in release of lysosomal contents which together 
with other activated systems and host cells cause extensive 
tissue damage. Once the epithelial barrier and the 
chemotactic gradient are re-established the destructive 
process subsides and PMNs are again guided towards the 
sulcus/pocket. The second model suggested by Wilton 
(1986), involves crevicular PMN function which can be 
viewed as a two phase system: fluid and surface. In the 
fluid phase, PMNs phagocytose plaque bacteria, while their 
released enzymes can inhibit bacterial attachment and/or
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remove attached bacteria. Enzymes released during this 
process can be neutralised by protease inhibitors present 
in the area. Contrary to the fluid phase, in the surface 
phase PMNs attach to the plague surface or the sulcular and 
junctional epithelium, where they release their enzymes and 
oxygen metabolites. Since, this process takes place in a 
closed environment, inaccessible to protease inhibitors 
(Wright & Silverstein, 1984), could result in damage to the 
epithelium and connective tissue. However, both the above 
models are over simplifications of the processes leading to 
periodontal destruction, but they still provide both the 
clinician and researcher with some valuable information as 
how the PMNs contribute to the pathogenesis of periodontal 
disease.
1.7.5 Proteinases in pathogenesis of periodontal 
disease
Proteinases (endopeptdases) have been extensively 
investigated regarding their possible role in the 
pathogenesis of periodontal disease. These proteinases are 
believed to be effective in periodontal destruction. PMNs 
and monocyte/macrophages are the main source of these 
enzymes, although other host cells such as fibroblasts, 
keratinocytes, epithelial and endothelial cells have some 
contribution.
61
Over the past two decades various studies including cross- 
sectional, experimental gingivitis and longitudinal studies 
before and after periodontal treatment, have been conducted 
in order to assess proteinases activity/amount in GCF. In 
most cases proteinases activity has been assessed by using 
either native proteins or chromogenic and fluorogenic 
substrates, whereas immunoassays have been used for the 
assessment of the amount of the enzymes.
Proteinases of bacterial origin have also been implicated 
in the pathogenesis of periodontal disease. Several 
putative periodontal pathogens including P. gingivalis and 
A. actinomycetemcomitans demonstrate proteolytic activity 
(Robertson et al., 1982 and Birkedal-Hansen et al., 1988). 
However, it has been questioned whether these enzymes could 
penetrate the periodontal tissues and maintain sufficient 
concentrations to destroy periodontal tissues (Kelstrup & 
Theilade, 1974; Birkedal-Hansen et al., 1988). 
Furthermore, it has been shown that the predominant 
collagenase in GCF are of host origin as they cleave the 
collagen molecule into three and one quarter fragments, 
which is characteristic of vertebrate collagenase function 
(Villela et al., 1987; Sorsa et al., 1990).
As mentioned briefly in section 1.7.2, connective tissue 
degradation in destructive periodontal disease is partially 
caused by matrix metalloproteinases, which will be reviewed 
in detail in the following section.
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1.7.6 Proteinases: Matrix metalloproteinases (MMPs)
1.7.6.1 Definition, characteristics and nomenclature
MMPs are members of a family of homologous zinc contained 
proteinases of animal origin which act outside the cell on 
components of the extracellular matrix (Nagase, Barreett & 
Woessner, 1992a).
Woessner (1991) outlined the main characteristics of MMPs 
as follows: a) their catalytic mechanism depends on zinc at 
the active centre; b) the proteinases are secreted/released 
in zymogen form; c) the pro-enzyme can be activated by 
proteinases or by organomercurials; d) their activation is 
accompanied or followed by a loss of Mv of about 10,000; e) 
their cDNA sequences all show similarity to that of 
collagenase; f) the enzymes cleave one or more components 
of the extracellular matrix; g) the enzymes' activity is 
inhibited by tissue inhibitors of metalloproteinases 
(TIMPs).
The term "matrixin" has been suggested to designate this 
family of enzymes. "Collagenase gene family" is another 
term proposed for this group of proteinases. It seems that 
these terms have not been accepted as the majority of 
investigators in the field use the term "matrix 
metalloproteinases" to name the family of enzymes. 
Individual MMPs have been named after their substrates in
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Table 1.1 Matrix metalloproteinase (MMPs)
Enzyme Abbre. MMP# Substrate
Fibroblast
collagenase
FIB-CL MMPl 57 Collagen I, 
11,111, (III»I), 
VII, VIII, X, 
gelatin
M,. 72K 
gelatinase 
type IV 
collagenase
Mr 72K GL MMP2 72 Gelatin, collagen 
IV, V, VII, X, XI 
elastin, 
fibronectin
Stromelysin-1 SL-1 MMP3 60
55
Fibronectin, 
laminin, collagen 
IV, V, IX, X, 
elastin
pro-collagenase
Putative
metallo-
proteinase-1
PUMP-1 MMP7 28 Fibronectin, 
laminin, collagen 
IV, gelatin, 
pro-collagenase
PMN-type
collagenase
PMN—CL MMP8 75 Same as FIB-CL 
(I»III)
Mr 92K 
gelatinase 
type IV 
collagenase
Mr 92K GL MMP9 92 Gelatin, collagen 
IV, V, elastin
Stromelysin-2 SL-2 MMP10 60
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Same as SL-1
Stromelysin-3 SL-3 MMPll ★ ★
*= not determined
Mr= molecular weight (kO)
Modified from Birkedal-Hansen (1993) and Birkedal Hansen 
et al. (1993).
the extracellular matrix, mostly different types of 
collagen. Stromelysin has been named after its origin, the 
stromal cell (Chin, Murphy & Werb, 1985). Some authors 
have suggested that the members of MMPs be designated by a 
sequence of numbers, therefore the enzymes' names would be: 
matrix metalloproteinase 1, which is abbreviated MMP-1 
(Nagase et al., 1992a). However, at present both systems 
are used by workers. Table 1.1 shows the names of the MMPs 
as well as their correspondent numbers.
1.7.6.2 Sources of matrix metalloproteinase
Some MMPs are produces by resident cells such as 
fibroblasts from different sources, keratinocytes, 
endothelial cells, chondrocytes and osteoblasts. These 
enzymes are synthesized on demand by initiating 
transcription of the corresponding genes. This process 
causes a lag period of 6 to 12 hours before enzymes can be 
detected in the extracellular environment, but once that 
starts, production and secretion can be sustained for 
several days. PMNs are the other source of MMPs. The 
enzymes are synthesized during the development of a PMN and 
stored in its specific granules. The proteases are rapidly 
released when the cell is triggered. The PMN responds in 
full force but the destructive activity can not be 
sustained beyond minutes. A prolonged response is 
achieved, when needed, by continuous recruitment of new 
cells (reviewed by Birkedal-Hansen et al., 1993).
64
1.7.6.3 Modular structure of matrix metalloproteinases
All MMP are regarded as derivatives of the five-domain 
modular structure, characteristic of collagenases and 
stromelysins, formed either by addition or deletion of 
domains (Fig. 1.1). Among these domains are the catalytic 
domain that contains the Zn** binding site and a COOH 
terminal domain which plays a role in determining substrate 
specificity (reviewed by Birkedal-Hansen, 1993; and 
Birkedal-Hansen et al., 1993).
1.7.6.4 Regulation of matrix metalloproteinases
The activity of MMPs in the extracellular environment is 
regulated in four different ways namely: a) transcriptional 
regulation of MMP genes; b) precursor activation; c) 
differences in substrate specificity; and d) MMP
inhibitors.
Transcriptional regulation. Cytokines and growth factors 
play an important role in the regulation of most of MMPs at 
transcriptional level. Thus, stimulation or repression of 
the MMP genes by these mediators gives cause to 20 to 50 
fold change in mRNA and protein levels. Interleukin-la and 
13 (ILl-a and 13) and tumour necrosis factor-a (TNF-a) 
increase the enzyme production (Meikle et al., 1989), while 
interferon-y (IFN-y) down-regulates MMPs expression. 
Transforming growth factor-13 (TGF-13) decreases some MMPs'
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Figure 1.1 Domain structure of matrix metalloproteinases 
Modified from Birkeda-Hansen et al. (1993).
production and increases others (Birkedal-Hansen, 1993). 
TGF-131 has been shown to reduce enzymes synthesis 
(Overall, Wrana & Sodek, 1991).
Activation of precursor. MMPs are secreted/released in a 
latent form. The activation process of the precursors in 
the extracellular space, therefore, is another step in the 
regulation of MMPs (Nagase et al., 1992b). The mechanism 
of activation of MMP precursors is reviewed in section
1.7.6.5
Substrate specificity. Despite somewhat overlapping 
substrate specificities, the MMP activity is regulated, to 
some extent, at the substrate level. The ability of FIB-CL 
and PMN-CL in dissolving type I, II and III collagens is 
not shared by other MMPs (Birkedal-Hansen et al., 1993).
Inhibition. The activity of MMPs is regulated by protease 
inhibitors. a2-macroglobulin (a2-M) plays an important
role in the regulation of MMP activity by the rapid capture 
of the enzymes (Birkedal-Hansen, 1993). Tissue inhibitors 
of metalloproteinases (TIMPs) act in the very local area 
around the cell from which metalloproteinases are secreted 
(Cawston, McLaughlin & Hazelmanet, 1987) and thus, regulate 
the activity of MMPs.
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1.7.6.5 Activation of matrix metalloproteinase
As mentioned in section 1.7.6.1. MMPs are synthesized as 
proenzymes and are presumably activated by certain 
physiological agents after secretion into the extracellular 
environment. Organomercurials, trypsin and plasmin have 
been shown to activate pro-MMPs in vitro (Grant et al,, 
1992; Nagase et al,, 1992b). Although MMPs can readily be 
activated in vitro, the biologic activation mechanisms are 
still poorly understood. Since organomercurials and 
trypsin are not present in the tissues, it is likely that 
in vivo activation is caused by plasmin. Plasminogen may 
enter the tissues from the circulation, and the mesenchymal 
cells can produce plasminogen activator (Woessner, 1991). 
Murphy et al, (1992) have reported that the presence of 
both plasminogen and cell layers was necessary for MMP 
activation indicating a plasmin dependent mechanism.
Activation of FIB-CL with incubation by organomercurials or 
serine proteinases (trypsin and plasmin) results in a 
partially active enzyme (Mr 43000) which, when was further 
incubated with SL converted to a fully active enzyme (Mr 
41000). The incubation of FIB-CL with SL alone for a long 
time (96 hours) results in fully active enzyme (Nagase et 
al., 1992b). However, Woesssner (1991) has questioned the 
in vivo validity of these observations. Furthermore, Sorsa 
et al. (1992a) have shown that proteases produced by 
periodontopathogenic bacteria such as P. gingivalis can
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activate latent FIB-CL and to a lesser extent PMN-CL.
1.7.6.6 The role of matrix metalloproteinases in the 
pathogenesis of periodontal disease
Soon after the discovery of collagenase in the involuting 
tadpole tail in the early 60s, which was followed by the 
identification of a similar enzyme in a mammalian tissue 
(Birkedal-Hansen, 1988), a new line of investigation was 
introduced in the periodontal field by the pioneer work of 
Fullmer and co-workers (1966) who reported collagenase 
activity in cultures of human diseased gingival tissues. 
Later, Fullmer et al. (1969a) reported work in gingival 
tissues which indicated that both epithelial cells and 
inflamed gingival connective tissue are capable of 
producing collagenase in tissue culture. Collagenase 
production has been reported to be higher in inflamed 
gingival specimens than those obtained from clinically 
healthy gingivae (Fullmer et al., 1969b). Ohlsson and co­
workers (1973) have reported that collagenase activity was 
found to be 7 times higher in material collected from 
inflamed gingiva compared to those from healthy gingiva. 
The enzyme was of PMN origin. However, in this experiment 
two groups of healthy and inflamed samples were taken from 
two different groups of individuals thus, not allowing the 
host response to be taken into account. Presence of 
collagenase has been demonstrated in homogenates of gingiva 
obtained from periodontitis patients by measuring
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collagenase activity (Uitto, Turto & Saxen, 1978). 
Iiranunolocalization of collagenase demonstrated that 
gingival biopsies taken from patients with periodontal 
disease showed some immunoreactive enzyme, although 
relatively little in most of the samples, whereas gingival 
specimens obtained from treated subjects expressed no 
significant immunoreactive enzyme (Woolley & Davies, 1981). 
Heath et al. (1982) using radio-labelled substrates 
demonstrated that explants of gingival tissue from 
periodontally affected patients were able to synthesize 
three MMPs, collagenase, gelatinase and stromelysin in 
culture. The relationship between collagenase in GCF and 
disease activity has been investigated by evaluating the 
changes in collagenase activity before and after treatment 
in a group of patients with localized juvenile 
periodontitis (LJP)(Larivee, Sodek & Ferrier, 1986). The 
LJP patients received periodontal treatment including 
scaling and root planing, antibiotics (tetracycline for 21 
days) and flap surgery. The enzyme activity for active 
collagenase showed a significant reduction 5 weeks after 
periodontal surgery, whereas the total enzyme activity 
remained high after surgical treatment (5 weeks) and then 
dropped significantly, at the recall visit, 6 months after 
the last surgery. In another attempt, the association 
between GCF collagenolytic activity and disease severity 
has been investigated in four groups of subjects with 
gingivitis, adult periodontitis, localized juvenile 
periodontitis as well as periodontally healthy controls
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(Villela et al., 1987). This study showed that 
collagenolytic activity in GCF increases with the severity 
of disease in the order: healthy < gingivitis <
periodontitis. Collagenase and gelatinase activity in 
mouthrinse samples has also been assessed from patients 
with AP and LJP as well as healthy controls, before and 
after periodontal therapy. A number of edentulous subjects 
were also sampled as an additional control to rule out the 
possibility of enzymes being derived from any source other 
than gingival crevice (Gangbar et al., 1990). AP patients 
received oral hygiene, scaling and root planing whereas 
subjects with LJP received antibiotics (tetracycline) as 
well. Some of the patients in both groups underwent 
surgical therapy. The authors reported that periodontitis 
patients had significantly higher active enzyme activity 
than healthy subjects whereas edentulous individuals showed 
neither active nor latent enzyme activity. Both 
collagenase and gelatinase activity were reported to be 
reduced following treatment which was significant only for 
active collagenase after scaling and antibiotic therapy in 
LJP patients. From an attempt to correlate GCF collagenase 
activity with disease progression in a group of patients 
with recurrent periodontal disease, Lee et al. (1991) 
reported that the finding of active collagenase at a site 
is associated with recent disease activity. Uitto, 
Suomalainen and Sorsa, (1990) conducted an experiment on 
salivary collagenase which was observed to be mainly of PMN 
origin. They also reported that in healthy individuals
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collagenase was partially latent, whereas in saliva 
obtained from periodontitis patients it was mostly in an 
active form and collagenase activity was found to be higher 
in saliva from diseased than from healthy subjects. The 
collagenase activity reduced significantly after treatment. 
Collagenase in GCF from adult periodontitis patients has 
been reported to be PMN derived while, GCF collagenase in 
subjects suffering from juvenile periodontitis seems to be 
of fibroblast origin (Suomalainen et al., 1991, 1992).
Sorsa and coworkers (1992b) have also suggested that GCF 
collagenase in LJP patients is fibroblast derived while in 
subjects suffering from diabetes mellitus, the enzyme is 
mostly from PMN origin. These authors state that the 
collagenase in LJP patients is of fibroblast-type because 
of the reported impaired PMN function. This seems 
questionable as the dysfunction of PMNs in LJP patients is 
in dispute (Kinane et al., 1989a, b); and it has been found 
that collagenase in patients suffering from diabetes is of 
PMN origin (Sorsa et al., 1992) whilst this group of 
patients are reported to have impaired PMN function 
(Manouchehr-Pour et al., 1981a, b). Scaling and root
planing has been demonstrated to reduce collagenase 
activity and the proportion of active enzyme in GCF 
(Suomalainen, 1992). By the use of reverse transcription 
polymerase chain reaction (RT-PCR), Nomura et al. (1993) 
reported a higher FIB-CL mRNA levels in gingivae from 
periodontitis patients than those from healthy subjects. 
In a recent study, using mouthrinses, Ingman et al. (1993)
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investigated the origin of the salivary collagenase and the 
enzyme activity in patients with adult and juvenile 
periodontitis as well as healthy subjects. These workers 
found the salivary collagenase activity in LJP patients was 
comparable to collagenase activity detected in healthy 
subjects, whereas it was significantly higher in AP 
patients. They also suggested that the enzyme was of 
fibroblast origin in LJP patients. Another recent study 
carried out by the same group (Ingman et al., 1994), 
revealed that both saliva and GCF collected from different 
groups of subjects contain gelatinase of PMN as well as 
fibroblast origin. Moreover, immunolocalization of both 
fibroblast and PMN collagenases and stromelysin has shown 
that PMNs in inflamed connective tissue and gingival 
granulation tissue specimen obtained from AP patients 
contain PMN-CL, whereas FIB-CL and SL were detected in 
fibroblasts and macrophages from granulation tissues only. 
However, control specimens showed no immunoreactivity for 
either of the enzymes (Ingman, 1994). Moreover, Meikle et 
al. (1994), using the same technique, reported that in 
gingival biopsies obtained from periodontally affected 
patients fibroblasts, macrophages and epithelial cells 
contained fibroblast type collagenase and gelatinase as 
well as SL. A significant reduction in collagenase 
activity in saliva after periodontal therapy has been 
reported by Hayakawa et al. (1994). These workers have 
also reported that most of the total collagenase in saliva 
of healthy subjects was in latent form, whereas mainly
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active collagenase was present in saliva from periodontally 
affected patients.
However, care should be exercised when different studies on 
MMPs in which, subjects with distinct forms of disease 
participated and different proteins have been analyzed and 
various methods of GCF collection, laboratory techniques, 
expression of results have been employed, are being 
compared.
1.7.7 Inhibition of matrix metalloproteinases
The control of extracellular proteolysis is of great 
importance which is accomplished by protease inhibitors 
either locally produced or circulating in plasma. Tissue 
inhibitors of metalloproteinases (TIMPs) form the first 
line of defence against MMPs in a local area whereas the 
second line of defence is found in the serum by a2- 
macroglobulin (a2-M)(Woessner, 1991). This protease 
inhibitor is an excellent substrate for FIB-CL which 
inactivates the enzyme rapidly. SL also binds to a2-M, but 
at a much slower rate than collagenase (Enghild et al., 
1989). It has been suggested that a2-M is very effective 
where the local supply of TIMP is exhausted and so can act 
as a back-up control mechanism to prevent connective tissue 
breakdown for a prolonged period of time (Cawston et al., 
1987).
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1.7.7.1 Tissue inhibitors of metalloproteinase (TIMPs)
Tissues contain members of TIMP family which form non- 
covalent bonds with active forms of MMPs and, in some 
instances, with latent enzymes as well (Birkedal-Hansen, 
1993). These family of inhibitors have low molecular 
weight (28.5 kDa for TIMPl and 21 kDa for TIMP2)(Banda et 
al., 1992) and are produced by most of the cells capable of 
secreting FIB-CL and SL (MacNaul et al., 1990). TIMPl 
appears to preferentially inhibit FIB-CL and SL (Banda et 
al., 1992), whereas TIMP2 is more effective against 
gelatinases (Birkedal-Hansen, 1993). A new inhibitor named 
large inhibitor of metalloproteinases (LIMP) with a 
molecular weight of 76 kD has been purified from fibroblast 
culture medium which inhibits fibroblast-type collagenase 
and gelatinase as well as SL and is distinct from TIMP 
(Cawston et al., 1990). The role played by TIMPs in 
regulating matrix degradation is exerted by proteinase 
elimination as well as by blockage of MMP activation 
(Birkedal-Hansen et al., 1993).
TIMP production by fibroblasts is upregulated by 
interleukin-IB (IL-1B) as well as transforming growth 
factor B1 (TGF-B1), whereas it is suppressed in the 
presence of interferon-y (IFN-y) in conjunction with IL-1B; 
however, IFN-y alone has no effect on TIMP expression 
(Unemori et al., 1991).
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Therefore the interaction of cytokines and growth factors 
with resident cells of periodontium in regulation of MMPs 
(reviewed in section 1.7.5.5) and TIMP, which seems very 
complicated, may determine whether repair or destruction of 
periodontium will occur and why gingival inflammation may 
or may not turn to periodontitis.
1.7.7.2 Tissue inhibitor of metalloproteinases in 
periodontal disease
Little attention has been paid to TIMP in the periodontal 
field than other proteinase inhibitors. In an early in 
vitro study Heath and co-workers (1982) showed that human 
diseased gingival tissues (fibroblasts) could produce TIMP. 
Larivee et al. (1986) reported that GCF collected from 
healthy subjects and healthy sites within LJP patients had 
significantly higher inhibitor than diseased sites in LJP 
patients and there was a significant increase in inhibitor 
activity of diseased sites after treatment. The authors 
stated that they excluded blood contaminated samples in 
order to analyze TIMP activity which is produced locally. 
However, considering the method they used for GCF 
collection, the chance that samples being contaminated with 
serum can not be ruled out thus, resulting in the analysis 
of other inhibitors as well. These results are in 
agreement with the findings of Hayakawa et al. (1994) who 
measured the concentration of TIMP in saliva. Using 
reverse transcription polymerase chain reaction (RT-PCR),
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Nomura et al. (1993) reported a higher mRNA levels for 
TIMPl in gingivae from periodontitis patients than those 
from healthy subjects, while there was no difference in the 
level of TIMP2 mRNA between healthy and periodontitis 
sites. More recently, Meikle et al. (1994) have been able 
to immunolocalize TIMPl within gingival connective tissue 
cells in specimens harvested from periodontitis patients.
In conclusion, recent knowledge regarding the function of 
the MMPs and TIMP in tissues has been gathered via 
measurements of activity in culture media or tissue 
extracts, immunoassays of protein or amplification of mRNA 
which is circumstantial.
However, the presence of these enzymes in higher 
level/activity in diseased than healthy sites (Ohlsson et 
aim, 1973; Heath et al., 1982), their increase during 
experimental gingivitis (Kowashi et al., 1979) and decrease 
after periodontal treatment (Larivee et al., 1986 and 
Makela et al., 1991) strengthens the case for MMPs 
involvement in periodontal tissue breakdown. Among the 
MMPs both PMN and FIB-CL have the unique ability of 
cleaving the triple helix of type I, II and III collagens, 
thus initiating extracellular matrix degradation which is 
not shared by the other members of the family (Woessner, 
1991). PMN—CL, is thought to be carried into the crevice 
in migrating PMNs (Birkedal-Hansen et al., 1993) thus 
reflecting the number of emigrating PMN into the crevice
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rather than the tissue destructive potential (Birkedal- 
Hansen, 1993). The ability of SL in activating FIB-CL and 
the preference of TIMP-1 to inhibit the aforementioned 
enzymes (Banda et al., 1992) along with the fact that all 
these components are secreted by resident cells (MacNaul et 
al. 1990) suggest, these enzymes and enzyme inhibitor are 
of particular interest in GCF.
TIMP-1 is referred to as 'TIMP' throughout this manuscript.
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CHAPTER 2 
MATERIALS
METHODS
2.1 Subjects
Prior to the commencement of these studies ethical approval 
was granted from the local ethical committee. Subjects 
participating in these studies were informed of the 
protocol and consent was obtained. All participants in the 
longitudinal experiment were given the option of 
withdrawing from the study at any time.
These individuals had no history of systemic conditions 
which could influence the course of periodontal disease. 
They were not on any medications that could affect the 
manifestations of periodontal disease, such as chronic 
antibiotic use, phenytoin, cyclosporin and calcium channel 
blockers.
2.1.1 C r o s s - s e c t i o n a l  s t u d y  of m a t r i x  
metalloproteinases and their inhibitor in 
gingival crevicular fluid
Forty patients attending the Periodontal Clinic of the 
Glasgow Dental Hospital participated in this study, of 
which 15 subjects were newly referred to the Dental 
Hospital whereas, the other 25 were among periodontal 
patients on maintenance care. Of these subjects 26 were 
female and 14 were male with a mean age of 43.1 ranging 
from 21-71 years.
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2.1.2 Longitudinal study of matrix metalloproteinases
and their inhibitor in gingival crevicular fluid 
before and after treatment
Twenty six individuals, newly referred to the Periodontal 
Clinic of Glasgow Dental Hospital with advanced periodontal 
disease (pocket depths greater than 5.5mm in all quadrants) 
took part in this study. 4 subjects excluded themselves 
from this study due to poor compliance and one individual 
had to withdraw from the study because of her pregnancy. 
Of 21 patients who remained in this study 11 were female 
and 10 were male with a mean age of 43.9 ranging from 33 to 
53 years.
2.2 Buffers and reagents
All chemicals were analytical grade and were obtained from 
BDH Chemicals Ltd., Poole, Dorset, England, unless 
otherwise stated.
2.2.1 Phosphate buffered saline (PBS)
PBS was prepared by dissolving 8g NaCl, 0.2g KH2P04, 0.2g 
KC1, 1.44g Na2HP04 . 2 H20 up to 1 litre of distilled water 
(pH 7.4).
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2.2.2 Coating buffer (CB)
Carbonate-bicarbonate buffer prepared by dissolving 1.59g 
Na2C03 and 2.93g NaHC03 up to 1 litre of distilled water. 
The pH was adjusted to 9.6 (titration with 1M HC1).
2.2.3 Incubation buffer (IB)
This was prepared by dissolving 8g NaCl, 0.2g KH2P04/ 0.2g 
KC1, 1.44g Na2HP04 . 2 H20, 0.5g Tween 20 (SIGMA Chemical 
Company Ltd., Poole, Dorset), and lg lyophilised bovine 
serum albumin (BSA) (SIGMA, St. Louis, USA) up to 1 litre 
distilled water (pH 7.4).
2.2.4 Wash buffer (PBST)
A stock solution of 10 times concentrated incubation buffer 
(nil BSA) was prepared. This was diluted 1/10 prior to 
use.
2.3 Purified standards and antibodies for enzyme
linked immunosorbent assays (ELISAs)
Purified recombinant human fibroblast collagenase (FIB-CL), 
stromelysin (SL) and tissue inhibitor of metalloproteinases 
(TIMP), as well as Mac 64 and Mac 66 anti-collagenase 
monoclonal antibodies, Mac 19 and Mac 15 anti-TIMP 
monoclonal antibodies as well as Mac 78 anti-stromelysin
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monoclonal antibody and Rabbit anti-stromelysin polyclonal 
antibody were donated by Cell Tech. Ltd. Slough, UK. 
Donkey anti rabbit- HRP conjugated IgG was purchased from 
Jackson Immuno-research Laboratories, Avondale, PA, USA.
Reagents were replaced regularly to avoid deterioration.
2.4 Clinical methods
2.4.1 Clinical indices
Two calibrated examiners (AH) and (EA) were used throughout 
these studies to record all clinical indices.
2.4.1.1 The Modified Gingival Index
The Modified Gingival Index (MGI) (Lobene et al., 1986) 
was used to assess gingival inflammation and is described 
below:
0 Absence of inflammation.
1 Mild inflammation; slight change in colour, little 
change in texture of any portion but not the entire 
marginal or papillary gingival unit.
2 mild inflammation; criteria as above but involving the 
entire marginal or papillary gingival unit.
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3 Moderate inf lamination; glazing, redness, oedema, 
and/or hypertrophy of the marginal or papillary 
gingival unit.
4 Severe inflammation; marked redness, edema and or 
hypertrophy of the marginal or papillary gingival 
unit, spontaneous bleeding, congestion or ulceration.
This index differs from the commonly used Gingival Index 
(Loe & Silness, 1963) in that it eliminates the bleeding 
upon probing/pressure component, and provides increased 
sensitivity in the lower region of the scoring scale. The 
MGI was, therefore, preferred because it permits non- 
invasive evaluation of the severity of gingival 
inflammation, and thus facilitates GCF sampling. In both 
studies, unless otherwise stated, site scores refer to a 
single MGI recording.
2.4.1.2 The Plaque Index
The plaque index (P1I) of Silness and Loe, (1964) was used 
for recording plaque accumulation. The scoring system for 
this index is as follows:
0 No plaque in the gingival area.
1 A film of plaque adhering to the free gingival margin 
and adjacent area of the tooth. The plaque may only
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be recognised by running a probe across the tooth 
surface.
2 Moderate accumulation of soft deposits within the
gingival crevice, on the gingival margin and/or
adjacent tooth surface, which can be seen by the naked 
eye.
3 Abundance of soft matter within the gingival crevice
and/or on the gingival margin and adjacent tooth 
surface.
In both studies site scores refer to a single site PlI 
recording.
2.4.1.3 Bleeding on probing
Bleeding upon probing (BOP) was scored dichotomously using 
the Florida Periodontal Probe. Scoring was performed
within 30s of probing.
2.4.1.4 Suppuration
Presence or absence of suppuration was recorded after 
applying gentle pressure on the gingival wall of the pocket 
at an apico-coronal direction using a ball burnisher.
83
2.4.2 Probing depth and attachment level measurements
In the cross-sectional study of matrix metalloproteinases 
and their inhibitor in gingival crevicular fluid, pocket 
(PD) depth was recorded to the nearest mm using a manual 
pressure sensitive probe with a constant force of 25 g.
The Florida Probe (Florida Probe Corporation, Florida, USA) 
(Gibbs et al., 1988) was used for probing depth and 
attachment level (AL) recording in the longitudinal study 
of matrix metalloproteinases and their inhibitor in 
gingival crevicular fluid before and after treatment. This 
is an electronic pressure sensitive probe set at 20g. The 
Florida Probe records PD/AL to the nearest 0.2mm. The 
system consists of a pocket depth and an attachment level 
('stent') handpiece, a foot switch, computer interface and 
portable personal computer. The measurements of PD and AL 
are made electronically, using the 'pocket depth' (Fig.
2.1) and 'attachment level, stent' (Fig. 2.2) handpieces 
respectively, and transferred automatically to the computer 
when the foot switch is pressed. Recordings are displayed 
on the computer screen which was turned away from the 
operator in order to allow 'blind' measurements. In 
addition, measurements were recorded on paper by the other 
examiner. The probe tip has a diameter of 0.4mm, no 
visible graduations along its length and it reciprocates 
through a sleeve. The edge of the sleeve is the reference 
from which measurements are recorded.
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Figure 2.1 Probing depth measurement with the Florida 
probe.
Figure 2.2 Attachment level measurement using the Florida 
probe and occlusal stent.
A fixed reference point is required for attachment level 
measurements. The Florida Probe 'stent' handpiece has a 
2mm diameter disc at the edge of its sleeve which, during 
attachment level measurement, is seated on a custom made 
soft acrylic stent covering the crowns of the teeth. These 
stents were constructed for both upper and lower arches for 
each patient from a 2mm thick silicone layer using a 
modification of the method described by Isidor, Karring and 
Attstrom, (1984). The stents were made on individually 
cast models using a vacuum forming unit. The stent was 
then trimmed to cover approximately the coronal one third 
of the crowns of the teeth at the sites selected for the 
study. At other sites as much as possible of the stent was 
preserved in order to assist location and retention. 
Grooves approximately 1mm deep, 2mm wide and 1mm high were 
cut, about 1mm away from the apical edge of the stent, at 
the sites to be used in the study, using an inverted cone 
bur and a low speed handpiece. The grooves were then 
marked with a permanent pen for ease of identification. 
The disc of the probe handpiece was located in these 
grooves during AL measurements. Attachment level was 
assessed relative to the point at which the probe handpiece 
disc was seated on the stent (Fig. 2.2). In this way, 
attachment level measurements do not rely on careful 
location of the cementoenamel junction (CEJ). The 
identification of the CEJ is often complicated by its 
subgingival location or the presence of restorations. 
Buccal/lingual AL measurements were taken at the tooth's
85
largest curvature. Interproximal AL recordings were taken 
at the mid point between the contact point and the adjacent 
line angle. The grooves on the stent were located 
relatively to these points.
PD is recorded when the probe sleeve is brought into 
contact with the gingival margin (Fig. 2.1). Care was 
taken for the probe tip to be parallel to the long axis of 
the tooth. PD measurements were taken at the same points 
as AL recordings.
2.4.2.1 Change in attachment level
Attachment level change between two points in time was 
assessed using a modification of the tolerance method of 
Haffajee et al. (1983b). Duplicate AL measurements at each 
time point provide a measure of examiner error. The 
standard deviation of pooled duplicate measurements of a 
site, at the first, second and third time points, served as 
'site standard deviation'. Differences between all 
duplicate measurements for all sites selected for the study 
within a patient, were used to compute the mean difference 
of duplicate measurements for each individual. The standard 
deviation of the mean difference was termed the 'patient 
standard deviation'. Patient standard deviations were 
averaged to derive a 'population standard deviation'. For 
the mean of the second pair of AL measurements to be 
considered significantly different from the mean of the
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first pair, attachment level change:
a) had to exceed the 'population threshold' (which was 2 
population standard deviations);
b) had to exceed the 'patient threshold' (which was 3 
patient standard deviations); and finally
c) had to be greater or equal to the 'site threshold' 
(which was 3 site standard deviations). Significant 
attachment level gain or loss was assessed retrospectively 
on completion of the study using the above method.
2.4.3 Sample collection
2.4.3.1 Gingival crevicular fluid sampling
Whatman grade 4 (Whatman Labsales Ltd., Maidstone, Kent) 
paper strips (2x13mm) were used for GCF collection. 
Although Whatman grade 3 chromatography paper is 
recommended by some authors (Griffiths, Curtis & Wilton, 
1988), this type of paper could not be used, as it was 
impossible to obtain a zero reading with the Periotron 6000 
when the strips were dry. The Whatman grade 4 paper strips 
were cut manually using a steel ruler and scalpel. Rubber 
gloves were worn during their preparation in order to avoid 
contamination of the strips by substances from the 
operators hands. A line was drawn on each strip at 8mm, 
indicating the length of the paper strip to be inserted 
between the Periotron jaws and that part of the strip to be 
used for GCF sampling. The strips were then placed in
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glass universal bottles for autoclaving and storage.
In the clinic, GCF was sampled after the PlI and MGI scores 
were taken but prior to any other clinical recordings which 
could cause irritation of the tissues and serum 
contamination of the sample. Such recordings included PD 
or AL measurements, BOP, suppuration etc. The individual 
crevicular site was gently air-dried in an apico-coronal 
direction and any visible supragingival plaque was removed. 
The area was carefully isolated with cotton wool rolls and 
saliva ejector to avoid saliva contamination of the 
samples. The paper strip was introduced into the crevice 
until mild resistance was felt, whilst care was taken to 
avoid mechanical injury of the tissues (Fig. 2.3). The 
strip was left in the crevice for 30s, and then transferred 
to the chairside located Periotron 6000 (Harco Electronics, 
Winnipeg, Manitoba, Canada) (Fig. 2.4) for volume 
determination. It was then stored in labelled individual 
sterile 1ml microcentrifuge tubes, and placed on ice until 
all sampling was completed. The strips were subsequently 
transported to the laboratory and stored frozen at -30°C 
until further processing.
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Figure 2.3 Gingival crevicular fluid sampling.
■Hi
Figure 2.4 The Periotron.
2.4.4 Selection of periodontal sites
2.4.4.1 C r o s s - s e c t i o n a l  study of ma tr i x  
metalloproteinases and their inhibitor in 
gingival crevicular fluid
Sites to be sampled were selected by clinical inspection 
and the use of pre-existing pocket charts. In this way, 
periodontal probing, which could cause irritation of the 
tissues and serum contamination of the sample, was avoided.
2.4.4.2 Longitudinal study of matrix metalloproteinases 
and their inhibitor in gingival crevicular fluid 
before and after treatment
A conventional pocket chart, constructed on a recruiting 
appointment using a PC12 periodontal probe, was used for 
site selection in this study. Two non-adjacent sites in 
each quadrant, (accessible to GCF sampling and attachment 
level recording) exhibiting pocketing ^ 4mm on the pocket 
chart were selected for this study. Interproximal sites 
were preferred to mid-buccal or mid-lingual sites due to 
their higher chance of demonstrating attachment loss 
(Haffajee et al., 1983a). Mesial sites were preferred to 
distal sites as they are more accessible. On the upper 
posterior molars, palatal sites were preferred to buccal 
sites and on the lower teeth buccal/labial sites were 
preferred to lingual sites as these sites are less prone to
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saliva contamination of the GCF sample.
2.4.5 Clinical design
2.4.5.1 C r o s s - s e c t i o n a l  study of m a t r i x  
metalloproteinases and their inhibitor in 
gingival crevicular fluid
In the cross-sectional study, as the term implies, samples 
were obtained and clinical recordings made at one time 
point. Clinical indices used in this study were the MGI, 
PD and GCF volume. In order to establish the levels of GCF 
FIB-CL, SL and TIMP in relation to the clinical 
presentation of the sites sampled, sites were categorised 
into one of three clinical groups: 'healthy', 'gingivitis' 
and 'periodontitis'. Sites with MGI scoring of 0 or 1 and 
PD lower or equal to 2mm were categorised as 'healthy'. 
MGI between 2 and 4, and PD less than or equal to 3mm were 
the criteria for the 'gingivitis' sites, whereas sites with 
MGI between 0 to 2 and PD exceeding 4mm comprised the 
'periodontitis' sites. Each subject provided the three 
sites (one of each).
2.4.5.2 Longitudinal study of matrix metalloproteinases 
and their inhibitor in gingival crevicular fluid 
before and after treatment
All the clinical recordings and sample collections in this
90
study were carried out at three time points: i) baseline 
appointment; ii) reassessment appointment; and iii) follow- 
up appointment. Prior to the baseline appointment, at the 
initial recruitment appointment the consent form was signed 
by the patient and the clinician in charge. A medical 
history form was also completed by the patient and the 
pocket charting, to be used for site selection, was 
constructed in this session. An alginate impression was 
taken and from the resulting cast, a soft acrylic stent for 
attachment level measurements was constructed (section 
2.4.2). Subsequently, the patient was recalled for the 
baseline appointment. During this appointment and in the 
following order:
a) PlI and MGI recordings were taken first;
b) GCF samples were then taken from the preselected sites 
and GCF Periotron readings recorded;
c) the first set of AL measurements at the sites sampled 
was subsequently made. During this procedure bleeding on 
probing and suppuration were also registered. The stent 
was then removed;
d) after changing patient position and reapplying the stent 
the duplicate set of AL measurements was made;
e) finally PD was assessed.
The same procedure was followed at the reassessment and the 
follow-up appointments.
All patients underwent hygiene phase of therapy including
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oral hygiene instruction and scaling and root planing under 
local anaesthesia. Six weeks after last treatment session 
the patient was recalled for reassessment. At this visit 
all the procedures in the baseline appointment were 
repeated. After recording clinical parameters and sample 
collection a conventional pocket chart was constructed. 
This pocket chart along with the state of bleeding on 
probing was used to assess the overall treatment success 
and determine further treatment needs. At this 
reassessment session sites were assigned to 'no treatment', 
'repeated root planing' and 'surgery' treatment groups 
based on the following criteria: a) no treatment: no
bleeding on probing; PD<3.5mm
b) repeated root planing: bleeding on probing; PD>3.5 to 
5. 5mm
c) surgery: bleeding on probing; PD>5.5mm
The subjects received further treatment according to the 
above mentioned criteria in different sites. Six weeks 
after the last treatment session patients attended for the 
follow-up visit in which all the procedures in the 
reassessment appointment repeated. The follow-up
examination was postponed for another 4 weeks in subjects 
who had received surgical treatment as visual inspection as 
well as gentle probing in non-study sites revealed signs of 
inflammation at six weeks only following the treatment 
session.
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2.5 Experimental methods and preliminary experiments
In this section, to aid clarity, methods as well as the 
preliminary experiments necessary to establish these 
methods, and the results will be presented and discussed 
together.
2.5.1 Calibration of the Periotron 6000
2.5.1.1 Calibration of the Periotron 6000 for use in
clinical trials
Prior to the commencement of our studies a Periotron 
calibration curve was constructed, using distilled water as 
the experimental fluid. Linear regression analysis was 
used to fit the standard curve. GCF volumes could then be 
estimated from Periotron values, using the linear function 
of the type 1= a + b x v, where 1= Periotron indication, v= 
volume, a= the intercept and b= the v coefficient. This 
type of standard curve was used when assessing GCF volumes 
for both cross-sectional and longitudinal studies. In 
order to transform the Periotron digital readings for each 
paper strip into volumes and also assess the accuracy of 
instrument, known volumes of distilled water were delivered 
onto Whatman grade 4 paper strips with a Hamilton 
microsyringe in a range of volumes (0.05-lpl). Each 
measurement was performed 3 times and the mean value for 
each volume was used in a linear regression analysis to
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determine the volumes of GCF collected. In an effort to 
reduce daily variability and thus improve accuracy, the 
instrument was calibrated in the periodontal clinic each 
day samples were collected. The curve was split into an 
upper and a lower portion as described by Lamster et al. 
(1985) and two separate lines fitted by the regression 
method as shown in Figure 2.5. The lower portion included 
volumes of 0.05, 0.1 and 0.2^1 whereas the upper portion 
included all the remaining volumes. Determination of GCF 
volume from given Periotron indications was performed from 
the corresponding part of the Periotron calibration curve 
using the appropriate equation. If a sample yielded a 
reading beyond the measuring range of the Periotron 6000, 
it was assigned a volume of 1.334^,1 which was the averaged 
values from 20 Periotron readings of 201 (the maximum 
reading) in 20 different calibration curves. However, this 
only occurred for 5 samples (1%) in the longitudinal study 
of matrix metalloproteinases in gingival crevicular fluid 
before and after treatment.
2.5.2 Quantification of GCF constituents
FIB-CL, SL and TIMP, in GCF were quantified using the 
enzyme linked immunosorbent assays (ELISAs). In both 
cross-sectional and longitudinal studies on matrix 
metalloproteinases in gingival crevicular fluid, FIB-CL, SL 
and TIMP were assessed in the same GCF sample.
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Figure 2.5 Calibration curves of the Periotron at the 
volume range of : (a) 0.05-0.2^1 and (b) 0.2-1^1.
2.5.2.1 Sandwich ELISA methodology
The three sandwich ELISAs (FIB-CL, SL and TIMP) are based 
on a modification of the method of Cooksley et al, (1990). 
In summary (Fig. 2.6), the 96-well polystyrene microplate 
(Immulon 4 Dynatech Laboratoriesf Billinghurst, Sussex, 
U.K) was coated with the first antibody, specific to the 
antigen to be quantified. These antibodies were Mac 64 
anti-collagenase monoclonal antibody for FIB-CL, Mac 78 
anti-stromelysin monoclonal antibody for SL and Mac 19 
anti-TIMP monoclonal antibody for TIMP. The eluate of the 
sample was then added and any antigen present was captured 
by the immobilized antibody. Then the plate was incubated 
with a biotin-conjugated monoclonal second antibody. 
Finally the plate was incubated with Extr Avidin-Peroxidase 
(Sigma). These antibodies were biotinylated Mac 66 to 
reveal FIB-CL and biotinylated Mac 15 to reveal TIMP. The 
stromelysin assay differed in that a rabbit polyclonal 
antibody was used as the second antibody followed by Horse 
Radish Peroxidase (HRP)-conjugated anti-rabbit IgG (donkey) 
(Jackson Immuno-research Laboratories, Avondale, USA). The 
anti-SL monoclonal and polyclonal and anti-FIB-CL 
monoclonals detected both the proenzyme and active forms of 
the SL and FIB-CL. Anti-TIMP monoclonals detected only 
free TIMP (Cooksley et al., 1990). Visualisation was 
achieved by incubation with TMB substrate, and the reaction 
stopped with 2.5% NaF (sodium fluoride). The plate was 
read at 630 nm (dual wavelength with 490 nm as reference
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Adding HRP-anti- 
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Avidin Peroxidase
basic principles
wavelength), on a Dynatech MR5000 plate reader. Serial 
dilutions of standard antigen were run for each plate and 
their ODs were used in a linear regression analysis from 
which the slope and intercept were used to determine the 
samples' levels of FIB-CL, SL and TIMP.
In the sandwich assays the amount of antigen present in the 
sample is directly proportional to the amount of the second 
biotinylated antibody or antiserum (rabbit), which was 
quantified indirectly by the addition of the HRP conjugated 
anti-rabbit IgG, resulting in high ODs for high antigen 
concentrations. The method is described in detail in Table
2.2. The working range for each assay is given in Table
2.3. Only the central wells were used when running 
standards or samples (in duplicate) in an effort to avoid 
the edge-effect. Control wells (control 14; Table 2.1) in 
central wells in each plate were included which contained 
no sample or standard antigen in order to calculate 
background binding. The mean OD plus two standard 
deviations of these wells was taken as a cut-off point for 
detectability (Tijssen, 1985). The peripheral wells were 
used for assaying the controls (except for the control 14) 
which were as shown in Table 2.1. All controls were run in 
duplicate except for the zero-antigen (control 14; Table
2.1) which was run in quadruplicate.
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Table 2.1 Control tests for sandwich ELISAs. When the 
addition of a reagent was omitted the equivalent volume 
of the respective buffer alone was added. Coating refers 
to the first antibody and antiserum refers to the second 
antibody. Standard was added at its fifth concentration 
in the standard curve. For volumes and concentrations of 
reagents refer to table 2.2.________________________________
Control Step
Coating Standard Antiserum
HRP/Extr Avidin 
Peroxidase
1 - - - -
2 + - - -
3 - + - -
4 - - + -
5 - - - +
6 + + - -
7 + - + -
8 + - - +
9 - + + -
10 - + - +
11 - - + +
12 + + + -
13 + + - +
14 + - + +
15 - + + +
Table 2.2 Steps and reagents for fibroblast collagenase 
(FIB-CL), stromelysin (SL) and tissue inhibitor of 
metalloproteinase (TIMP)sandwich ELISAs. Standard
SANDWICH ELISAS
STEPS REAGENT
1. Wash thrice with 200^1/well PBS for 
FIB-CL and CB for SL and TIMP.
2. Coat with 50|il/well specific 
antiserum. Incubate 
overnight at 4°C.
3. Wash with approximately 200pil/well 
PBST, 4x4+1 times and dry. Removal of 
excess and loosely coated antibody.
4. Add 100iil/well IB for 1 hr at RT to 
block the free sites.
5. Wash with approximately 200jj.l/well 
PBST, 4x4+1 times and dry.
6. Add 50}xl/well standard antigen or 
eluted samples in duplicate. Incubate 
for 1 hr on the shaker with speed 100, 
at RT.
7. Wash with approximately 200nl/well 
PBST, 4x4+1 times and dry. Removal of 
free and loosely-bound antigen.
8. Add 50fil/well second antibody 
incubate for 1 hr on the shaker with 
speed 100, at RT.
9. Wash with approximately 200nl/well 
PBST, 4x4+1 times and dry. Removal of 
free and loosely-bound antibody.
10. Add 50^1/well Extr Avidin 
Peroxidase for FIB-CL and TIMP and HRP 
conjugated Anti-rabbit IgG for SL. 
Incubate for 1 hr on the shaker with the 
speed of 100, at RT.
11. Wash with approximately 200(il/well 
PBST, 4x4+1 times and dry. Removal of 
excess Extr Avidin Peroxidase and HRP 
conjugated Anti-rabbit IgG.
12. Add 50jx/well TMB. Incubate for 20 
min. on the shaker with the speed of 
100, at RT.
13. Add 50^1/well NaF to stop colour 
development.
14. Read at 630nm on a plate reader.
Mac 64 anti-FIB-CL, Mac 
78 anti-SL and Mac 15 
anti-TIMP.
Recombinant FIB-CL, SL 
and TIMP served as 
standard antigens.
Biotin-Mac 66 anti FIB- 
CL, Biotin-Mac 15 anti 
TIMP and Rabbit anti 
SL.
Extr Avidin Peroxidase: 
1/10000 for FIB-CL and 
1/5000 in IB for TIMP. 
HRP: 1/20000 in IB for 
SL.
PBST* wash buffer 
CB* coating buffer 
IB= incubation buffer 
RT* room temperature 
HRP* horse radish peroxidase 
UtB= peroxidase substrate
2.5.2.2 Preliminary experiments and modification of the 
sandwich ELISAs
(a) Selection of microtitre plate type for the 
sandwich ELISAs
Based on an experiment aiming at the selection of the best 
plate, among five different types of Immulon (Dynatech 
Laboratories) microelisa plates, carried out in our
laboratory, the Immulon IV plates were selected for the
sandwich ELISAs in these studies.
(b) Modifying the FIB-CL, SL and TIMP sandwich ELISAs
FIB-CL, SL and TIMP sandwich ELISAs described by Cooksley 
et al. (1990) were modified in order to meet the
requirements and to consider the limitations of our study. 
The modifications were as follows:
a) Since we had to use the eluate from the same paper strip 
for different ELISAs it was not possible to use three 
different assay buffers to elute each individual paper 
strip. Therefore all the paper strips were eluted in the 
incubation buffer (section 2.2.3).
b) Based on an experiment determining suitable volume of 
incubation buffer in which the paper strips were to be 
diluted, the samples were diluted in 500^,1 of incubation 
buffer. Since we had to use this eluate for three 
different ELISAs and at the same time keep some of that for
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back up, it was necessary to reduce the sample volume in 
each well from 200ptl to 50^1.
c) Considering the range of absolute amounts of FIB-CL, SL 
and TIMP detected in preliminary experiments, the 
calibration line was altered toward the right side (lower 
concentration).
The precision ranges of each of the four sandwich ELISAs 
are shown in Table 2.4. Precision range was defined as the 
linear part of the working range (Table 2.3). A
prerequisite was that the OD of the lowest standard (mean 
±SD) of the precision range differed significantly from 
that of the zero antigen control (meaniSD) (control 14; 
Table 2.1). Outwith the precision range, experimental 
error increased due to the typical flattening of the curve.
Figure 2.7 (a to c) shows typical standard curves
(precision ranges) for the FIB-CL, SL and TIMP sandwich 
ELISAs. The least squares method was used to plot the best
fitting line and r2>0.99 were obtained for all assays.
Linear functions of the type lognOD = a + b x (lognc), where 
OD= optical density, c= concentration, a= the intercept and 
b= the lognc coefficient were thus produced, and used for 
the determination of sample antigen quantities. A similar 
standard curve was generated and a new line fitted each 
time an assay was run.
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Figure 2.7 Typical calibration curves for (a) fibroblast 
collagenase (FIB-CL), (b) stromelysin (SL) and (c) tissue 
inhibitor of metalloproteinases (TIMP).
Table 2.3 Working range of the standard antigen for the 
fibroblast collagenase, stromelysin and tissue inhibitor 
of metalloproteinase (TIMP) sandwich ELISAs. This was 
produced by serial two fold dilutions of the standard 
antigen (recombinant protein) in the appropriate buffer, 
resulting in 10 standard solutions for the construction 
of a standard curve. _____
Assay Working range (ng/ml in IB*)
Fibroblast collagenase 50 - 0.1
Stromelysin 12.5 - 0.025
TIMP 12.5 - 0.025
Table 2.4 Precision range of the standard antigen for 
the fibroblast collagenase, stromelysin and tissue 
inhibitor of metalloproteinase (TIMP) sandwich ELISAs. 
Precision range was defined the linear part of the
Assay Precision range (ng/ml in IB*)
Fibroblast collagenase 25 - 0.39
Stromelysin 6.25 - 0.05
TIMP 6.25 - 0.10
IB= incubation buffer
Table 2.5 Intra and inter-plate variability in sandwich 
ELISAs for fibroblast collagenase (FIB-CL), stromelysin 
(SL) and tissue inhibitor of metalloproteinases (TIMP).
Assay Intra-plate 
variation %CV*
Inter plate 
variation (p)*
FIB-CL 7.6 0.378
SL 4.4 0.841
TIMP 5.4 0.926
*- covariant of variation [(SOxlOO)/mean] is a measure of variability among repeated tests. 
**- significance level (p) for repeated measures analysis of variance comparing the levels of 
proteins in four plates.
To investigate if serum components would interfere when 
assaying GCF FIB-CL, SL and TIMP and thus influence the 
reliability of the assay, serum at 1/500 dilution in 
incubation buffer was added in the FIB-CL, SL and TIMP 
standards and the resolution of the standard curves 
examined. The 1/500 dilution of serum was used for the 
following reasons: a) GCF samples are eluted 500pl of 
incubation buffer; b) assuming a maximum of approximately 
IjaI of GCF and a consistency similar to that of serum, the 
maximum concentration of serum components in the 
experimental eluate would be 1/500 of their original 
concentrations in serum. Addition of 1/500 serum in our 
standards did not influence the resolution of the standard 
curves for FIB-CL, SL and TIMP.
In an attempt to investigate the intra-plate variability, 
aliquots of standard proteins at different concentrations 
were run in one plate. The coefficient of variation (CV % 
= SDxlOO/ mean OD), which is a measure of variability among 
repeated tests, was calculated to measure the intra-plate 
variability (Table 2.5). In order to assess inter-plate 
variability, aliquots from the standard proteins with the 
same concentration were run in duplicate in four different 
plates. Repeated measures analysis of variance
demonstrated no significant difference between the levels 
of GCF components in four different plates (Table 2.5).
Finally, GCF samples (FIB-CL, SL and TIMP n=4) originally
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eluted in 500p,l of incubation buffer were diluted a further 
1/2 in incubation buffer and two serial two-fold dilutions 
in incubation buffer produced which were assayed for FIB- 
CL, SL and TIMP. This experiment confirmed that the three 
GCF components respond in a similar way to the highly 
purified standard and that the assays developed could be 
used for their quantitation in GCF.
The above experiment also provided some information on the 
amount of incubation buffer in which the paper strips were 
going to be eluted. Some more GCF samples were then tested 
and it was established that the elution of GCF samples in 
500^,1 of incubation buffer for all three GCF components 
would yield concentrations in the eluate within the 
precision range of each ELISA.
2.5.3 Gingival crevicular fluid elution
2.5.3.1 Gingival crevicular fluid elution technique
GCF samples were eluted in 500[j,l of incubation buffer for 
lh at room temperature using a rotary mixer. The strips 
were then discarded and the eluates were aliquoted and 
stored in microcentrifuge tubes at -30°C.
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2.5.3.2 Recovery rate of fibroblast collagenase,
stromelysin and tissue inhibitor of 
metalloproteinases from Whatman grade 4 paper 
strips
By the use of sandwich ELISAs it was possible to quantify 
all three GCF components in the same GCF sample. It 
therefore became imperative to determine their recovery 
rate when absorbed on paper strips as this would influence 
the determination of their relative levels in GCF.
To achieve this, the following protocol was followed for 
FIB-CL,SL and TIMP; 5pil of 195ng/ml stock FIB-CL and 5^ .1 of 
lOOng/ml of SL and TIMP stock solution were delivered by a 
Hamilton microsyringe either:
a) onto Whatman grade 4 paper strips (n=7 for FIB-CL and 
n=9 for SL and TIMP) which were subsequently eluted in 
500|xl of incubation buffer for lh at room temperature using 
a rotary mixer; or
b) directly (n=9) in 500p,l of incubation buffer which was 
also rotated for lh at room temperature.
The eluates were then stored at -30°C until further
analysis. The level of each of the above GCF components in 
the 500^1 eluate of the strips was compared against that in 
the 500^,1 eluate when direct delivery in buffer was used
and the % recovery calculated (Table 2.6).
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Table 2.6 Recovery rate of fibroblast collagenase (FIB- 
CL), stromelysin (SL) and tissue inhibitor of 
metalloproteinases (TIMP). 5^1 of 195ng/ml recombinant 
FIB-CL and 5^1 of lOOng/ml of recombinant SL and TIMP were 
delivered, either: on paper strips (n=7 for FIB-CL and n=9 
for SL and TIMP) which were subseguently eluted in 500^1 of 
IB; or b) directly (n=9) in 500pl of IB. The mean level 
(pg/50nl) and (SD) of eluate resulting from both methods of 
delivery as well as % recovery are shown.
Level of protein (pg/50jxl eluate)
Protein IB* strip
Recovery
rate
FIB-CL 89.3 (4.0) 82.9 (9.8) 92.3%
SL 48.7 (6.8) 42.5 (5.5) 87.3%
TIMP 51.6 (2.4) 50.6 (3.9) 98.0%
II- 1 W U B U 1 *  H 1 H 0
Finally, an experiment was performed in order to ensure 
that paper strips were not contaminated by any of the 
proteins and inhibitor to be tested, prior to their use on 
patients. Sterile paper strips (n=10), were eluted in the 
standard procedure and the 500^1 eluate tested by the 
sandwich ELISAs for FIB-CL, SL and TIMP. Twenty wells in 
each plate were run using incubation buffer. None of the 
strips yielded positive results at the lowest detectability 
limits of the assays. The results obtained from paper 
strips were also comparable to those of incubation buffer 
containing wells.
2.5.4 Fluctuation in the GCF levels of fibroblast 
collagenase, stromelysin and tissue inhibitor of 
metalloproteinases
An experiment was conducted to investigate if there is any 
significant difference between the level of FIB-CL, SL and 
TIMP in GCF samples collected from the same sites over a 
working week. Ten individuals participated in this study 
from whom eight healthy and seven gingivitis sites were 
sampled for five successive days. Probing pocket depth and 
gingival inflammation were assessed using a pressure 
sensitive probe with a constant force of 25 g and MGI. 
These clinical parameters remained unchanged over the 
period of study. Subjects were neither given oral hygiene 
instruction nor were asked to change their oral hygiene 
habits. Paper stirps were eluted in the standard procedure
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Table 2.7 Using multivariate repeated measures analysis of 
variance, GCF levels (pg/30s) of SL and TIMP showed no 
significant difference in both healthy and gingivitis sites 
over a period of one week. Geometric mean and p value for 
MANOVA are shown. The GCF levels of these proteins were 
significantly lower (p<0.001) in healthy than in gingivitis 
sites.
Healthy Gingivitis
Visit SL TIMP SL TIMP
Day 1 1.7 11.3 7.8 121.0
Day 2 1.6 12.0 10.5 137.4
Day 3 1.5 10.8 9.6 98.60
Day 4 1.7 14.8 8.2 112.9
Day 5 1.6 12.4 7.2 104.8
MANOVA p=0.798
SL: stromelysin
TIMP: tissue inhibitor of metalloproteinases
and assayed for FIB-CL, SL and TIMP. Using MANOVA, this 
experiment showed no significant difference between the 
level of SL and TIMP over the period of the study (Table 
2.7). However, FIB-CL was only detected in 6 (%8) GCF
samples.
2.6 Statistical Analysis
All statistical analyses were performed on an IBM PC 
computer using the Minitab or SPSS/PC statistical package.
In the cross-sectional study of matrix metalloproteinases 
and their inhibitor in gingival crevicular fluid, 
associations between SL or TIMP in the GCF and the clinical 
indices (MGI, PD and GCF volume) were determined by the 
non-parametric Spearman rank correlation coefficient. In 
the cross-sectional study of matrix metalloproteinases and 
their inhibitor in gingival crevicular fluid the site was 
considered as the statistical unit. SL and TIMP levels in 
GCF were markedly skewed and required logarithmic 
transformation (log10 (x+1) x=original data value) in order 
to satisfy their distributional requirements prior to 
statistical analysis. Due to this skewed distribution, 
the geometric mean and 95% confidence intervals are shown 
rather than the standard error or standard deviation. A 
multivariate repeated measures analysis of variance 
(MANOVA) was applied in order to perform within patient 
comparison of healthy, gingivitis and periodontitis sites.
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When a significant effect was detected by repeated measures 
analysis of variance, follow up analysis was performed 
using univariate paired t-test in order to determine the 
direction and location of the differences. A Bonferroni 
correction was applied and significance level for the t- 
test was set at 0.025 (0.05/V3-0.025, where 3=number of 
comparisons made) in order to compensate for multiple 
comparisons (Brown & Swanson Beck, 1988).
In the longitudinal study of matrix metalloproteinases and 
their inhibitor in gingival crevicular fluid before and 
after treatment, analysis of the clinical findings was 
performed considering both subject and site as the 
experimental unit. When the subject was considered as the 
experimental unit, GCF volumes and clinical indices as well 
as GCF levels of FIB-CL, SL and TIMP within the subject 
were averaged, and one score for each clinical index (MGI, 
PlI, GCF volume, AL change, BOP and suppuration) as well as 
one value for each biochemical parameters (FIB-CL, SL and 
TIMP) produced per patient. BOP and suppuration scores (0 
= absence or negative and 1 = presence or positive)
averages produced scores, ranging from 0 to 1, with the 
decimal digits being equivalent to the percentage of 
bleeding or suppurating sites per subject. In order to 
satisfy the distributional requirements of the data for the 
tests a log10 transformation was required (log10(l+x), 
x=original data value) wherever the original data showed 
skewness. Multivariate repeated measures analysis of
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variance (MANOVA) followed by paired t-tests were employed 
to investigate differences in the levels of FIB-CL, SL and 
TIMP as well as the differences in the GCF volumes, pocket 
depths (PD) and attachment levels (AL) between three 
examinations. Significance level for the paired t-tests 
was set at 0.025 (0.05/^3-0.025, where 3=number of
comparisons made). Non-parametric repeated measures 
analysis of variance (Friedman test) followed by Sign tests 
were used to reveal differences in MGI and PlI scores 
between different examinations. Changes in bleeding and 
suppuration status (dichotomous data) between three 
appointments were studied using Cochran Q test followed by 
Chi-square tests. One way analysis of variance was 
employed to investigate wether FIB-CL, SL and TIMP levels 
are able to distinguish between sites with different pocket 
depths. In order to assess the effect of individual 
clinical parameters and their combination on the level of 
proteins, discriminant analysis was performed. Using 
Pearson correlation coefficient as well as Spearman rank 
correlation coefficient, the association of GCF volumes and 
clinical indices with the mean levels of SL and TIMP was 
investigated. Clinical and biochemical parameters were 
compared in sites which did or did not respond to treatment 
by the means of Mann-Whitney test (for MGI) and two sample 
t-test. Paired t-test and sign test were used to compare 
the mean levels of enzymes, the inhibitor, GCF volumes and 
clinical indices in sites which demonstrated attachment 
gain, before and after treatment.
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In order to illustrate the diagnostic potential of a test 
based on the level of TIMP in GCF, a 2x2 table based on the 
data of this protein at the follow-up visit from best 
responding sites (BRS) and worst responding sites (WRS) was 
formulated. A test based on the value of TIMP was applied. 
Thus, the test was considered positive (successful 
treatment) when a site demonstrated TIMP below a designated 
threshold value. This threshold value represents the
geometric mean of TIMP (pg/30s) in successfully treated 
sites at the follow-up visit. Specificity and sensitivity 
values as well as positive and negative predictive values 
were calculated using standard methods as shown in Table 
2.8.
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Table 2.8 Diagnostic test characteristics and
definitions.
Disease Disease
absent
a b
Positive test True False
Positive Positive
c d
Negative test False True
negative negative
Sensitivity
a/ (a+c)
Specificity
d/ (b+d)
Positive
Predictive
Value
a/ (a+b)
Negative
Predictive
Value
d/ (c+d)
CHAPTER 3 
RESULTS
3.1 Matrix metalloproteinases and tissue inhibitor
of metalloproteinases in gingival crevicular 
fluid from healthy, gingivitis and periodontitis 
sites
This cross-sectional study was carried out to examine if 
the level of fibroblast collagenase (FIB-CL), stromelysin 
(SL) and tissue inhibitor of metalloproteinases (TIMP) in 
gingival crevicular fluid (GCF) could differentiate between 
healthy, gingivitis and periodontitis sites. GCF samples 
were collected from one hundred and twenty sites in total, 
forty in each clinical group (healthy, gingivitis and 
periodontitis). Twenty five of the subjects were among 
periodontal patients on maintenance care and the other 15 
patients had been newly referred to the Periodontal Clinic. 
In this study FIB-CL, SL and TIMP were assessed in the same 
GCF samples and results were expressed as absolute amounts 
i.e. pg/30s of sample collection. Multivariate repeated 
measures analysis of variance (MANOVA) and paired t-tests 
were employed on the log10 transformed data in order to 
determine significant differences in GCF levels of the 
enzymes and inhibitor among the three clinical groups. 
Using non-parametric Spearman rank correlation coefficients 
the associations between the clinical indices and the 
levels of SL and TIMP were assessed. In order to 
compensate for multiple comparisons, the significant level 
for the t-tests was set at 0.025 (section 2.6).
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3.1.1 Clinical and biochemical findings
Table 3.1 presents the average (±SEM) clinical indices and 
GCF volumes of the healthy, gingivitis and periodontitis 
sites. The levels (95% confidence intervals) of SL and 
TIMP are presented in Table 3.2.
3.1.1.1 Fibroblast derived collagenase at healthy, 
gingivitis and periodontitis sites
FIB-CL was detectable in only 25 (20.8%) out of 120 sites, 
of which 7 (17.5%) belonged to the healthy group
(mean=193.6 pg/30s, SD=265.9), 11 (27.5%) sites belonged to 
the gingivitis group (mean=286.3 pg/30s,297.3) and 7 
(17.5%) sites belonged the to periodontitis group (287.2 
pg/30s, SD=271.8). FIB-CL level was much higher than SL in 
sites where it was detected. In 20 subjects FIB-CL was not 
detected in any site. The association of SL and TIMP with 
the clinical indices was also investigated.
3.1.1.2 Stromelysin at healthy, gingivitis and 
periodontitis sites
SL was detected in 75 (62.5%) sites sampled of which 19 
(47.5%) belonged to the healthy group and 28 (70%) both in 
the gingivitis and periodontitis groups. Multivariate 
repeated measures analysis of variance (MANOVA) 
demonstrated a significant effect (p=0.006) when healthy,
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Table 3.1 Clinical parameters from the three categories 
of sites in 40 patients.___________________________________
Site Status MGI PD GCF
Healthy 0.17 ±0.06* 1.41 ±0.06 0.092 ±0.02
Gingivitis 3.00 ±0.07 2.37 ±0.12 0.320 ±0.05
Periodontitis 1.70 ±0.12 5.71 ±0.14 0.380 ±0.06
MGI= modified gingival index 
PD= pocket depth in mm 
GCF* gingival crevicular volume 
*= m e w  & SEM
Table 3.2 Stromelysin and TIMP absolute amounts 
(pg/30s) in GCF from healthy, gingivitis and
periodontitis sites in 40 patients. Geometric means
(95% confidence intervals) are shown together with 
repeated measures analysis of variance (MANOVA)
significance level. Follow up analysis was performed
using univariate paired t-test and the results are given 
as footnotes.
Site status Stromelvsin* TIMP**
Healthy 3.9 (2.4-6.10) 32.3 (19.4-53.70)
Gingivitis 8.9 (5.5-14.4) 74.0 (44.2-123.8)
Periodontitis 9.4 (5.8-15.3) 93.7 (63.2-138.9)
MANOVA p value 0.006 0.001
p=0.882
** healthy va gingivitis: p=0.008, healthy va periodontitia:p<0.001f gingivitis vs periodontitis: 
p=0.373
gingivitis and periodontitis sites within each patient were 
compared for their GCF SL levels (Table 3.2). Follow up 
analysis (Table 3.2) demonstrated that diseased sites 
(gingivitis and periodontitis) had significantly higher 
levels of SL than healthy sites (p= 0.007 & p=0.002
respectively). However, no significant difference could be 
detected between gingivitis and periodontitis sites
(p=0.882)•
3.1.1.3 Tissue inhibitor of metalloproteinases at
healthy, gingivitis and periodontitis sites
TIMP was detected in 108 (90%) sites in total. TIMP was 
present at detectable level in 34 (85%) healthy, 36 (90%) 
gingivitis and 38 (95%) periodontitis sites. Similarly to 
SL, multivariate repeated measures analysis of variance 
demonstrated a significant effect when healthy, gingivitis 
and periodontitis sites were compared for their GCF TIMP 
levels (Table 3.2). Follow-up analysis demonstrated that 
gingivitis and periodontitis sites had significantly higher 
levels of TIMP than healthy sites (p=0.008 & p<0.001)
respectively). GCF TIMP levels could not however 
differentiate gingivitis from periodontitis sites (p=0.373) 
(Table 3.2).
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3.1.2 Correlation between clinical indices and GCF 
levels of stromelysin and TIMP
When data from healthy, gingivitis and periodontitis sites 
were pooled, SL and TIMP levels correlated positively and 
significantly with GCF volume, MGI and PD. Overall, TIMP 
demonstrated higher correlation coefficients than SL with 
clinical indices and GCF volume (Table 3.3). However, when 
data from different groups of sites were separately 
analyzed the picture changed; so that, there was neither 
significant nor even moderate correlation between clinical 
and biochemical parameters.
3.1.3 Comparison between GCF levels of stromelysin and 
tissue inhibitor of metalloproteinases in 
maintenance and newly referred patients
Healthy, gingivitis and periodontitis sites in 
periodontally affected patients who had newly been referred 
to the Periodontal Clinic showed higher levels of SL and 
TIMP than the similar sites in maintenance patient. 
However, these differences did not reach the significant 
level. When clinical parameters, in different categories 
of sites, were compared between two groups of patients 
except for the pocket depth in periodontitis sites no other 
significant difference was observed (Table 3.4). The 
percentages of gingivitis and periodontitis sites with 
detectable amount of FIB-CL were higher in newly referred
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Table 3.3 Spearman rank correlation coefficient (r) 
between clinical indices and TIMP and SL levels in GCF 
from 40 patients. Probability levels are shown in 
parenthesis._________________________________________________
Parameter_______ Stromelysin________________ TIMP
Vol.
CO00CM•
oIIM (p=0.002) r=0.643 (p<0.001)
MGI r=0.228 (p=0.012) r=0.361 (p<0.001)
PD r=0•256 (p=0•005) r=0.308 (p=0.001)
Vol.* GCF volume in pi 
MGI* modified gingival index 
PD* pocket depth in mm
Table 3.4 Comparison between GCF levels of SL and TIMP 
in new and maintenance patients. Geometric means (95% 
confidence intervals) are shown together with two-sample 
t-test significance level.________________________________
New patients 
(n=15)
Maintenance patients 
(n=25)
Parameter Mean 
(95% Cl)
Mean 
(95% Cl)
p value
SL (H)* 5.2 
(2.9-7.5)
3.2 
(1.5-4.9) 0.347
SL (G)** 12.5
(10.2-14.8)
7.3 
(5.5-9.1) 0.282
SL (P)*** 14.4
(12.3-16.5)
7.3 
(5.4-9.2) 0.181
TIMP (H) 32.5
(29.0-36.0)
32.2
(30.4-34.0) 0.987
TIMP (G) 75.2
(72.5-77.9)
73.3
(71.5-75.5) 0.962
TIMP (P) 107.2
(105.1-109.3)
86.4
(84.8-88.0)
0.606
*= healthy sites 
**= gingivitis sites 
***= periodontitis sites 
SL* stromelysin
TIKP* tissue inhibitors of metalloproteinases
patients, whereas it was not the case in healthy sites.
3.2 Longitudinal study of gingival crevicular
matrix metalloproteinases and tissue inhibitor 
of metalloproteinases
This longitudinal study was undertaken to evaluate the 
changes in GCF levels of FIB-CL, SL and TIMP after 
periodontal treatment, their ability to predict further 
treatment needs, to differentiate between bleeding and non­
bleeding, suppurating and non-suppurating as well as their 
possible association with GCF volume and clinical indices. 
Multivariate repeated measures analysis of variance 
(MANOVA) were employed on the log10 transformed data in 
order to determine significant differences in GCF levels of 
the proteinases and their inhibitor as well as changes in 
attachment levels (AL), pocket depths (PD) and GCF volumes 
between different appointments. When a significant effect 
was detected by the use of MANOVA, follow up analysis was 
performed using univariate paired t-tests in order to 
determine the direction and location of the differences. 
Non-parametric repeated measures analysis of variance 
(Friedman test) was used to determine the differences in 
plaque index (PlI) and gingival index (MGI) between three 
visits. Follow up analysis was performed by the use of 
Sign test to locate the differences. Attempts were made to 
demonstrate differences in dichotomous data (bleeding on 
probing and suppuration) between three examinations by
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using Cochran Q test which was followed by Chi-square test 
in order to locate the differences. Using two-sample t- 
tests, the baseline levels of FIB-CL, SL and TIMP were 
compared between groups of bleeding and non-bleeding sites, 
suppurating and non-suppurating sites, BRS and WRS as well 
as sites which did or did not gain attachment. Using one 
way analysis of variance, the levels of MMPs and TIMP were 
compared in groups of sites with different pocket depths. 
In these series of analyses, because of the number of 
comparisons the significant level was set at 0.025. The 
levels of the enzyme and inhibitor in the above mentioned 
groups of sites were compared between different visits by 
the use of paired t-tests. The associations between the 
clinical indices and the levels of SL and TIMP were 
assessed using the non-parametric Spearman rank correlation 
coefficients. The Pearson correlation coefficient tests 
were performed on log10 transformed data to assess the 
association between the response to treatment and 
percentage of bleeding sites and those with PD>3.5mm at the 
reassessment and the follow-up visits. GCF samples were 
obtained from twenty one subjects, each provided 8 sites, 
with advanced periodontitis. The enzymes and inhibitor 
were examined in the same GCF samples and results were 
expressed as total amounts in pg/30s of sample collection.
3.2.1 Baseline findings
One hundred and sixty eight sites with advanced periodontal
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tissue breakdown were sampled. Table 3.5 presents the mean 
±SEM of clinical indices, GCF volumes and the mean levels 
plus 95% confidence intervals of SL and TIMP in study 
sites.
3.2.1.1 GCF levels of FIB-CL at baseline: comparisons 
between different groups of sites
FIB-CL was detectable in only 45 (26.8%) out of 168 sites. 
This enzyme was detected , on average, in 2.1 out of 8 sites 
(26.2%) per subject. FIB-CL had much higher levels than SL 
in sites where it was detected. Five subjects had no 
detectable FIB-CL in any site examined. The enzyme was 
detected in only one site in 4 subjects. Two sample t-test 
showed no significant difference in the levels of FIB-CL 
between bleeding (n=131) and non-bleeding (n=37) sites 
(p=0.146). There was no significant difference in the mean 
GCF levels of enzyme when suppurating (n=36) and non­
suppurating (n=132) sites were compared (two-sample t-test, 
p=0.721). One way analysis of variance failed to discover 
any significant difference between three groups of sites 
with different pocket depths (PD^5mm, 5mm>PD^6.5mm and 
PD>6,5mm) for their FIB-CL levels (p=0.484)(Table 3.6).
3.2.1.2 GCF levels of SL at baseline: comparisons 
between different groups of sites
Analysis of GCF samples showed that SL was present at
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detectable levels in 82 (48.8%) sites, 3.9 out of 8 sites 
on average per patients. One subject did not have SL at 
any of the eight sites examined. Two-sample t-test 
demonstrated a significant effect (p=0.020) when bleeding 
and non-bleeding sites were compared for their GCF SL 
levels. There was no significant difference when 
suppurating and non-suppurating sites were compared (two- 
sample t-test, p=0.530). There was no significant 
difference between three groups of sites with different 
pocket depths (PD^5mm, 5mm>PD^6.5mm and PD>6.5mm) for their 
SL levels (one way ANOVA, p=0.824)(Table 3.6).
3.2.1.3 GCF levels of TIMP at baseline: comparisons
between different groups of sites
TIMP was detected in 167 (99.4%) sites. In contrast to the 
SL findings, the two sample t-test did not show a 
significant difference between the TIMP levels in bleeding 
and non-bleeding sites (p=0.257), while when sites with 
PD^5mm and those with PD>5mm were compared for their GCF 
TIMP levels a significant effect was found at p=0.024. 
Similarly to SL, suppurating and non-suppurating sites 
showed no significant difference in their TIMP levels (two- 
sample t-test, p=0.580) (Table 3.6). No significant 
difference was found when other groups of sites with 
different pocket depths (5mm>PD^6.5mm and PD>6.5mm) were 
compared for their TIMP levels.
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Table 3.5 Clinical and biochemical parameters (pg/30s)
from 168 sites in 21 patients._____________________________
Parameter________________________________Mean SEM/(95% Cl)
Modified GI 3.14010.05
Plaque Index 1.30010.19
Pocket depth (mm) 5.58010.10
GCF volume (|xl) 0.40610.02
Stromelysin 5.7 (3.4-8)
TIMP 229.6 (201.0-259.8)
Table 3.6 Comparison between FIB-CL, SL and TIMP levels 
from different group of sites using two sample t-test. 
Probability levels are shown against each comparison for 
FIB-CL, SL and TIMP. The number of sites in each groups 
are shown as footnotes.
Comparison D for FIB-CL D for SL D for TIMP
Bleeding vs 
non-bleeding
0.146 0.020 0.257
Suppurating vs 
non-suppurating
0.721 0.530 0.580
PD£5mm vs PD>5mm 0.793 0.834 0.024
FIB-CL= fibroblast: derived collagenase 
SL= stromelysin
TIMP- tissue inhibitor of metalloproteinases
bleeding sites n* 131
non-bleeding sites n= 37
suppurating sites n- 36
non-suppurating sites n= 132
sites with PD<5mm n= 64
sites with PD>5mm n= 104
Table 3.7 Spearman rank correlation coefficients (r) 
between clinical indices and SL and TIMP levels (pg/30s) 
in GCF from 168 sites in 21 patients at the baseline 
examination. Probability levels (p) are shown.____________
Parameter_________Stromelysin_____________ TIMP
Vol. r=0.078 (p=0.318) r=0.592 (p<0.001)
MGI r=0.192 (p=0.013) r=-0.001(p=0.989)
P1I r=0.002 (p=0.984) r=0.075 (p=0.334)
PD
o>o•oIIU (p=0.527) r=0.193 (p=0.012)
Vol.= GCF volume in pi 
MGI= modified gingival index 
P1I= plague index 
PD= pocket depth in mm
In order to assess the weight of individual clinical 
parameters and their combination on the levels of FIB-CL, 
SL and TIMP discriminant analysis was performed, and this 
revealed the followings:
MGI had the greatest effect on FIB-CL level while 
BOP+suppuration had the least effect. A combination of 
clinical parameters including BOP+suppuration, GCF volume, 
MGI and PD was found to have exerted the most effect on the 
level of this enzyme. These clinical parameters were able 
to predict the presence or absence of FIB-CL in 64% of the 
sites.
BOP+suppuration had the greatest effect on SL level while 
it was the opposite for GCF volume. BOP+suppuration, PD 
and MGI, in combination had the most effect on the level of 
SL in GCF. This combination of clinical parameters was 
able to predict the enzyme's level in 63% of the sites.
GCF volume was found to have the greatest effect on TIMP 
level while BOP+suppuration had the least effect. A 
combination of clinical parameters including GCF volume, PD 
and MGI showed the greatest effect on the GCF level of 
TIMP. These clinical parameters were able to predict the 
level of TIMP in 67% of the sites.
115
3.2.1.4 Correlation between clinical findings and GCF 
levels of matrix metalloproteinases and their 
inhibitor at the baseline examination
The association of SL and TIMP with the clinical indices 
and GCF volume is shown in Table 3.7. Overall, SL and 
TIMP's correlation with clinical indices and GCF volume 
were either weak or not significant.
3.2.2 Clinical and biochemical findings at the 
reassessment and the follow-up visits
At least six weeks after the last treatment session of the 
hygiene phase therapy (HPT) all the patients were assessed 
at a reassessment visit. After recording clinical 
parameters GCF samples were collected and a conventional 
pocket chart was constructed. At this visit sites were 
assigned to 'no treatment', 'repeated root planing' and 
'surgery' treatment groups based on their pocket depth and 
the state of bleeding on probing (section 2.4.5.2). Six 
weeks after repeated root planing, 10 weeks after surgical 
treatment and for those who did not need further treatment, 
almost 3 months after the reassessment examination, all the 
patients attended for a follow-up visit in which all the 
procedures in the baseline and the reassessment visits 
were repeated. One of the study teeth between the baseline 
and the reassessment visits had been extracted, thus the 
number of study sites decreased to 167 at reassessment and
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all the comparisons between the baseline and the 
reassessment data were made on 167 sites. Between the 
reassessment and the follow-up examinations, a further 
study tooth was lost also, reducing the number of sites to 
166. During this period one subject had a wire splint 
fitted which excluded another 6 teeth from attachment level 
measurements. Analysis was performed considering both the 
site and subject as the experimental unit. When the 
subject was considered as the unit, sites within each 
subjects were averaged and one score produced per subjects 
for each clinical and biochemical parameter. Wherever data 
was not normally distributed it was transformed to log10 in 
order to use parametric tests.
3.2.2.1 GCF volume and clinical indices at the 
reassessment and the follow-up examinations
The mean, SD and SEM for GCF volumes and clinical indices 
in three examinations are shown in Table 3.8. Multivariate 
repeated measures analysis of variance (MANOVA) as well as 
paired t-test was used to determine significant differences 
between GCF volume, attachment level (AL) and pocket depth 
(PD) between these three appointments (Tables 3.9 & 3.10). 
Non-parametric repeated measures analysis of variance 
(Friedman test) and Sign tests were also employed to detect 
changes in plaque index (PlI) and gingival index scores 
(MGI). The number of bleeding and suppurating sites 
decreased at the reassessment and the follow-up visits as
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Table 3.8 Multivariate repeated measures analysis of 
variance (MANOVA) for clinical parameters with subjects 
as unit of analysis. Mean, SEM and SD are shown against 
each parameter for different examinations. Significance 
level (p value) is given.___________________________________
Clinical data 
Averaqe of subiects
Parameter n Mean SEM SD
Attachment level 
Baseline
(mm)
21 10.8735 0.2790 1.2784
Reassessment 21 10.1670 0.2740 1.2557
Follow—UP 21 10.2732 0.2877 1.3182
Pocket depth (ram) 
Baseline 21 5.5786 0.1542 0.7065
Reassessment 21 3.9940 0.1247 0.5715
Follow-up 21 3.3134 0.1830 0.8384
GCF Volume (til) 
Baseline 21 0.4064 0.0342 0.1568
Reassessment 21 0.3023 0.0272 0.1246
Follow-up 21 0.1833 0.0139 0.0639
Modified GI 
Baseline 21 3.1429 0.0988 0.4529
Reassessment 21 1.7662 0.1323 0.6061
Follow-up 21 1.4422 0.1169 0.5357
Plaaue Index 
Baseline 21 1.2679 0.1684 0.7719
Reassessment 21 0.6922 0.1231 0.5641
Follow-up 21 0.6335 0.1048 0.484
Bleedinci on probinq 
Baseline 21 0.7798 0.0621 0.2848
Reassessment 21 0.3724 0.0474 0.2173
Follow-up 21 0.3189 0.0548 0.2512
Suppuration
Baseline 21 0.2143 0.0623 0.2854
Reassessment 21 0.0298 0.0191 0.0875
Follow-up 21 0 0 0
MANOVA p=0.002
Table 3.9 Multivariate repeated measures analysis of 
variance (MANOVA) for clinical parameters with sites as 
unit of analysis. Mean, SEM and SD are shown against 
each parameter for different examinations. Significance 
level (p value) is given.__________________________________
Parametric clinical data
Parameter n Mean SEM SD
Attachment level (mm) 
Baseline 168 10.8735 0.1505 1.9504
Reassessment 166 10.1663 0.1426 1.8374
Follow-up 160 10.2244 0.1479 1.8708
Pocket depth (mm) 
Baseline 168 5.5786 0.1019 1.3201
Reassessment 167 3.9940 0.1005 1.2986
Follow-up 166 3.3229 0.1005 1.2944
GCF Volume (|il) 
Baseline 168 0.4064 0.0229 0.2964
Reassessment 167 0.3014 0.0194 0.2511
Follow-up 166 0.1835 0.0119 0.15372
MANOVA p<0.000 
1
Table 3.10 Follow up analysis for the MANOVA of the 
Table 3.9 for clinical parameters. Mean differences, 
SD, number of pairs and significance levels (p values) 
for paired t-tests are given.______________________________
Parametric clinical data
n mean 
dif.
SD t-test p
Attachment level (mm) 
Baseline-Reassessment 166 0.6967 1.062 <0.001
Baseline-Follow-up 160 0.6109 1.175 <0.001
Reassessment-Follow-up 160 -0.1125 0.991 0.153
Pocket depth (mm) 
Baseline-Reassessment 167 1.5808 1.405 <0.001
Baseline-Follow-up 166 2.2229 1.527 <0.001
Reassessment-Follow-up 166 0.6398 0.239 <0.001
GCF Volume (til) 
Baseline-Reassessment 167 0.1042 0.349 <0.001
Baseline-Follow-up 166 0.2226 0.316 <0.001
Reassessment-Follow-up 166 0.1160 0.256 <0.001
Table 3.11 Clinical indices' mean, SD, frequency
distribution (f ) and percentage (%) for each score in 
different examinations. Number of sites in each visit is
shown.
Non-parametric clinical data
n Mean SD Score
Modified GI f %
Baseline 168 3.143 0.631 0 - -
l 1 0.60
2 20 11.9
3 101 60.1
4 46 27.4
Reassessment 167 1.760 0.788 0 7 4.2
1 55 33.0
2 76 45.5
3 29 17.3
4 - -
Follow-up 166 1.446 0.734 0 11 6.6
1 83 50.0
2 59 35.5
3 13 7.90
4 — —
Piaaue index
Baseline 168 1.268 0.944 0 39 23.2
1 64 38.1
2 46 27.4
3 19 11.3
Reassessment 167 0.695 0.742 0 79 47.3
1 60 35.9
2 28 16.8
3 - -
Follow-up 166 0.632 0.819 0 94 56.6
1 42 25.3
2 27 16.3
3 3 1.8
BOP
Baseline 168 _ _ 0 37 22.0
1 131 78.0
Reassessment 167 _ _ 0 105 62.9
1 62 37.1
Follow-up 166 _ _ 0 113 68.1
1 53 31.9
Suppuration
Baseline 168 _ _ 0 132 78.6
1 36 21.4
Reassessment 167 __ __ 0 162 97.0
1 5 3.00
Follow-up 166 _ _ 0 166 100
1 •
BOP= bleeding on probing
Table 3.12 Comparison of gingival and plague scores 
between different visits using non-parametric repeated 
measures analysis of variance (Friedman test) followed by 
paired Sign tests. Dichotomous data (bleeding on probing 
and suppuration) are compared using Cocharn Q test 
followed by Chi-square tests. Significance levels (p 
values) are given. Base, Reass and Follow represent the 
baseline, the reassessment and the follow-up examinations 
respectively.______________________________________________
Non-parametric clinical data
Friedman
p-value
Sign test 
p-value
Ba-e-Reass Base-Follow Reass-Follow
MGI <0.0001 <0.0001 <0.0001 0.0002
P1I <0.0001 <0.0001 <0.0001 0.1824
Cochran
Q
p-value
Chi-square test 
p-value
Base-Reass Base-Follow Reass-Follow
BOP <0.0001 <0.0001 <0.0001 0.3211
S <0.0001 <0.0001 <0.0001 0.1250
MGI- modified gingival index 
P1I= plaque index 
BOP= bleeding on probing 
S= suppuration
Table 3.13 Follow up analysis of MANOVA in Table 3.8 
with subject as unit of analysis. Using paired t-tests, 
the clinical parameters between different visits are 
compared. Mean differences, SD and the significance 
levels (p values) are given.______________________________
Parametric clinical data 
Averaae of n=21 subiects
n mean dif SD t-test p
Attachment level (mm) 
Baseline-Reassessment 
Baseline-Follow-up 
Reassessment-Follow-up
21
21
21
0.7065
0.6003
-0.1062
0.478
0.699
0.445
<0.001
0.001
0.287
Pocket depth (mm) 
Baseline-Reassessment 21 1.5849 0.873 <0.001
Baseline-Follow-up 21 2.2651 1.029 <0.001
Reassessment-Follow-up 21 0.6803 0.759 0.001
GCF Volume (nl) 
Baseline-Reassessment 21 0.1041 0.157 0.006
Baseline-Follow-up 21 0.2231 0.152 <0.001
Reassessment-Follow-up 21 0.1190 0.117 <0.001
Modified GI 
Baseline-Reassessment 21 1.3767 0.453 <0.001
Baseline-Follow-up 21 1.7007 0.606 <0.001
Reassessment-Follow-up 21 0.3240 0.536 0.049
Plaaue Index 
Baseline-Reassessment 21 0.5757 0.789 0.003
Baseline-Follow-up 21 0.6344 0.786 0.001
Reassessment-Follow-up 21 0.0587 0.474 0.577
Bleedinq on probincr 
Baseline-Reassessment 21 0.4073 0.297 <0.001
Baseline-Follow-up 21 0.4609 0.385 <0.001
Reassessment-Follow-up 21 0.0536 0.310 0.438
Suppuration
Baseline-Reassessment 21 0.1845 0.287 0.008
Baseline-Follow-up 21 0.2143 0.285 0.003
Reassessment-Follow-up 21 0.0298 0.088 0.135
well as the percentage of sites with higher plaque and 
gingival scores (Table 3.11). Cochran Q and Chi-square 
tests were used in the cases of bleeding on probing (BOP) 
and suppuration (Table 3.12). When data was analyzed both 
on the site and subject basis, mean GCF volumes and PD 
measurements decreased significantly at the reassessment 
and the follow-up sessions from the baseline as well as at 
the follow-up from the reassessment visit (Tables 3.10 & 
3.13). Mean attachment levels (AL), plaque index scores 
(PlI), bleeding on probing (BOP) and suppuration showed 
significant reduction at the reassessment and the follow-up 
appointments from the baseline on both site and subject 
basis whereas they failed to demonstrate any significant 
difference at the follow-up from the reassessment visit. 
However, AL measurements, at both site and subject levels, 
increased at the follow-up from the reassessment 
examination which were not significant (Tables 3.9, 3.11, 
3.12 & 3.13). Mean modified gingival scores (MGI) reduced 
significantly at the reassessment and the follow-up visits 
from the baseline when it was analyzed on both site and 
subject basis whereas, its reduction at the follow-up from 
the reassessment visit was only significant when site was 
the unit of analysis (Tables 3.12 & 3.13).
3.2.2.2 GCF levels of fibroblast collagenase at the 
reassessment and the follow-up examinations
FIB-CL was detected in 29 (17.4%) sites and 20 (12%) sites
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at the reassessment and the follow-up examinations 
respectively. The mean number of sites with detectable 
amounts of FIB-CL per subject dropped from 2.1 (26.2%) at 
the baseline to 1.4 (17.2%) and 0.95% (11.9%) sites at the 
reassessment and the follow-up visits respectively. The 
enzyme did not reach the detectable levels in any site in 
10 subjects at both the reassessment and the follow-up 
visits. By the means of multivariate repeated measures 
analysis of variance (MANOVA) and paired t-test and 
considering the site as the unit of analysis it was 
revealed that GCF mean levels of FIB-CL decreased 
significantly at the reassessment and the follow-up 
examinations from the baseline (p=0.025 and p<0.001 
respectively) (Tables 3.14 & 3.15). Using the same
statistics and on a subject basis, the mean level of enzyme 
reduced significantly only at the follow-up session from 
the baseline (p=0.023)(Table, 3.17).
3.2.2.3 GCF levels of stromelysin at the reassessment 
and the follow-up examinations
SL reached the detectable levels in 70 (42%) and 45 (27.1%) 
sites at the reassessment and the follow-up visits 
respectively. This MMP was detected, on average, in 3.3 
(41.2%) and 2.1 (26.2%) out of 8 sites per subject at the 
reassessment and the follow-up examinations, thus the 
number of sites expressing SL in each individual decreased 
by 7.6% and 22.5% respectively. 4 subjects at the
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Table 3.14 Geometric means and 95% confidence intervals 
for FIB-CL, SL and TIMP (pg/30s) at different visits. 
Number of sites and significance level (p value) for 
MANOVA is given._____________________________________________
Protein n Mean 95% C.I.
Fibroblast collacrenase 
Baseline 166 3.9 2.8-5.6
Reassessment 166 2.3 1.7-3.0
Follow—UD 166 1.9 1.4-2.5
Stromelysin
Baseline 166 5.6 4.2-7.4
Reassessment 166 4.0 3.1-5.2
Follow-up 166 2.4 1.9-2.9
TIMP
Baseline 166 228.7 201.8-259.2
Reassessment 166 333.9 291.8-382.8
Follow-up 166 93.30 78.90-110.1
MANOVA p<0.0001
Table 3.15 Comparison of GCF levels of FIB-CL, SL and 
TIMP on log10 transformed data between different visits. 
Follow up analysis for MANOVA of Table 3.14 for the 
enzymes and inhibitor. Mean differences, SD, number of
pairs and significance 
tests are qiven.
levels (p values) for paired
Protein n Mean Dif SD P
Fibroblast collaqenase 
Baseline-Reassessment 167 0.2326 1.325 0.025
Baseline-Follow-up 166 0.3166 1.117 <0.001
Reassessment-Follow-up 166 0.0826 1.170 0.364
Stromelysin
Baseline-Reassessment 167 0.5580 1.027 0.052
Baseline-Follow-up 166 0.3777 1.031 <0.001
Reassessment-Follow-up 166 0.2302 0.924 0.002
TIMP
Baseline-Reassessment 167 -0.1656 0.489 <0.001
Baseline-Follow-up 166 0.3896 0.572 <0.001
Reassessment-Follow-up 166 0.5539 0.537 <0.001
Table 3.16 Multivariate repeated measures analysis of 
variance (MANOVA) for MMPs and TIMP (pg/30s) with 
subjects as unit of analysis. Geometric means and 95% 
confidence intervals are shown against each parameter for 
different examinations. Significance level (p value) is 
given._____________________________________________________
Average of 21 subiects
Protein n Mean 95% C.I.
Fibroblast collagenase
Baseline 21 3.9 2.5-6.3*
Reassessment 21 2.3 1.5-3.5
Follow-up 21 1.9 1.3-2.8
Stromelvsin
Baseline 21 5.7 3.7-8.6
Reassessment 21 4.0 2.5-6.4
Follow-up 21 2.4 1.7-3.3
TIMP
Baseline 21 230.4 185.8-285.7
Reassessment 21 336.8 264.8-428.4
Follow-up 21 93.40 72.20-120.9
MANOVA p<0.0001
* The wider range of confidence intervale shown in this Table compared with those of Table 3.14 is 
due to the smaller sample size in the present Table.
Table 3.17 Follow up analysis of MANOVA in Table 3.16 
with subject as unit of analysis. Using paired t-tests, 
GCF levels of MMPs and TIMP (on log10 transformed data) 
between different visits are compared. Mean differences, 
SD and the significance levels (p values) are given.
Average of 21 subiects
Protein n Mean Dif SD P
Fibroblast collagenase 
Baseline-Reassessment 21 0.5278 1.303 0.078
Baseline-Follow-up 21 0.5305 0.984 0.023
Reassessment-Follow-up 21 0.0027 1.405 0.993
Stromelvsin
Baseline-Reassessment 21 0.3110 0.577 0.023
Baseline-Follow-up 21 0.5389 0.723 0.003
Reassessment-Follow-up 21 0.2279 0.684 0.143
TIMP
Baseline-Reassessment 21 -0.1812 0.309 0.014
Baseline-Follow-up 21 0.3515 0.309 <0.001
Reassessment-Follow-up 21 0.5326 0.360 <0.001
reassessment and 7 subjects at the follow-up sessions did 
not have detectable SL at any site examined. Using 
multivariate repeated measures analysis of variance 
(MANOVA) and paired t-test on the site basis, the mean GCF 
levels of SL decreased significantly at the follow-up visit 
both from the baseline and the reassessment visits (p<0.001 
and p=0.002 respectively)(Tables 3.14 & 3.15). However, 
the difference between the mean levels of SL at the 
baseline and the reassessment visits was just outwith the 
level of statistical significance (p=0.052)(Table 3.15). 
Similar statistical tests, when used on a subject basis, 
showed that SL mean levels reduced significantly at both 
the follow-up and the reassessment from the baseline 
examination (Tables 3.16 & 3.17). However, the levels of 
theses GCF components showed a large site to site variation 
within and between subjects.
3.2.2.4 GCF levels of tissue inhibitor of
metalloproteinases at the reassessment and the 
follow-up examinations
TIMP was found at detectable levels in 100% of the sites 
(n=167) at the reassessment and in 98.2% (n=163) of the 
sites at the follow-up sessions. TIMP was detected in 100% 
and 98.2% of the 8 sites examined per individual at the 
reassessment and the follow-up visits respectively. 
Multivariate repeated measures analysis of variance and 
paired t-test, on both site (Tables 3.14 & 3.15) and
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subject basis (Tables 3.16 & 3.17), revealed that mean GCF 
levels of TIMP increased significantly after hygiene phase 
therapy i.e. at reassessment (p<0.001 and p=0.014 
respectively), whereas it showed significant decrease at 
the follow-up both from the baseline and the reassessment 
examinations with a (p) value <0.001 for all occasions.
3.2.2.5 Correlation between clinical findings and GCF 
levels of matrix metalloproteinases and their 
inhibitor at the reassessment and the follow-up 
examinations
With the exception of mean levels of SL and TIMP which 
showed positive and significant associations with the mean 
GCF volume all other correlations were either negative or 
low and failed to reach statistical significance (Table 
3.18). At the follow-up visit, in addition to the positive 
and significant correlation between GCF volume and SL and 
TIMP (mean levels), mean MGI scores was associated with the 
mean GCF levels of SL and TIMP (Table 3.19)
3.2.3 Prediction of response to treatment at the
reassessment visit according to the baseline GCF 
levels of matrix metalloproteinases and their 
inhibitor
At the reassessment visit, as part of normal clinical 
procedure to determine further treatment needs, all the
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Table 3.18 Spearman rank correlation coefficient (r) 
between clinical indices and FIB-CL, SL and TIMP levels 
in GCF from 167 sites in 21 patients at the reassessment
examination. Probability levels (p) are shown.
Parameter Stromelvsin TIMP
Vol. r=0.313 (p<0.001) r=0.440 (p<0.001)
MGI r=0.022 (p=0.782) r=-0.036(p=0.646)
P1I r=0.057 (p=0.461) r=0.057 (p=0.467)
PD r=-0.05 (p=0.523) r=-0.029(p=0.706)
Vol .= GCF volume in |il 
MGI= modified gingival index 
P1I= plague index 
PD= pocket depth in mm
Table 3.19 Spearman rank correlation coefficient (r) 
between clinical indices and SL and TIMP levels in GCF 
from 166 sites in 21 patients at the follow-up 
examination. Probability levels (p) are shown._________
Parameter Stromelvsin TIMP
Vol. r=0.155 (p=0.046) r=0.696 (p<0.001)
MGI r=0.167 (p=0.031) r=-0.164(p=0.035)
P1I r=0.101 (p=0•195) r=0.058 (p=0.457)
PD r=-0.075(p=0.336) r=-0.058(p=0.459)
Vol. = GCF volume in |il 
MGI= modified gingival index 
P1I- plague index 
PD= pocket depth in mm
sites were examined for pocket depth and bleeding on 
probing. Treatment was considered successful i.e. a 
positive response, if a site did not bleed on probing and 
had a pocket depth of equal or less than 3.5mm. Bleeding 
(62 (37.1%)) and non-bleeding (105 (62.9%)) as well as
sites with more (99 (59.3%)) or less (68 (40.7%)) than
3.5mm pocket, which were on the study, formed different 
groups and their baseline levels of MMPs and TIMP were 
compared. Forty three (25.7%) sites met both criteria for 
treatment success at the reassessment examination whereas 
41 (24.6%) sites failed to do so. The baseline levels of 
the enzymes and inhibitor were compared in these groups of 
sites. The differences in MMPs and TIMP between the 
baseline and the reassessment visits were also assessed. 
Using a more stringent criteria including PD measurements, 
MGI scores and the state of bleeding and suppuration and in 
order to eliminate the smoothing effects of intermediately 
responding sites, the best responding sites (BRS) (n=15) 
and worst responding sites (WRS) (n=15) were selected 
(Table 3.20). The baseline levels of MMPs and TIMP, in 
this groups of sites, were compared to investigate their 
ability in predicting treatment outcome.
3.2.3.1 Prediction of response to treatment at the
reassessment session according to the baseline 
levels of fibroblast collagenase
Using two-sample t-test, the baseline levels of FIB-CL was
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compared between groups of bleeding and non-bleeding sites 
as well as sites with pocket depth of less or more than 
3,5mm. The mean enzyme's levels at the baseline visit 
failed to differentiate between two groups of sites with 
pocket depth less or more than 3.5mm at the reassessment 
examination (p=0.231)(Table 3.21). Mean levels of FIB-CL 
at the baseline visit was not able to distinguish bleeding 
sites from those which did not bleed upon probing to the 
base of the pocket after hygiene phase therapy at the 
reassessment visit (p=0.082)(Table 3.22). FIB-CL mean 
baseline's levels, also failed to predict the response to 
the treatment, when both bleeding status and pocket depth 
were considered as criteria for treatment success (two- 
sample t-test, p=0.057). The baseline levels of this 
enzyme could not differentiate between BRS and WRS at the 
reassessment visit (two-sample t-test, p=0.781) (Table 
3.23) .
3.2.3.2 Prediction of response to treatment at the
reassessment session according to the baseline 
levels of stromelysin
Different groups of sites, based on their bleeding status 
as well as their pocket depths at reassessment, were 
compared for their SL levels at the baseline (two-sample t- 
test). The mean levels of SL at the baseline was not able 
to differentiate between sites with PD of <3.5mm and those 
with >3.5mm pocket (p=0.453)(Table 3.21). There was no
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Table 3.20 Comparisons of GCF volumes, gingival scores, 
pocket depths and GCF levels of stromelysin (SL) and TIMP 
between best responding sites (BRS) (n=15) and worst 
responding sites (WRS) (n=15) at the reassessment 
examination. Mean ±SEM for clinical parameters and the 
geometric mean and 95% confidence intervals for proteins 
(pg/30s) are shown. Significance level (p value) for 
each paired t-test and Sign test (for gingival scores) is 
given._______________________________________________________
BRS WRS
Parameter Mean ±SEM 
(95% CI1
Mean ±SEM 
(95% c n
p value
Vol. 0.253±0.065 0.507±0.073 0.015
MGI 0. 9±0.091 2.5±0.133 <0.001
PD 2.6±0.105 5.5+0.133 <0.001
SL 3.1
(1.3-7.20)
3.3 
(1.5-7.2)
0.911
TIMP 379.7
(200.4-710.2)
412.3
(301.4-563.9) 0.816
Vol.= gingival crevicular fluid volume in pi 
MGI- Modified Gingival Index 
PD= pocket depth in mm.
SL= etromelyein
TIMP* tissue inhibitor of metalloproteinases
Table 3.21 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites with less or more than 3.5nun 
PD after HPT, at the reassessment visit. Geometric mean, 
95% confidence intervals and number of sites in each 
group are shown. Significance level (p value) for each
comparison is given.________________________________________
Prediction of response to treatment according to
_______________ baseline MMPs and TIMP levels_______________
Protein_____________________ n______ Mean_______95% C.I.
FIB-Collaqenase_________
PD<3.5 after HPT 68 5.1 2.8-9.3
PD>3.5 after__ HPT_______  99 3.2 2.1-5.0
t-test p-value = 0.231_____________________________________
Stromelvsin_____________
PD<3.5 after HPT 68 6.5 4.1-10.2
PD>3.5 after HPT_________  99 5.2 3.6-7.4
t-test p-value = 0.453_____________________________________
TIMP_____________________
PD<3•5 after HPT 68 219.9 185.5-260.7
PD>3.5 after HPT_______  99 235.7 197.1-281.9
t-test p-value = 0.577_____________________________________
Table 3.22 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites which did or did not bleed on 
probing after HPT, at the reassessment visit. Geometric 
mean, 95% confidence intervals and number of sites in 
each group are shown. Significance level (p value) for
each comparison is given.__________________________________
Prediction of response to treatment according to
baseline MMPs and TIMP levels
Protein n Mean 95% C.I.
FIB-Collaaenase
no BOP after HPT 105 3.0
VO•
<5*1o•CM
BOP after HPT 62 6.0 3.1-11.3
t-test p-value = 0.082
Stromelvsin
no BOP after HPT 105 5.1 3.6-7.2
BOP after HPT 62 6.8 4.2-11.0
t-test p-value = 0.350
TIMP
no BOP after HPT 105 222.8 185.8-267.2
BOP after HPT 62 240.3 207.5-278.3
t-test p-value = 0.520
Table 3.23 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between best responding sites (BRS) and 
worst responding sites (WRS) after HPTf at the 
reassessment visit. Geometric mean and 95% confidence 
intervals are shown. Significance level (p value) for
each comparison is given.___________________________________
Prediction of response to treatment according to
baseline MMPs and TIMP levels
Protein n Mean 95% C.I.
FIB-Collaaenase
BRS after HPT 15 6.0 1.5-23.6
WRS after HPT 15 7.9 2.0-31.2
t-test p-value = 0.781
Stromelvsin
BRS after HPT 15 8.0 3.2-20.2
WRS after HPT 15 4.8 2.0-12.0
t-test p-value = 0.440
TIMP
BRS after HPT 15 167.6 114.3-245.6
WRS after HPT 15 249.2 190.8-325.5
t-test p-value = 0.101
significant difference when bleeding and non-bleeding 
sites, at the reassessment appointment, were compared for 
their SL levels at the baseline (p=0.350) (Table 3.22). 
The mean baseline levels of SL also could not predict the 
response to treatment, when the state of bleeding on 
probing and pocket depth were both used as criteria for 
treatment success (two-sample t-test, p=0.387). The 
baseline levels of SL failed to distinguish BRS from WRS 
after HPT (two-sample t-test, p=0.440)(Table 3.23).
3.2.3.3 Prediction of response to treatment at the
reassessment session according to the baseline 
levels of tissue inhibitor of 
metalloproteinases
At the reassessment visit, sites with PD<3.5mm showed no 
significant difference over those with PD>3.5mm in their 
baseline GCF TIMP levels (two-sample t-test, p=0.577) (Table 
3.21). Two sample t-test did not show significant 
difference between the baseline TIMP levels in sites which 
bled on probing at reassessment and those which did not 
(p=0.520)(Table 3.22). The mean baseline level of TIMP 
could not predict the response to treatment, when the state 
of bleeding on probing and pocket depth were both employed 
as criteria for treatment success (two-sample t-test, 
p=0.192). TIMP's baseline levels also failed to
discriminate between BRS and WRS at the reassessment visit 
(two-sample t-test, p=0.101)(Table 3.23).
124
3.2.3.4 Comparison of clinical and biochemical 
parameters between the sites which did or did 
not respond to treatment at the reassessment 
examination
In order to investigate the effect of hygiene phase of 
therapy on the levels of enzymes and inhibitor in sites 
which did or did not respond to treatment, as was assessed 
by a combination of criteria, the levels of proteins as 
well as clinical parameters, at the reassessment visit, 
were compared in those sites. When different groups of 
sites i.e. sites with PD<3.5mm versus those with PD>3.5mm 
and bleeding versus non-bleeding sites were compared for 
their MGI (Mann-Whitney test), GCF volume as well as the 
mean levels of FIB-CL, SL and TIMP (two-sample t-test), no 
significant difference was observed.
3.2.3.5 Comparisons between different groups of sites 
for their GCF levels of matrix
metalloproteinases and their inhibitor at the 
reassessment examination
The experimental sites were grouped according to their 
pocket depths and state of bleeding on probing at the 
reassessment visit. One way analysis of variance showed no 
significant difference between GCF levels of MMPs and TIMP 
in groups of sites with PD<3.5mm which did or did not bleed 
on probing as well as those with PD>3.5mm and different
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bleeding status (Table 3.24).
3.2.3.6 Comparisons between best and worst responding 
sites for their GCF levels of matrix 
metalloproteinases and their inhibitor at the 
reassessment examination
Since the mean levels of FIB-CL, SL and TIMP failed to 
distinguish between different groups of sites which did or 
did not respond to treatment (sections 3.2.3.4 and 3.2.3.5) 
when the discriminating factors for treatment success were 
pocket depth and the state of bleeding on probing, using a 
more stringent criteria, the enzymes and inhibitor between 
the best responding sites (BRS)(n=15) and worst responding 
sites (WRS)(n=15) were compared. The BRS were those with 
no BOP, PD<3mm and MGI^l whereas the WRS bled on probing 
with PD>4mm and MGI^2 at the reassessment examination. 
None of the sites in both groups showed suppuration on 
probing. Two-sample t-tests demonstrated lower levels of 
FIB-CL, SL and TIMP in BRS than in WRS. However these 
differences did not reach the statistical significance 
(Table 3.20) .
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3.2.3.7 Comparisons between before and after hygiene
phase therapy of GCF volume, clinical indices, 
matrix metalloproteinases and their inhibitor 
in sites which responded to the treatment at 
the reassessment examination
The mean GCF levels of FIB-CL, SL and TIMP as well as GCF 
volume and gingival scores in sites (n=47) which responded 
to treatment, at the reassessment examination, were 
compared to their baseline levels. The mean levels of FIB- 
CL and SL decreased at reassessment, but the differences 
did not reach significance (paired t-test, p=0.672 and 
p=0.379 respectively), whereas TIMP's level increased 
significantly (p=0.002). GCF volume showed some reduction 
which was not significant, whereas PD significantly 
decreased (paired t-test, p=0.082 and p<0.001 
respectively). The mean gingival scores reduced
significantly at the reassessment examination (Sign test, 
p<0.001)(Table 3.25).
3.2.4 Prediction of response to treatment at the 
follow-up visit according to the baseline GCF 
levels of matrix metalloproteinases and their 
inhibitor
All subjects who either did or did not require further 
treatment after hygiene phase therapy were re-examined at 
the follow-up session. Among other clinical parameters,
127
Table 3.24 Comparison between GCF levels of MMPs and 
TIMP in different sites which were grouped according to 
their PD and state of bleeding on probing at the 
reassessment visit. Number of sites in each group and 
significance level (p value) for one way analysis of 
variance are given.________________________________________
FIB-CL SL TIMP
Group of 
sites
Mean 
(95% c n
Mean 
(95% c n
Mean 
(95% c n
PD<3.5mm, 
no BOP n=47
2.8 
(1.5-5.2)
4.7 
(2.9-7.7)
339.5
(251.9-457.5)
PD<3.5mm, 
BOP n=21
4.0
(1.4-11.2)
4.9
(2.2-10.7)
280.5
(185.3-424.4)
PD>3.5mm, 
no BOP n=58
2.2 
(1.4-3.6)
3.6 
(2.3-5.7)
310.3
(252.2-381.8)
PD>3. 5mm, 
BOP n=41
1.4 
(1.0-1.9)
3.3 
(1.9-5.7)
405.2
(310.2-529.3)
D value 0.123 0.684 0.369
FIB-CL= fibroblast derived collagenase 
SL= strcmelysin
TIMP= tissue inhibitor of metalloproteinases
Table 3.25 Comparisons of GCF volumes, gingival scores 
and GCF levels of MMPs and TIMP between the baseline and 
the reassessment visits in 47 sites with PD<3.5mm which 
did not bleed on probing at the reassessment examination. 
Mean ±SEM for clinical parameters and the geometric mean 
and 95% confidence intervals for proteins (pg/30s) are 
shown. Significance level (p value) for each paired t- 
test and Sign test (for gingival scores) is given._______
Baseline_________Reassessment
Parameter Mean ±SEM 
(95% c n
Mean ±SEM 
(95% c n
P
value
Vol. 0.346±0.037 0.287±0.032 0.082
MGI 3 . 1±0.093 1.7±0.106 <0.001
PD 4.7±0.132 2.8±0.063 <0.001
FIB-CL 3.5 
(1.8-6.9)
2.8 
(1.5-5.2)
0.672
SL 6.5
(3.8-11.1)
4.7 
(2.9-7.7) 0.379
TIMP 219.0
(176.4-271.9)
339.5
(251.9-457.5) 0.002
Vol•= gingival crevicular fluid volume in |xl
MGI= Modified Gingival Index
PD= pocket depth in mm
FIB-CL= fibroblast derived collagenase
SL= stromelysin
TIMP= tissue inhibitors of metalloproteinases
pocket depths as well as the status of bleeding upon 
probing to the base of the pocket/sulcus were recorded. 
The response to the treatment was considered positive if a 
site did not bleed on probing and had a pocket depth of 
<3.5mm. At this visit 107 (64.5%) of the study sites had 
a pocket depth of <3.5mm, while PD in the rest of the study 
sites (59, 35%) was >3.5mm. Out of 166 study sites 
available, 113 (68%) sites did not bleed on probing whereas 
other 53 (32%) bled upon probing. Eighty one (48.8%) sites 
neither bled upon probing nor had a PD>3.5mm at the follow- 
up examination and 27 (16.3%) sites failed to meet these 
criteria. The baseline levels of the enzymes and inhibitor 
were compared in these groups of sites. The differences in 
MMPs and TIMP between the baseline and the follow-up visits 
were also assessed. However 58 (36.1%) sites failed to 
meet both criteria together. The baseline levels of MMPs 
and TIMP, in best responding sites (BRS) (n=17) and worst 
responding sites (WRS) (n=17) were also compared in order 
to investigate their ability in predicting treatment 
outcome. Clinical and biochemical parameters in BRS and 
WRS at the follow-up examination are shown in Table 3.26.
3.2.4.1 Prediction of response to treatment at the 
follow-up session according to the baseline 
levels of fibroblast collagenase
The mean GCF levels of FIB-CL at the baseline failed to 
distinguish sites with PD<3.5mm from those with pocket
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depth of more than 3.5mm (two-sample t-test, p=0.971) (Table
3.27). Two-sample t-test showed no significant difference 
between bleeding and non-bleeding sites, at the
reassessment visit, when they were compared for their 
baseline mean levels of enzyme (p=0.416)(Table 3.28). The 
mean baseline levels of FIB-CL could not predict the 
response to the treatment, when the state of bleeding on 
probing and pocket depth were both employed as criteria for 
treatment success (two-sample t-test, p=0.192). Using the 
same statistics the baseline levels of this enzyme failed 
to differentiate between BRS and WRS (p=0.493)(Table 3.29).
3.2.4.2 Prediction of response to treatment at the
follow-up session according to the baseline 
levels of stromelysin
The mean levels of GCF SL at the baseline was able to 
predict the response to treatment at the follow-up visit. 
Two-sample t-test demonstrated a highly significant 
difference (p=0.001) between sites with PD<3.5mm and those 
with PD>3.5mm at the follow-up visit, when they were 
compared for their baseline mean GCF levels of SL (Table
3.27). The sites which did or did not bleed at the follow- 
up examination could also be differentiated based on their 
mean GCF levels of SL at the baseline visit (two-sample t- 
test, p=0.009) (Table 3.28). The mean baseline levels of 
SL was able to differentiate sites which responded to the 
treatment, when the state of bleeding on probing and pocket
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depth were both used as criteria for treatment success 
(two-sample t-test, p=0.001), although its baseline level 
was higher in sites which responded to the treatment. No 
significant difference was observed, when BRS and WRS were 
compared for their baseline levels of SL (two-sample t- 
test, p=0.055) (Table 3.29).
3.2.4.3 Prediction of response to treatment at the 
follow-up session according to the baseline 
levels of tissue inhibitor of metalloproteinases
There was no significant difference between sites with 
PD<3.5mm and sites with PD>3.5mm at the follow-up visit, 
when they were compared for their mean baseline levels of 
TIMP (two-sample t-test, 0.077)(Table 3.27). Using the 
same statistical method, it was shown that the mean 
baseline levels of TIMP could not distinguish bleeding from 
non-bleeding sites at the follow-up session (p=0.192)(Table
3.28). The mean levels of TIMP at the baseline, also 
failed to predict the response to the treatment, when both 
bleeding status and pocket depth were considered as 
criteria for treatment success (two-sample t-test, 
p=0.575). TIMP's mean baseline levels was not able to 
differentiate between BRS and WRS (two-sample t-test, 
p=860)(Table 3.29).
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Table 3.26 Comparisons of GCF volumes, gingival scores 
and GCF levels of MMPs and TIMP between best responding 
sites (BRS)(n=17) and worst responding sites (WRS)(n=17) 
at the follow-up examination. Mean ±SEM for clinical 
parameters and the geometric mean and 95% confidence 
intervals for proteins (pg/30s) are shown. Significance 
level (p value) for each paired t-test and Sign test (for 
gingival scores) is given.__________________________________
BRS WRS
Parameter Mean ±SEM 
(95% Cl)
Mean ±SEM 
(95% Cl)
p value
Vol. 0•150±0.039 0•250±0•045 0.100
MGI 0.9±0.081 2.5±0•125 <0.001
PD 2.1±0.096 5.8±0.311 <0.001
FIB-CL 2.6 
(0.9-7.8)
1.9 
(0.8-4.5) 0.656
SL 1.8 
(0.9-3.2)
4.4 
(1.9-9.8) 0.082
TIMP 51.9
(25.2-107.0) (40.1-135.3) 0.465
Vol.= gingival crevicular fluid voluna in |il
MGI* Modified Gingival Index
PD* pocket depth in nm
FIB-CL* fibroblaat derived collagenase
SL* strcsaelysin
TIMP* tissue inhibitors of netalloproteinases
Table 3.27 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites with less or more than 3.5mm 
PD at the follow-up visit. Geometric mean, 95% 
confidence intervals and number of sites in each group 
are shown. Significance level (p value) for each
comparison is given._______________________________________
Prediction of response to treatment according to
baseline MMPs and TIMP levels
Protein n Mean 95% C.I.
FIB-Collagenase
PD<3.5 at follow-up 107 3.9 2.5-6.1
PD>3.5 at follow-up 59 4.0 2.2-7.2
t-test p-value = 0.971
Stromelvsin
PD<3.5 at follow-up 107 7.8 5.5-11.2
PD>3.5 at follow-up 59 3.1 2.0-4.70
t-test p-value = 0.001
TIMP
PD<3.5 at follow-up 107 250.4 217.5-288.4
PD>3.5 at follow-up 59 194.1 151.6-248.5
t-test p-value = 0.077
Table 3.28 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites which did or did not bleed on 
probing, at the follow-up visit. Geometric mean, 95% 
confidence intervals and number of sites in each group 
are shown. Significance level (p value) for each 
comparison is given.________________________________________
Prediction of response to treatment according to 
__________ baseline MMPs and TIMP levels__________
Protein n Mean 95% C.I.
Fibroblast collaaenase
no BOP at follow-up 113 3.5 2.3-5.4
BOP at follow-up 53 4.9 2.5-9.4
t-test p-value = 0.416
Stromelvsin
no BOP at follow-up 113 7.2 5.1-10.2
BOP at follow-up 53 3.3 2.1-5.2
t-test p-value = 0.009
TIMP
no BOP at follow-up 113 217.2 184.1-256.1
BOP at follow-up 53 255.6 212.4-307.5
t-test p-value = 0.192
Table 3.29 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between best responding sites (BRS) and
worst responding sites (WRS) at the follow-up
examination. Geometric mean and 95% confidence intervals
are shown. Significance level (p value) for each
comparison is given.
Prediction of response to treatment according to 
__________ baseline MMPs and TIMP levels__________
Protein n Mean 95% C.I.
FIB-Collaaenase
BRS at follow-up 17 3.7 1.1-12.3
WRS at follow-up 17 6.6 2.1-20.6
t-test p-value = 0.493
Stromelvsin
BRS at follow-up 17 7.4 2.8-19.2
WRS at follow-up 17 2.2 1.1-4.50
t-test p-value = 0.055
TIMP
BRS at follow-up 17 200.8 142.8-282.3
WRS at follow-up 17 193.2 148.2-251.2
t-test p-value = 0.860
3.2.4.4 Comparison of clinical and biochemical 
parameters between the sites which did or did 
not respond to treatment at the follow-up 
examination
The effect of periodontal therapy on the levels of enzymes 
and inhibitor in sites which did or did not respond to 
treatment, as was assessed by a combination of criteria, 
was evaluated by comparing the levels of proteins as well 
as clinical parameters at the follow-up visit. Different 
groups of sites i.e. sites with PD<3.5mm versus those with 
PD>3.5mm and bleeding versus non-bleeding sites for their 
MGI (Mann-Whitney test), GCF volume as well as the mean 
levels of FIB-CL, SL and TIMP (two-sample t-test), at the 
follow-up visit. With the exception of the mean MGI scores 
which was significantly lower in sites with PD<3.5mm over 
those with PD>3.5mm as well as non-bleeding sites compared 
to bleeding sites at the follow-up examination, none of the 
comparisons reached the statistical significance.
3.2.4.5 Comparisons between different groups of sites 
for their GCF levels of matrix
metalloproteinases and their inhibitor at the 
follow-up examination
Different groups of sites were compared for their GCF 
levels of MMPs and TIMP at the follow-up visit. Using one 
way analysis of variance it was demonstrated that there was
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no significant difference between GCF levels of MMPs and 
TIMP in sites which did or did not bleed on probing and had 
a pocket depth of <3.5mm. The same results were obtained 
for sites with PD>3.5mm which showed different bleeding 
status (Table 3.30).
3.2.4.6 Comparisons between best and worst responding
sites for their GCF levels of matrix 
metalloproteinases and their inhibitor at the 
follow-up examination
As described in section 3.2.3.6, the mean levels of FIB-CL, 
SL and TIMP could not distinguish between different groups 
of sites which did or did not respond to treatment 
(sections 3.2.4.4 and 3.2.4.5). The discriminating factors 
for treatment success used here were pocket depth and the 
state of bleeding on probing. Using more stringent
criteria, the enzymes and inhibitor between the best 
responding sites (BRS)(n=17) and worst responding sites 
(WRS)(n=17) were compared. The criteria for the selection 
of the BRS and WRS have been described in section 3.2.3.6. 
Two-sample t-tests demonstrated lower levels of SL and TIMP 
in BRS than in WRS, although these differences were not 
statistically significant. However, the mean GCF level of 
FIB-CL was higher in BRS (Table 3.26). These results along 
with those described in sections 3.2.3.4, 3.2.3.5, 3.2.3.6, 
3.2.4.4 and 3.2.4.5 suggest that it is not possible to 
differentiate successfully treated sites from sites which
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Table 3.30 Comparison between GCF levels of MMPs and 
TIMP (pg/30s) in different sites which were grouped 
according to their PD and state of bleeding on probing at 
the follow-up visit. Number of sites in each group and 
significance level (p value) for one way analysis of 
variance are given._________________________________________
FIB-CL SL TIMP
Group of 
sites
Mean 
(95% c n
Mean 
(95% c n
Mean 
(95% c n
PD<3. 5 mm, 
no BOP n=81
1.9 
(1.3-2.8)
2.0 
(1.5-2.7)
97.1
(76.7-122.8)
PD<3. 5mm, 
BOP n=26
2.3 
(1.0-5.0)
2.2 
(1.3-3.8)
79.2
(53.9-116.5)
PD>3. 5mm, 
no BOP n=32
1.7 
(0.8-3.0)
3.1 
(1.7-5.4)
116.6
(74.3-183.2)
PD>3.5mm, 
BOP n=27
1.8 
(0.9-3.5)
3.0 
(1.6-5.8)
74.2
(48.3-114.1)
D value 0.923 0.393 0.361
FIB-CL= fibroblast; derived collagenase 
SL- stxaeielysin
TIMP= tissue inhibitor of metalloproteinases
failed to respond to treatment using a diagnostic test 
based on the levels of MMPs and TIMP in GCF. This is 
illustrated by assessing its sensitivity, specificity and 
predictive values. Since, FIB-CL and SL were not detected 
in 29 sites (85.3%) and 23 (67.7%) sites respectively, a 
test based on the value of TIMP was used. Thus, the test 
was considered positive (successful treatment) when a site 
demonstrated TIMP ^ 51.9pg/30s. This threshold value 
represents the geometric mean of TIMP in successfully 
treated sites (Table 3.26). The sensitivity of the test 
was low (24%), whereas its specificity reached 76%. Both 
positive and negative predictive values were 50%, 
indicating that in 50% of the cases a positive test would 
have misclassified a site with treatment failure as a 
successfully treated site and vice versa (Table 3.31).
3.2.4.7 Comparisons between the baseline and the follow
up levels of GCF volume, clinical indices, 
matrix metalloproteinases and their inhibitor 
in sites which responded to the treatment at 
the follow-up examination
At the follow-up examination 81 sites showed no signs of 
bleeding on probing while their PD was <3.5mm. The mean 
levels of FIB-CL, SL and TIMP in these sites, at the 
follow-up visit, were compared to their baseline levels. 
The enzymes and inhibitor mean levels showed a highly 
significant reduction at the follow-up examination (paired
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t-tests, p=0.023 for FIB-CL and p<0.001 for SL and TIMP). 
The number of sites expressing detectable amounts of FIB-CL 
reduced from 20 (12%) sites at the baseline to 10 (6%) 
sites at the follow-up visit. Significant reductions were 
observed in GCF volume and pocket depth (paired t-test, 
p<0.001) as well as in gingival scores (Sign test, p<0.001) 
at the follow-up examination (Table 3.32).
3.2.4.8 Correlation between the response to treatment
and the baseline levels of metalloproteinases 
and their inhibitor on a subject basis
In order to investigate if the average baseline levels of 
FIB-CL, SL, and TIMP could be associated with the 
percentage of sites which bled on probing or had a PD>3.5mm 
at the reassessment and the follow-up examinations, with 
subject as a unit of analysis, the Pearson correlation 
coefficient tests were performed on log10 transformed data. 
The average levels of the enzymes and the inhibitor were 
obtained by averaging the subjects' mean levels. The only 
significant association was found between the percentage of 
sites with a pocket depth of more than 3.5mm at the follow- 
up visit and the average baseline levels of SL (r=-0.4872, 
p=0.025)(Table 3.33). The significance of this finding is 
further reduced by Bonferroni correction which renders it 
insignificant. SL showed negative and insignificant 
correlation with sites having PD>3.5mm at the reassessment 
as well as with bleeding sites at both the reassessment and
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the follow-up examinations. However, there was no 
significant correlation, either positive or negative, 
between the FIB-CL and TIMP's baseline levels with bleeding 
sites as well as sites with PD>3.5mm at both post therapy 
visits (Table 3.33).
3.2.5 Changes in attachment levels after hygiene phase 
therapy and at the follow-up examination
At each of the three examination visits, two attachment 
level measurements were taken from the study sites. This 
experimental design provided a measure of examiner error 
during the study as well as the appropriate measures for 
the use of the tolerance method for detecting attachment 
level changes (section 2.4.2.1).
After hygiene phase therapy, at the reassessment 
examination 24 (14.4%) sites, in 12 subjects, demonstrated 
significant attachment gain whereas, attachment loss was 
not observed in any site. According to the follow-up 
attachment level measurements, 25 sites (15%), in 11 
subjects, had gained attachment from the baseline levels. 
However, at this visit 5 (3%) sites within 3 patients
showed significant attachment loss from the baseline.
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Table 3.31 Characteristics of a diagnostic test based on 
the levels (pg/30s) of tissue inhibitor of 
metalloproteinases (TIMP) at the follow-up examination. 
Sensitivity, specificity and positive and negative 
predictive values are shown.
Positive test
IIMPS51.9pg/30s
Negative test
TZMP>51.9pg/30s
Successful
treatment
Unsuccessful
treatment
4 4
13 13
Positive
Predictive
Value
50%
Negative
Predictive
Value
50%
Sensitivity Specificity
24% 76%
Table 3.32 Comparisons of GCF volumes, gingival scores 
and GCF levels of MMPs and TIMP between the baseline and 
the follow-up visits in 81 sites with PD<3.5mm which did 
not bleed on probing at follow-up examination. Mean ±SEM 
for clinical parameters and the geometric mean and 95% 
confidence intervals for proteins (pg/30s) are shown. 
Significance level (p value) for each paired t-test and
Baseline Follow-up
Parameter Mean ±SEM 
(95% Cl)
Mean ±SEM 
(95% Cl)
p value
Vol. 0.395±0•033 0.173±0.016 <0.001
MGI 3.1±0.074 1.2±0.069 <0.001
PD 5.3+0.139 2.6±0.065 <0.001
FIB-CL 3.6 
(2.2-6.0)
1.9 
(1.3-2.8) 0.023
SL 8.8
(5.8-13.2)
2.0 
(1.5-2.7) <0.001
TIMP 236.6
(202.0-277.1)
97.1
(76.7-122.8) <0.001
Vol. = gingival crevicular fluid volume in |il
MGI= Modified Gingival Index
PD= pocket depth in am
FIB—CL* fibroblast derived collagenase
SL= stromelysin
TIMP** tissue inhibitor of netalloproteinases
Table 3.33 Pearson correlation coefficients on loglO 
transformed data between the percentage of sites in each 
subject that bled on probing or had PD>3.5mm at the 
reassessment (after HPT) and the follow-up visits and 
averaged baseline levels of MMPs and TIMP in 21 subjects. 
Correlation coefficients (r) and significance levels (p 
values) are given.___________
Response to treatment according to baseline MMP and 
inhibitor levels correlations n=21 subiects
Mean
Protein
%sites 
with BOP 
after HPT
%sites 
with BOP 
at follow- 
up
%sites 
with 
PD>3.5 
after HPT
%sites 
with 
PD>3.5 at 
follow-up
FIB-CL r=0.126 
p=0.586
r=0.155 
p=0.504
r=0.013 
p=0•955
r=0.135 
p=0.558
SL r=-0.279
p=0.221
r=-0.153 
p=0.508
r=-0.233 
p=0.310
r=-0.487 
p=0.025
TIMP r=-0.050 
p=0.830
r=-0.144 
p=0.534
r=0.189 
p=0.412
r=-0.403 
p=0.070
FIB-CL= fibroblast derived collagenase 
SL* stromelysin
TIMP= tissue inhibitor of netalloproteinases
3.2.5.1 Prediction of response to the treatment from the 
changes in the attachment levels at the 
reassessment and the follow-up examinations 
according to the baseline levels of matrix 
metalloproteinases and their inhibitor
Using a more accurate approach, the response to the 
treatment in relation to the baseline levels of the enzymes 
and the inhibitor was assessed. In order to investigate if 
the baseline levels of FIB-CL, SL and TIMP could 
differentiate between sites which showed attachment gain 
and those which remained unchanged at the reassessment 
visit, each site demonstrating attachment gain (n=24) was 
matched with an unchanged site for its GCF volume and 
clinical indices at the baseline. Two-sample t-test showed 
no significant difference between the mean baseline levels 
of the enzymes and the inhibitor when two groups of sites 
were compared (Table 3.34). The same procedure was 
performed for the sites which exhibited attachment gain at 
the follow-up examination (n=25). No significant 
difference was found in the mean baseline levels of FIB-CL 
and SL between the sites which gained attachment and their 
matched controls (two-sample t-test)(Table 3.35).
136
3.2.5.2 Comparisons between before and after hygiene
phase therapy of GCF volume, clinical indices, 
matrix metalloproteinases and their inhibitor 
in sites which demonstrated attachment gain at 
the reassessment examination
Attempts were made to investigate if the mean GCF levels of 
FIB-CL, SL and TIMP in sites which responded to HPT by 
attachment gain differ from their baseline levels. Using 
paired t-tests, the mean levels of the SL and the inhibitor 
in sites which gained attachment at the reassessment 
examination were compared with their levels at the 
baseline. The mean level of SL decreased significantly 
(p=0.029) after HPT, whereas TIMP's level increased, 
although it did not reach the statistical significance 
(p=0.307). The number of sites with detectable levels of 
FIB-CL reduced to half at the reassessment visit (4 sites, 
(16.7%)). The change in the GCF volume was not significant 
(paired t-test, p=0.427). However, there was a decrease in 
GCF volume at this visit. The mean pocket depth (paired t- 
test, p<0.001) as well as the mean gingival scores (Sign 
test, p<0.001) showed a significant reduction at the 
reassessment examination (Table 3.36).
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Table 3.34 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites which showed attachment gain 
and their baseline matched controls which did not show 
attachment gain after HPT, at the reassessment visit. 
Geometric mean and 95% confidence intervals are shown.
Significance level (p 
given.
value) for each comparison is
Prediction of response to treatment according to 
baseline MMPs and TIMP levels
Protein n Mean 95% C.I.
FIB-Collagenase
AL gain after HPT 24 5.5 2.0-15.4
AL unchanged after HPT 24 2.8 1.2-6.40
t-test p-value = 0.296
Stromelysin
AL gain after HPT 24 9.9 4.6-21.2
AL unchanged after HPT 24 7.1 3.3-15.3
t-test p-value = 0.536
TIMP
AL gain after HPT 24 231.7 170.2-315.5
AL unchanged after HPT 24 290.8 217.6-388.7
t-test p-value = 0.289
Table 3.35 Baseline levels of MMPs and TIMP (pg/30s) 
were compared between sites which showed attachment gain 
and their baseline matched controls which did not show 
attachment gain at the follow-up visit. Geometric mean 
and 95% confidence intervals are shown. Significance 
level (p value) for each comparison is given.___________
Prediction of response 
baseline MMPs
to treatment according to 
and TIMP levels
Protein n Mean 95% C.I.
Fibroblast collagenase
AL gain at follow-up 
AL unchanged at follow-up
25
25
5.0
4.3
1.9-13.1
1.9-10.4
t-test p-value = 0.826
Stromelysin
AL gain at follow-up 
AL unchanged at follow-up
25
25
9.4
6.5
4.4-20.2
3.3-12.8
t-test p-value = 0.446
TIMP
AL gain at follow-up 
AL unchanged at follow-up
25
25
251.4
229.9
192.5-328.4
182.6-289.5
t-test p-value = 0.614
Table 3.36 Comparisons of GCF volumes, gingival scores, 
PD and GCF levels of SL and TIMP between the baseline and 
the reassessment visits in 24 sites which demonstrated 
attachment gain at the reassessment examination (after 
HPT). Means ±SEM for clinical parameters and the 
geometric mean and 95% confidence intervals for the 
proteins (pg/30s) are shown. Significance level (p 
value) for each paired t-test and Sign test (for gingival 
scores) is given.__________________________________________
Baseline Reassessment
Parameter Mean ±SEM 
<95% Cl)
Mean ±SEM 
<95% Cl)
p value
Vol. 0.397+0.057 0.34110.058 0.463
MGI 3.5+0.104 1.710.138 <0.001
PD 6.5±0.293 3.710.234 <0.001
SL 9.9
(4.6-21.2)
3.1 
(1.9-5.6) 0.029
TIMP 231.7
(170.2-315.5)
291.3
(217.0-391.2) 0.307
Vol.= gingival crevicular fluid volume in pi 
MGI= Modified Gingival Index 
PD= pocket depth in m  
SL= atrooelyain
TIMP= tissue inhibitor of metalloproteinases
Table 3.37 Comparisons of GCF volumes, gingival scores 
and GCF levels of SL and TIMP between the baseline and 
the follow-up visits in 25 sites which demonstrated 
attachment gain at the follow-up examination. Mean ±SEM 
for clinical parameters and the geometric mean and 95% 
confidence intervals for proteins (pg/30s) are shown. 
Significance level (p value) for each paired t-test and 
Sign test (for gingival scores) is given.________________
Baseline_______ Follow-up
Parameter Mean ±SEM 
<95% Cl)
Mean ±SEM 
<95% Cl)
p value
Vol. 0.38710.051 0.22010.040 0.002
MGI 3.410.114 1.410.151 <0.001
PD 6.410.289 3.010.147 <0.001
SL 9.4
(4.4-20.2)
2.0 
(1.5-2.7) 0.003
TIMP 251.4
(192.5-328.4)
115.9
(71.5-188.0) 0.005
Vol.= gingival crevicular fluid volume in pi 
MGI= Modified Gingival Index 
PD= pocket depth in mm.
SL= stromelysin
TIMP= tissue inhibitors of metalloproteinases
3.2.5.3 Comparisons between the baseline and the follow- 
up levels of GCF volume, clinical indices, 
matrix metalloproteinases and their inhibitor in 
sites which showed attachment gain at the 
follow-up examination
Twenty five sites demonstrated significant attachment gain 
at the follow-up visit. The mean levels of SL and TIMP at 
the follow-up visit were compared to their baseline levels. 
Both the enzyme and the inhibitor mean levels showed a 
highly significant reduction at the follow-up examination 
(paired t-tests, p=0.003 for SL and p=0.005 for TIMP). The 
number of sites expressing detectable amounts of FIB-CL 
reduced from 8 (25%) sites at the baseline to 1 (4%) site 
at the follow-up visit. Significant reductions were 
observed in GCF volume and pocket depth (paired t-test, 
p=0.002 and p<0.001 respectively) as well as gingival 
scores (Sign test, p<0.001) at the follow-up examination 
(Table 3.37).
3.2.5.4 Correlation between clinical findings and GCF 
levels of matrix metalloproteinases and their 
inhibitor in sites which gained attachment at 
the reassessment and the follow-up examinations
Since the reduction in the mean levels of the enzymes and 
inhibitor was concomitant with the a reduction in GCF 
volume, MGI and PD in sites with attachment gain at the
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reassessment and the follow-up examinations, in order to 
illustrate any possible relation between clinical and 
biochemical parameters, the association of SL and TIMP with 
clinical parameters was investigated. Using Spearman rank 
correlation coefficients, it was found that only TIMP had 
a strong positive correlation with GCF volume at both 
reassessment (r=0.609, p=0.002) and the follow-up (r=660, 
p<0.001) visits, whereas SL was correlated with GCF volume 
only at the reassessment examination (r=0.493, p=0.014). 
Pocket depths and gingival scores showed no significant 
association with the mean levels of SL and TIMP at both 
visits. However, because very small number of sites 
expressed detectable amounts of FIB-CL, no attempt was made 
to correlate its GCF level with the clinical parameters.
3.2.6 Prediction of treatment needs according to the 
baseline levels of metalloproteinases and their 
inhibitor
Response to the treatment after HPT was evaluated at the 
reassessment examination. Sites were assigned to three 
groups for their further treatment needs according to their 
pocket depths at this visit. One way analysis of variance, 
was used to investigate if the levels of the enzymes and 
inhibitor at the baseline visit could predict further 
treatment required after HPT. However, the mean baseline 
levels of MMPs and TIMP failed to distinguish between 
different treatment modalities needed after HPT. These
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findings suggest that the baseline levels of the FIB-CL, SL 
and TIMP in GCF can not be used as predictors of further 
treatment needs and treatment response and these proteins 
are probably best suited for monitoring or disclosing the 
current tissue host response status.
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CHAPTER 4 
DISCUSSION
4.1 Methodological considerations
4.1.1 Choice of threshold for further treatment needs
Generally accepted PD thresholds upon which further 
treatment needs are decided in routine clinical practice 
for sites which bleed on probing are: PD>3nun for re-root 
planing and PD>5mm for surgical intervention based on the 
findings that complete removal of subgingival deposits is 
difficult in PD ranging from 3 to 5mm whereas it is 
extremely difficult in sites with PD>5mm (Waerhaug 1973; 
Rabbani et al., 1981). In the longitudinal study 
conventional and Florida probing measurements, taken at the 
same visit, were compared at the reassessment and the 
follow-up examinations. Florida probe readings were higher 
than conventional probing. Therefore in analyzing the 
reassessment and the follow-up data the above mentioned 
thresholds were changed to 3.5 and 5.5mm in order to 
compensate for the difference observed. When the readings 
of the two methods of probing measurements were compared at 
the baseline visit conventional probing measurements were 
found to be higher than Florida probe readings. However, 
Florida probe measurements were made at least one week 
after conventional probing at which visit patients had 
received oral hygiene instructions which may have 
influenced the gingival tissue tonus thus, resulting in 
lower pocket readings. The follow-up examination was
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postponed for 4 weeks in subjects who had received surgical 
treatment as visual inspection as well as gentle probing in 
non-study sites showed signs of inflammation, six weeks 
following the treatment session.
4.1.2 Detection of attachment level changes
The selection of method for detection of attachment changes 
is crucial. Haffajee et al. (1983b) compared three 
different methods namely linear regression analysis, 
running median and tolerance method. The authors concluded 
that the "tolerance method" is superior to the two other 
methods for its ability in detecting changes over a short 
period of time as well as considering patient and 
population variances in addition to site variance. Aeppli 
and Pihlstrom (1989) reached the same conclusion. Fleiss 
et al. (1991) have also reported that variances for 
replicate measurements differs from patient to patient and 
even from site to site. In our longitudinal study, because 
of its relatively short duration and the necessity for 
detecting attachment level changes between individuals, the 
"tolerance method" was employed. It must also be kept in 
mind that attachment gain after periodontal therapy may not 
necessarily reflect the true connective tissue attachment 
level as the quality and tonus of gingival tissue improve 
following therapy which in turn offers a greater resistance 
to passage of the probe between the tooth and the gingiva 
(Magnusson & Listgarten, 1980; Fowler et al., 1982).
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However, no analysis was performed on sites which showed 
attachment loss after treatment since it might has been 
caused by subgingival instrumentation and remodelling of 
attachment levels during the healing (Badersten, Nilveus & 
Egelberg, 1987; Vanooteghem et al., 1990) and can not be, 
necessarily, taken as a sign of disease progression.
4.1.3 Quantification of gingival crevicular fluid 
matrix metalloproteinases and their inhibitor
The enzyme linked immunosorbent assay (ELISA) is being used 
increasingly in clinical laboratories for the assessment of 
constituents of biological fluids. ELISAs have taken the 
place of other methods such as radioimmunoassay, as they do 
not have the problem of radiation danger, as well as 
immunofluorescence techniques. The ELISA methodology also 
provides precision and low detectability limits, although 
visual assessment is possible, results can be automatically 
obtained using spectrophotometer. Performing preliminary 
experiments, described in chapter 2, the ELISAs used in 
these studies were validated and proven suitable for the 
quantification of MMPs and TIMP in GCF.
The ELISA methodology has the following inherent problems 
which may introduce erroneous results or make their 
interpretation difficult:
143
a) High background
The background of an assay can be determined by evaluating 
the OD readings in the control wells which contain no 
sample or standard. High background can readily obscure 
the results of positive samples, thus making the 
interpretation difficult. Increasing the number and 
efficiency of the wash steps as well as using a non­
specific protein i.e. bovine serum albumin (BSA) to bind 
unreacted sites on the solid phase may solve the problem 
(Carpenter, 1992). However, in these experiments there was 
not such a problem as the OD for control wells were much 
lower than those obtained for both samples and standards 
ranging from 0.004 to 0.01.
b) Edge effect
It has been noticed that outside wells of a plate may 
absorb more protein than the inside wells thus, resulting 
in an assay bias (Tijssen, 1985; Carpenter, 1992). In 
order to avoid this phenomenon (edge effect) only the 
inside wells were used for running samples and controls 
(Tijssen, 1985).
c) Hook effect
The hook effect is an unexpected fall in the amount of a 
substance at the high end of the dose-response curve, 
resulting in a gross underestimation of the substance 
(Carpenter, 1992). However, in these experiments the 
possibility of hook effect was negated as assaying serial
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dilutions of GCF eluates (chapter 2) did not demonstrate 
such an effect •
4.1.4 Reporting of gingival crevicular fluid 
constituents
The traditional method of expressing result from biological 
fluid analysis is in terms of concentrations (activity or 
amount of constituent per unit volume). When reporting 
data with this method, it is assumed that each sample 
contains an equal volume of fluid which is representative 
of the total fluid volume. As it has been pointed out by 
Lamster et al. (1986), expressing the data as a 
concentration might not be appropriate for GCF components. 
GCF differs from most other biological fluids in that it is 
produced in micro-amounts (generally <1^1) in the crevice 
and is constantly cleared towards the oral cavity. The 
amounts of GCF present in different sulci are extremely 
variable and usually, most or all of the fluid present in 
the crevice is removed by sampling. Thus, collecting 
standardized amounts of GCF may increase the gingival 
capillary permeability which results in the influx of the 
serum to the crevice and consequent dilution of the GCF 
components. When sampling time is standardized, expressing 
results as absolute amounts with a standardised collection 
time seems more appropriate for GCF biochemical components 
(Lamster et al., 1986, 1988; Smith & Geegan, 1991).
Reporting GCF constituents as absolute amounts has other
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advantages as the calculation of GCF volumes is not 
required for its determination. As it was mentioned above 
GCF volumes are usually below lp,l which makes their precise 
measurement difficult. In the assessment of GCF volumes, 
the Periotron is considered accurate, however small errors 
in the estimation of the latter would result in large 
alterations in the concentrations of GCF components 
(Lamster et al., 1988). When GCF volumes are extremely 
low, losses from evaporation could easily occur both during 
sampling and transferring the sample to the Periotron.
4.2 The choice of gingival crevicular fluid
components to be examined
These studies were carried out to investigate the level of 
FIB-CL, SL and TIMP in GCF samples from healthy, gingivitis 
and periodontitis sites in the same individuals (cross- 
sectional study) as well as comparing their levels before 
and after periodontal therapy and their ability to predict 
treatment outcome (longitudinal study). The reasons for 
choosing these MMPs and TIMP are: a) these fibroblast
derived enzymes and inhibitor have never been assessed 
before in GCF; b) most of the previous studies in the 
literature have focused on PMN derived enzymes in GCF 
(Ohlsson et al., 1973; Sorsa et al., 1990; Overall et al., 
1991); c) TIMP appears to preferentially inhibit FIB-CL and 
SL (Banda et al., 1992); d) the ability of SL in activating 
FIB-CL (Unemori et al., 1991); and finally e) the fact that
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all these components are secreted by resident cells 
(MacNaul et al., 1990).
A number of studies have shown that FIB-CL, SL and TIMP are 
locally produced by resident cells in gingival tissues 
(Woolley & Davies, 1981; Heath et al., 1982; MacNaul et 
al., 1990; Nomura et al., 1993). However, the extent of 
local production of proteins can be assessed using the 
relative coefficient of excretion (RCE). In order to 
calculate RCE, the GCF:serum ratios of both protein and 
albumin are calculated. The ratio of these two ratios 
(protein ratio:albumin ratio) gives the RCE which if is >1 
indicates local production of protein being more than its 
serum contribution and vice versa (Giannopoulou et al., 
1990). This experiment was not necessary to be carried out 
in the present studies because of the local production of 
these proteins and therefore, their negligible levels in 
serum in otherwise healthy subjects.
Some investigators have shown that repeated sampling 
resulted in a reduction in total amounts of GCF components 
(Lamster et al., 1989; Persson & Page, 1990). Therefore, 
in order to increase the chance of a higher detection rate 
for these proteins stagnant samples were assayed. However, 
the discovery later of the difficulty of detecting FIB-CL 
and to a lesser extent SL even in stagnant GCF samples 
suggests that the use of successive samples may result in 
even lower detectability for these enzymes.
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4.3 Cross-sectional study
4.3.1 Study design
In order to permit within subjects comparisons, samples 
were taken from different sites within the same individual 
and data were analyzed by the use of repeated measures 
analysis of variance (MANOVA) in which variables are not 
considered independent. By employing this experimental 
design, the host effect was also allowed for. Attempt was 
made to sample periodontitis sites with low gingival scores 
in order to be different from gingivitis sites as far as 
the degree of gingival inflammation of the tissues adjacent 
to the pocket was concerned. However, considering 
difficulties in finding different sites (healthy, 
gingivitis and periodontitis) in the same individual only 
three sites from each patient comprised the study sites.
4.3.2 Clinical findings
The mean GCF levels of SL was able to differentiate between 
healthy and diseased (gingivitis and periodontitis) sites 
which could render this GCF component a possible marker of 
inflammatory periodontal disease. Birkedal-Hansen et al. 
(1993) have also suggested that SL may act as a marker of 
stromal cell involvement in the process of tissue 
degradation. Villela et al. (1987), found PD to be good 
indicator of protease activity. However, in the present
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study there was no significant difference between the GCF 
levels of SL in gingivitis and periodontitis sites in spite 
of the presence of much shallower pockets in the former. 
There are several explanations in the literature for this 
observation, a) Considering that our antibodies detected 
total levels of proteinases (active plus latent), this 
observation could be explained by the finding of 
Kryshtalskyj, Sodek and Ferrier (1986) who reported that 
periodontitis sites had higher active collagenase compared 
to latent enzyme whereas, in gingivitis sites latent enzyme 
was higher than the active form of collagenase and the 
observation of Hayakawa et al. (1994) who reported that 
most of the collagenase in whole saliva of healthy subjects 
was in latent form while, enzyme present in whole saliva 
from periodontitis patients was active. This is further 
supported by a recent report (McCulloch, 1994) indicating 
that active collagenase was able to distinguish between 
gingivitis and periodontitis sites, b) In this cross- 
sectional investigation probing depths were the 
differentiating factor between gingivitis and periodontitis 
sites. Probing depth measurements taken at one point in 
time are indicative of past history of periodontal disease 
and do not necessarily reflect active periodontal 
destruction, indicating that all the periodontitis sites 
may not have been active at the time of sampling. Thus, 
the SL's levels in these sites may not necessarily be 
indicative of ongoing periodontal destruction. This is 
supported by the finding of Lee et al. (1991) who found
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higher collagenase activity in active sites than in 
inactive sites with comparable pocket depths, c) In 
addition, inflammation present superficially in gingivitis 
sites and at the depth of the pocket (Armitage et al., 
1977; Caton et al., 1981) may in periodontitis sites 
obscure the picture.
The mean GCF levels of TIMP could distinguish between 
healthy and diseased (gingivitis and periodontitis) sites. 
This GCF component could also be considered a possible 
marker of inflammatory periodontal disease. The fact that 
TIMP was higher in diseased sites than healthy sites is in 
agreement with findings of Nomura et al. (1993) who found 
the same results for TIMP mRNA in the periodontal tissues. 
This may be due to the fact that bacterial stimuli 
initially induce MMP expression by host cells causing an 
increase in tissue self destruction. Thereafter, the host 
cells recognize the ongoing tissue destruction and attempt 
to defend the host by producing tissue inhibitor of 
metalloproteinases (TIMP). However, in contrast to the 
aforementioned study and the present study, Larivee and co­
workers (1986) concluded that the activity of inhibitor is 
higher in healthy sites than in diseased sites. This 
discrepancy could be attributed to different GCF sampling 
methodology. They collected GCF by micro-capillary tubes 
following a 3 minute GCF sampling by means of paper strips 
for determining GCF flow. Both methods of GCF collection 
are thought to irritate the gingival tissues (Cimasoni,
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1983) and could increase the vascular permeability in the 
area, resulting in a dilution of the locally derived 
components. Moreover, considering the method they used for 
GCF collection, only excluding blood contaminated samples 
does not rule out the possibility of analyzing other mainly 
serum derived inhibitor e.g. a2-M. Although, it has been 
shown that a2-M is higher in diseased sites than in healthy 
ones (Adonogianaki, Mooney & Kinane, 1992). In our study 
a less invasive method of GCF collection (paper strips for 
30s) was used. In addition to sampling methodology
discrepancies, the present study reports the amount of 
enzymes rather than their activity as did the study of 
Larivee et al. (1986). However, the mean GCF levels of 
TIMP was not able to differentiate between gingivitis and 
periodontitis sites. The same results have been obtained 
by Adonogianaki et al. (1992) who investigated the levels 
of a2-M and al-antitrypsin (al-AT) in healthy, gingivitis 
and periodontitis sites. Considering the above argument 
indicating TIMP's production being provoked by destructive 
effects of MMPs along with the observation that SL's level 
did not differ significantly between gingivitis and 
periodontitis sites, the inability of TIMP in 
differentiating gingivitis from periodontitis is 
understandable.
Generally, it could also be suggested that the alteration 
in the levels of these GCF constituents may be initiated 
during the development of gingivitis and relate to this
151
inflammation rather than periodontal destruction. This view 
could also be supported by: the findings of Cao and Smith 
(1989) who measured the levels of myeloperoxidase; 
Adonogianaki et al. (1992) who analyzed the GCF levels of 
a2-M, al-AT and transferrin (TF) and; Ebersole et al.
(1993) who compared PGE2, IL-lfl and IL-2 in GCF from 
healthy, gingivitis and periodontitis sites.
The distribution of SL and TIMP in different diagnostic 
categories of sites visualised using mean values does not 
reflect the case in every individual. Various individuals 
respond differently and present with different tissue 
destructive potential in response to bacterial stimuli.
The observation that healthy, gingivitis and periodontitis 
sites in newly referred patients showed higher, although 
not statistically significant, levels of SL and TIMP than 
similar sites in maintenance patients, is consistent with 
the finding of Ebersole et al. (1993). These workers 
reported that the levels of PGE2 and IL-J3 were lower in 
healthy sites from healthy subjects than healthy sites 
within refractory periodontitis patients, and gingivitis 
sites from healthy subjects had lower levels of PGE2 than 
those in adult periodontitis and refractory periodontitis 
patients. These observations may indicate the presence of 
an intrinsic contribution from the individuals with 
different disease status into the local host response and 
therefore suggests that in studying GCF biochemical
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components subjects should be used as a basis for analysis.
In conclusion, this cross-sectional study showed that 
although the mean GCF levels of SL and TIMP were able to 
differentiate between healthy and diseased sites they 
failed to distinguish gingivitis from periodontitis sites.
4•4 Longitudinal study
4.4.1 Study design
The clinical design of this experiment allowed us to 
evaluate the effect of treatment on the GCF levels of MMPs 
and TIMP as well as the ability of these GCF constituents 
in predicting the response to treatment. By the 
measurement of both pocket depth and attachment level, it 
became possible to assess the above mentioned goals using 
different approaches. In order to prevent the possible 
leakage of GCF from neighbouring teeth, sampling of 
adjacent sites was avoided. Adult periodontitis patients 
were included in the study in an attempt to eliminate any 
possible effects of different disease category on the 
levels of enzymes as well as outcome of treatment. 
However, the inclusion of some sites in the study in each 
individual, while the entire dentition had to receive 
treatment imposed some problems when further treatment was 
delivered. As a result of these problems some of the study 
sites were overtreated due to their inclusion in a sextant
153
with its majority of non-study sites having deep pockets 
after hygiene phase therapy. By the use of MANOVA for 
analysis of the data, the host response was allowed for.
4.4.2 Baseline findings
The observation that FIB-CL was only detected in 26.8% of 
the sites is consistent with our cross-sectional study. SL 
was detectable in 48% of the sites which is lower than our 
previous finding. In spite of the two other GCF 
components, not surprisingly, TIMP was detected in almost 
all the sites (99.4%). This finding could be explained by 
the fact that there are other MMPs in the inflamed gingiva 
which collectively increase tissue destruction and this 
stimulates TIMP production (Nomura et al. 1993). Bleeding 
on probing and suppuration are traditionally considered to 
be signs of disease activity as well as indicative of 
further treatment need (Haffajee et al., 1983a and 
Badersten et al., 1990). Therefore, we compared the GCF 
levels of SL and TIMP in these different groups of sites. 
SL was able to differentiate between bleeding and non­
bleeding sites. This enzyme failed to discriminate 
suppurating from non-suppurating sites although its level 
was higher in the latter. Mean GCF levels of TIMP could 
not differentiate bleeding from non-bleeding and 
suppurating from non-suppurating sites. However, the 
levels of TIMP, although not statistically significant, 
were higher in bleeding and suppurating sites. Analyses
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were performed for three different pocket depth groups and 
it was noted that none of the enzymes and inhibitor could 
discriminate between different groups of sites. The 
observation that SL was significantly higher in bleeding 
sites and both the enzyme and inhibitor were higher in 
bleeding and suppurating sites may indicate the presence of 
a higher degree of inf lamination as well as more destructive 
activity in these groups of sites. However, although the 
latter is almost impossible to prove by the use of 
available clinical indices in a cross-sectional manner the 
validity of the former seems reasonable. The fact that PD 
may reflect prior disease experience and not necessarily 
current destruction (Haffajee et al,, 1983a) might be the 
reason behind the inability of MMPs and TIMP in 
discriminating different pocket depth groups.
4.4.3 Changes in GCF volume and clinical indices as a 
result of treatment
As expected, after the hygiene phase of therapy at the 
reassessment visit, as well as at the follow-up visit, GCF 
volume, AL and PD measurements, BOP, suppuration as well as 
gingival and plaque scores reduced significantly with both 
site and subject as the unit of analysis. These findings 
are indicative of an overall treatment success. However, 
at both occasions and particularly after HPT, there were 
some sites which did not respond to treatment. Mean GCF 
volume and PD measurement reduced significantly at the
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follow-up from the reassessment, indicating further 
improvement in gingival tissue condition. The observation 
that the mean AL, although not significantly, increased at 
the follow-up from the reassessment visit may reflect the 
effects of over treatment in some sites, which was 
inevitably performed in sextants which underwent surgical 
therapy due to the majority of the sextants' sites having 
persistent pockets.
4.4.4 Changes in GCF levels of matrix
metalloproteinases and their inhibitor as a 
result of treatment
The changes in the mean GCF levels of MMPs and TIMP, as a 
result of treatment, were investigated in the total study 
sites as well as in different groups of sites. In the 
whole sample, SL levels reduced after treatment at both 
after treatment examinations although its reduction was not 
significant at the reassessment visit. After hygiene phase 
therapy, the mean GCF levels of TIMP increased whereas, it 
showed a sharp reduction at the follow-up visit. Both 
changes were statistically significant. These trends were 
observed, either directionally or significantly, when 
before and after treatment levels of SL and TIMP were 
compared in different groups of sites. The observation 
that the mean levels of SL, in the best responding sites 
(BRS), in sites which gained attachment and in sites with 
some signs of improvement i.e. no BOP and PD reduction,
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decreased after treatment at both following examinations 
was not unexpected as a result of treatment success. These 
are in agreement with the findings of Larivee et al.
(1986), Gangbar et al. (1990), Suomalainen (1992) and 
Hayakawa et al. (1994). TIMP's level increased after HPT 
in these groups of sites which is in accordance with the 
findings of Larivee et al. (1986) and Hayakawa et al.
(1994) who reported an increase in inhibitor's level after 
treatment. This increase, although not significant, may 
reflect TIMP's involvement in the healing process. At the
follow-up visit the mean level of TIMP reduced
significantly from the baseline in all different groups of 
sites. To further elucidate this finding, the case is 
discussed in detail in group of sites which gained 
attachment after therapy. The decrease in TIMP's level at 
the follow-up visit following its increase after HPT could 
be explained by the observations that the inflammatory 
process has subsided and gingival tissues are being healed 
particularly in the light of the fact that more than one 
third of the sites which showed attachment gain at the 
follow-up visit had not received further treatment after 
HPT. Further evidence for this speculation is the 
observation that SL level showed a 3 times reduction at the 
reassessment visit while it decreased 4.5 times at the 
follow-up examination.
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4.4.5 Comparison of matrix metalloproteinases and
their inhibitor in sites which did or did not 
respond to treatment
The finding that the levels of FIB-CL, SL and TIMP in sites 
which failed to respond to treatment showed the same 
pattern of change as those which responded to treatment was 
unexpected, as they were still presenting with signs of 
disease. The following explanation could be provided to 
explain this observation: a) although these sites had no 
significant attachment gain, their clinical conditions had 
improved significantly after treatment; b) since our 
antibodies detected total enzyme (latent and active), the 
possibility can not be ruled out that the active enzyme has 
been lower in sites which gained attachment or had shallow 
pockets than those that showed no attachment gain or had 
deep pockets, as was the case in the studies carried out by 
Larivee et al. (1986) and Suomalainen (1992); c) treatment 
resulted in an alteration in the composition as well as 
reduction in the bacterial deposits and removal of the 
inflamed gingival tissues in both groups of the sites; d) 
the overall improved clinical condition, in an individual, 
may exert an indirect influence on the level of MMPs and 
TIMP in sites which did not respond to treatment, which is 
in agreement with the findings of Ebersole et al. (1993). 
These workers reported that the levels of PGE2 and IL-J3 
were lower in healthy sites from healthy subjects than 
healthy sites within refractory periodontitis patients and
158
gingivitis sites from healthy subjects had lower levels of 
PGE2 than those in adult periodontitis and refractory
periodontitis patients. Gustafsson et al. (1994) have also 
reported that elastase activity was higher in gingivitis 
sites from patients with periodontitis than clinically 
comparable gingivitis sites from gingivitis affected 
individuals. These results are consistent with our 
findings in the cross-sectional study in which the GCF 
levels of FIB-CL, SL and TIMP were lower in healthy,
gingivitis and periodontitis sites in subjects on 
maintenance care (with only few diseased sites) than 
patients with advanced periodontal disease.
Since the best responding sites (BRS) and worst responding 
sites (WRS) represent two extremes of response to treatrent 
their clinical and biochemical parameters are discussed 
separately.
Comparisons of the clinical and biochemical parameters 
between BRS and WRS at the reassessment examination 
revealed that although the mean GCF volume was 2 fold 
higher in WRS than in BRS, both groups of sites had almost 
the same levels of SL and TIMP in their GCF and FIB-CL was 
even lower in WRS. These proportional discrepancies 
between GCF volume, SL and TIMP was also observed in the
follow-up visit with SL showing the most prominent
difference (2.4 fold) between the two groups of sites. 
These differences between GCF volume and GCF levels of
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proteins may imply the local production of FIB-CL, SL and 
TIMP. One interesting finding here is that TIMP's level in 
the BRS, at the reassessment visit, whose average PD is 
2.6mm was 5 fold higher than in the WRS at the follow-up 
visit with an average PD of 5.8mm. The higher level of 
TIMP, even in the BRS, after HPT may reflect its 
involvement in the healing process. The lower level of 
TIMP, even in the WRS, at the follow-up visit from 
reassessment could be explained by the observations that 
inflammatory process has subsided and gingival tissues are 
healing. The levels of TIMP in both BRS and WRS at both 
post therapy visits showed the same pattern, despite the 
fact that their clinical conditions were extremely
different. One explanation for this finding could be the 
observation that clinical conditions in general had
improved significantly at the follow-up visit from 
reassessment, which may exert an indirect influence, 
particularly at the subject level, on the level of TIMP in 
sites which did not respond to treatment. This is 
supported by the findings of Ebersole et al. (1993),
Gustafsson et al. (1994) and by the results of our cross- 
sectional study in which the GCF levels of FIB-CL, SL and 
TIMP were lower in all categories of sites in subjects on 
maintenance care compared to those with advanced
periodontal disease.
These observations may indicate the presence of an 
individual subject based effect on the local host response
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which may imply that subject should be used as the unit of 
analysis, when biochemical components of GCF are being 
investigated.
The inability of FIB-CL and SL to differentiate BRS 
(healthy) from WRS (periodontitis sites) was not unexpected 
as FIB-CL and SL were not detected in 80% and 63.3% of 
sites, at the reassessment visit, respectively. The 
percentage of sites in which the enzymes did not reach the 
detectable levels at the follow-up examination were 85.3% 
for FIB-CL and 67.6% for SL. In addition to this, the 
following explanation could be provided. Even though the 
proteinases had been detected in all sites the finding of 
Larivee et al. (1986) that after treatment only active 
enzyme decreased whereas total enzyme remained unchanged 
and the observation of Uitto and co-workers (1990) that 
collagenase is mostly in latent form in health while in 
periodontitis it is found in active form along with the 
fact that our antibodies detected total enzymes would 
probably prevent them distinguishing successfully treated 
sites from those which did not respond to treatment. The 
inability of TIMP to differentiate BRS from WRS is 
demonstrated by the relatively low positive and negative 
predictive values of a test based on TIMP's level at the 
follow-up visit. The sensitivity of the test was very low 
(24%) demonstrating a very high rate of false negatives. 
However the relatively high specificity of the test may be 
due to the low number of positive tests. Moreover, these
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observations are in contrast with our finding from the 
cross-sectional study in which the levels of the enzymes 
and inhibitor were significantly lower in healthy than in 
periodontitis sites. As mentioned above Larivee et al. 
(1986) reported that the levels of total collagenase and 
inhibitor remained unchanged after treatment whereas they 
dropped dramatically at a recall visit 6 months after 
therapy. Therefore it could be speculated that a 
significant difference in the levels of MMPs and TIMP 
between BRS and WRS would have been found if these sites 
had been sampled much longer after therapy.
4.4.6 Prediction of the outcome of treatment
4.4.6.1 Prediction of treatment response: Using the
pocket depth and the state of bleeding on 
probing as criteria
The response to treatment in a routine clinical practice is 
assessed by pocket depth and the state of bleeding on 
probing, thus sites with PD<3.5mm and no BOP were 
considered as responding sites. Prediction of the 
treatment outcome, using baseline subjective criteria, has 
been investigated by Vanooteghem et al. (1990) who reported 
a maximum 30% diagnostic accuracy for subjective clinical 
parameters. Therefore at both post therapy visits the 
baseline levels of the enzymes and inhibitor were compared 
in sites which met either one of the two or both criteria.
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GCF level of SL at the baseline was able to distinguish 
bleeding from non-bleeding sites as well as sites with PD 
of less or more than 3.5mm. Quite surprisingly, on both 
occasions the baseline levels of SL was higher in 
responding sites which is very difficult to explain, 
although this observation may, in part, be due to the fact 
that our antibodies detected total enzyme.
However, failure in predicting treatment outcome by using 
PD and state of BOP as criteria for treatment success led 
us to use the gain in attachment level as an indicator of 
response to treatment.
4.4.6.2 Prediction of treatment response: Using the
attachment level changes as criterion
Longitudinal monitoring of attachment levels is the best 
available tool for evaluating treatment outcome at present. 
Since clinical parameters demonstrated rather poor ability 
to predict disease progression (Haffajee et al., 1983a; 
Badersten et al. 1985; Jenkins et al., 1988; Badersten, 
Nilveus & Egelberg, 1990; Kaldahl et al., 1990), attempts 
have been made to investigate the association between 
attachment loss and biochemical components of GCF in order 
to predict future disease activity (Offenbacher, Odle & Van 
Dyke, 1986; Lamster et al., 1988; Persson, De Rouen & Page, 
1990). No study investigated the ability of GCF 
constituents to predict the response to treatment as it is
evaluated by changes in attachment levels. Pre-treatment 
levels of FIB-CL, SL and TIMP failed to distinguish between 
sites that gained attachment and those which did not, 
although efforts were made to eliminate the effect of 
variations in the baseline GCF volumes and clinical 
parameters between two groups of sites on their biochemical 
properties, sites which showed attachment gain were 
carefully matched for their pre-treatment GCF volumes and 
clinical parameters. However, within subject matching 
which is preferable was not possible due to limited number 
of sites in each individual. This approach, although very 
accurate, might be criticised in that it did not take into 
account the state of gingival inflammation and pocket depth 
in groups of sites which did or did not gain attachment 
after therapy.
4.4.6.3 Prediction of treatment response: Using a
combination of clinical parameters as criteria
In order to fulfil these requirements a more stringent 
criteria, according which two groups of best responding 
sites (BRS) and worst responding sites (WRS) were selected 
at the both post-therapy visits, was adopted. To avoid the 
smoothing of the data by including intermediately 
responding sites e.g. sites with shallow pockets but BOP or 
high gingival score, sites with PD^3mm, no BOP and MGI 
scores of 0-1 comprised the BRS whereas WRS consisted of 
those with PD>4mm, BOP and gingival scores of ^2. However,
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none of the sites in either groups and in both occasions 
demonstrated suppuration after probing. Although
preferable, it was not possible to select BRS from those 
which gained attachment due to limited number of the 
latter. In spite of the highly significant differences in 
pocket depths and gingival scores as well as completely 
reverse status of BOP, between BRS and WRS, their pre­
treatment levels of MMPs and TIMP failed to predict the 
success and failure of treatment. However because of the 
limited number of the sites with above mentioned criteria 
in both groups their baseline matching for clinical 
parameters was not possible. Considering the facts that 
our antibodies detected total enzyme (latent and active) 
and that probing depth measurements taken at one point in 
time are indicative of past history of periodontal disease 
and do not necessarily reflect active periodontal 
destruction thus, it could be speculated that different 
sites in the present study, depending on whether they are 
active or inactive, had different proportions of active and 
latent enzymes which in turn may determine the destructive 
potential of the inflammatory exudate, the GCF. Lee et al.
(1991) reported that the frequency of active sites with 
active collagenase was higher than that of inactive sites 
with comparable pocket depths.
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4.4.7 General findings
In this section common observations between the cross- 
sectional and longitudinal studies are discussed.
4.4.7.1 Low detectability of fibroblast collagenase
In the cross-sectional study FIB-CL was found in only 18.9% 
of all the sites and only in 20.8% of periodontitis sites
and in the longitudinal study we were only able to detect
FIB-CL in 26.8%, 17.4% and 12% of the sites at the
baseline, the reassessment and the follow-up visits
respectively. These results are consistent with the 
finding of Woolley and Davies (1981). The possibility that 
the ELISA for FIB-CL was ineffective was negated as 
positive samples of FIB-CL were obtained from ovarian cyst 
carcinoma fluids and GCF samples of patients with LJP from 
Dr T. Sorsa, University of Helsinki, Finland. It is also 
of note the level of this enzyme, whenever was detected, 
was 1.5 fold higher than the control wells which contained 
no sample. However the number of sites expressing FIB-CL 
reduced to half after HPT and it was eight times smaller at 
the follow-up examination in sites with attachment gain. 
The rapid binding of a2-M to FIB-CL, reported by Cawston et 
al. (1987) could also explain the low detectability of this 
enzyme in GCF in the light of the fact that a2-M is present 
in both healthy and diseased sites (Adonogianaki et al., 
1992).
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4.4.7.2 Correlation between clinical parameters and 
gingival crevicular fluid biochemical 
components
In the cross-sectional study there was a moderate positive 
and significant correlation between GCF levels of SL and 
TIMP and clinical parameters when data from healthy, 
gingivitis and periodontitis sites were pooled. When data 
from different groups of sites were separately analyzed the 
picture changed; so that, there was neither significant nor 
even moderate correlation between clinical and biochemical 
parameters. In the longitudinal study correlation 
coefficients between clinical and biochemical parameters 
were either very weak or not significant at the baseline. 
The large site to site variation in the levels of SL and 
TIMP observed in this study may, in part, be responsible 
for the lack of correlation between these proteins and 
clinical parameters. TIMP showed significant positive 
correlation with GCF volume at both after treatment 
sessions; the important finding here is that GCF volume and 
TIMP's level changes, while correlated, were in opposite 
direction at the reassessment visit which is difficult to 
explain although may imply the local production of TIMP. 
SL showed the same direction of change with GCF volume at 
both post therapy sessions while they were only associated 
at the follow-up visit. The mean levels of the enzymes and 
inhibitor showed the same direction of change with the GCF 
volume, MGI and PD in sites which gained attachment at the
167
reassessment and the follow-up examination. Therefore, in 
order to illustrate any possible relation between clinical 
and biochemical parameters, the association of SL and TIMP 
with clinical parameters was investigated. Using Spearman 
rank correlation coefficients, it was found that only TIMP 
had a strong positive correlation with GCF volume at both 
the reassessment and the follow-up visits, whereas SL was 
correlated with GCF volume only at the reassessment 
examination. Pocket depths and gingival scores showed no 
significant association with the mean levels of SL and TIMP 
at both visits. There was no significant correlation, 
either positive or negative, between the FIB-CL, SL and 
TIMP's baseline levels with bleeding sites as well as sites 
with PD>3.5mm at both the reassessment and the follow-up 
visits. As very small number of sites expressed
detectable amounts of FIB-CL at post therapy visits, no 
attempt was made to correlate its GCF level with the 
clinical parameters.
There is no consensus in the literature regarding 
correlation between clinical parameters and proteinases and 
their inhibitor in gingival tissue/fluid. Kryshtalskyj et 
aim (1986) reported strong correlation between collagenase 
activity and GCF flow. Villela et al. (1987) have also 
reported positive but rather weak correlation between PD 
and GI and collagenase activity while Gangbar et al (1990) 
and Teng, Sodek and McColloch, (1992) failed to find any 
correlation between collagenase
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activity and clinical parameters. Gustafsson et al. (1992) 
reported that elastase activity in GCF showed a moderate 
correlation with PD and attachment loss, whereas the enzyme 
level did not show any correlation with these clinical 
parameters. Lactoferrin (LF) absolute amounts in GCF and 
gingival crevicular washings showed rather strong 
correlation with MGI, PD and GCF volume (Adonogianaki et 
al., 1993). Different methods of GCF sampling and 
laboratory techniques as well as variations in reporting 
the results may influence the presence and extent of 
correlation between clinical and biochemical parameters, 
thus correlations of biochemical parameters and clinical 
indices reported in previous papers should be viewed with 
caution. Moreover, the observation that using exactly the 
same clinical and laboratory techniques in cross-sectional 
and longitudinal studies and even analyzing data from 
cross-sectional study in different ways yielded different 
correlation coefficients suggests that not only these 
requirements are necessary but also the presence of 
identical clinical conditions between two or more groups of 
study sites is required for any reproducible relationship 
between clinical and biochemical parameters to be obtained.
4.5 Further research
The cross-sectional and longitudinal studies have 
demonstrated that mean GCF levels of SL and TIMP were able 
to distinguish between healthy and diseased sites and have
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also provided information on the changes of GCF MMPs and 
TIMP as a result of periodontal therapy. However, these 
GCF components were not able to discriminate between 
gingivitis and periodontitis sites and could not predict 
the outcome of treatment. They also failed to 
differentiate successfully treated sites from those which 
failed to respond to treatment. In order to overcome these 
shortcomings some changes in the design of the longitudinal 
study are proposed in the following section.
4.5.1 How these studies can be designed in the future
A recent paper (McCulloch, 1994) reported that active 
collagenase was able to distinguish between gingivitis and 
periodontitis sites. FIB-CL detection rate was very low in 
these studies. This enzyme also shows similarities to SL 
(Birkedal-Hansen et al., 1993). Therefore, it would be of 
interest to investigate if active SL is able to distinguish 
between gingivitis and periodontitis and predict the 
outcome of treatment. In addition, since under conditions 
of the present studies, SL was not detected in all sites 
the GCF samples could be eluted in smaller volumes of assay 
buffer, resulting in higher detection rate for this enzyme.
The results of these studies have also shown that TIMP was 
the best candidate for investigation as it was detectable 
in almost 100% of the sites. On the other hand, although 
the difference in TIMP levels was not significant between
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best responding sites (BRS) and worst responding sites 
(WRS) at the follow-up visit, its level in BRS was lower 
than in WRS. Therefore, using means and standard 
deviations of TIMP levels from these groups of sites at 
this visit, it was worked out that by increasing the number 
of patients to 38 (89% increase) a significant difference 
at 0.05 level in the amount of TIMP between responding and 
non-responding sites could be obtained. Since, TIMP levels 
showed a fluctuation over the period of the longitudinal 
study, in order to examine these changes more closely 
during the healing process the study sites should be 
sampled after treatment at monthly intervals for a period 
of 5 months. Discriminant analysis showed that PD and MGI 
had the greatest effect on the GCF levels of the SL and 
TIMP. Therefor, in selecting the study sites priority 
should be given to deeper sites with higher MGI scores.
4.5.2 Other lines of research
In situ hybridization could be used to locate the source of 
these GCF constituents as both healed and unhealed sites 
expressed, almost, the same levels of MMPs and TIMP. 
Active form of fibroblast derived gelatinase (72 k) may 
also be able to distinguish between periodontitis and 
gingivitis sites. The in vivo activation of MMPs is likely 
to be caused by plasmin. Plasminogen activator can produce 
plasmin from its precursor, plasminogen (Woessner, 1991). 
Therefore, the levels of plasminogen activator in GCF may
171
be able to distinguish between gingivitis and periodontitis 
sites.
In general, as discussed in section 4.3.2, the alteration 
in the levels of these GCF constituents may reflect the 
development of gingival inflammation rather than 
periodontal destruction. Therefore it seems justified to 
investigate the levels of GCF components which are resulted 
from bone destruction in order to distinguish gingivitis 
from periodontitis sites.
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Abstract
The ability of stromelysin (SL), fibroblast type collagenase (FIB-CL) and tissue
inhibitor of metalloproteinase (TIMP) to differentiate between healthy, gingivitis
and periodontitis sites was investigated. SL and FIB-CL are members of a
family of enzymes which are capable of degrading most of the extracellular
matrix macromolecules. Extracellular control of these enzymes is performed
by TIMP. 40 patients each provided 3 GCF samples from healthy, gingivitis
and periodontitis sites. GCF samples were collected by means of sterile paper
strips. GCF samples were eluted into 500 pJ of Assay Buffer and assays for 
SL, FIB-CL and TIMP were performed by a sandwich ELISA. The mean
amounts of SL and TIMP in diseased sites (gingivitis and periodontitis) were
significantly higher than the mean amount of these GCF components in
healthy sites (MANOVA p values were: 0.006 for SL and 0.001 for TIMP).
GCF SL and TIMP differentiated healthy from diseased sites. Both SL and
TIMP showed moderate correlation with clinical indices. FIB-CL was
detectable in only 20.8% of all sites and did not correlate with disease status.
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Introduction
Connective tissue degradation in periodontal disease is believed to result from 
the action of proteolytic enzymes. Among these, matrix metalloproteinases 
(MMP) are capable of degrading a variety of extracellular matrix components. 
MMP activity is inhibited by tissue inhibitors of metalloproteinases (TIMP) 
(Woessner, 1991), which are produced by host cells. The tissue degradation 
is further thought to be induced by an imbalance between MMPs and TIMP 
(Nomura et al. 1993). Analysis of these enzymes, thought to mediate 
degradation of collagen is a rational approach to diagnosis based on the 
importance of collagen as the major structural component of the periodontium 
(Lee et al. 1991). MMPs also seems to have an important role in the 
regulation of matrix turnover (Murphy etal. 1989). Among different members 
of this family of enzymes, polymorphonuclear leucocyte derived collagenase 
(PMN-CL), which is thought to be carried into the crevice in migrating PMNs 
(Birkedal-Hansen etal. 1993), has received more attention in the periodontal 
field than others (Ohlsson etal. 1973; Sorsa etal. 1990; Overall etal. 1991). 
However PMN proteases including PMN collagenase in the GCF of diseased 
sites may simply reflect the number of emigrating PMN into the crevice rather 
than the tissue destructive potential (Birkedal-Hansen, 1993). Adonogianaki 
et al. (1993) have reported a strong positive correlation between crevicular 
PMN numbers and the GCF level of one of its proteases, lactoferrin.
Bacterial components stimulate macrophages and lymphocytes to produce 
inflammatory mediators which are further thought to affect fibroblasts to
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produce MMPs (Meikle etal. 1989; Overall etal. 1991; Birkedal-Hansen 1993). 
SL and FIB-CL are the major MMPs of fibroblast origin (Chin et al. 1985). It 
has been observed that stromelysin can activate fibroblast type collagenase 
(Unemori et al. 1991). Most of the cells capable of secreting SL and FIB-CL 
also produce TIMP (MacNaul et al. 1990). Cawston and co-workers (1987) 
suggested that TIMP is locally produced and its main role is defending 
connective tissues in the very local area around the cell from which 
metalloproteinases are secreted. No studies have been so far conducted on 
the fibroblast derived MMPs and inhibitors in GCF. In the present study we 
measured GCF levels of FIB-CL, SL and TIMP from healthy, gingivitis and 
periodontitis sites, in an attempt to elucidate whether the level of fibroblast 
derived enzymes and enzyme inhibitor can differentiate these disease states.
Materials and methods
Clinical Criteria
Forty patients, (26 F; 14 M; mean age 43.1 (range 21-71)) attending the 
Periodontal Clinic of Glasgow Dental Hospital participated in this study. These 
individuals had no history of systemic disease and had not received antibiotics 
for the past three months. The modified gingival index (MGI) (Lobene et al. 
1986) was used to assess gingival inflammation and a pressure sensitive 
probe with a constant force of 25g was used to assess probing pocket depth. 
Sites with gingival scoring of 0 or 1 and pocket depth (PD) lower or equal to
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2mm were categorized as "healthy". MGI between 2 to 4 and PD^3mm were 
the criteria for "gingivitis" sites, and sites with MGI of between 0 to 2 and
PD>4mm comprised the "periodontitis" sites (Table 1.). Although difficulties
were experienced in finding the three types of sites (healthy, gingivitis and
periodontitis) within the same patient, there were considerable advantages with
this protocol as the subject variability could be excluded by ’pairing’ the three
sites to be compared in a repeated measures statistical analyses. The
following criteria for site selection were adopted: mesial sites were preferred
to distal sites as they are more accessible; upper molar palatal sites were
preferred to buccal sites; and on the lower teeth buccal/labial sites were
preferred to lingual sites, as these sites were less prone to saliva
contamination of the GCF sample.
Gingival Crevicular Fluid (GCF) Sampling and Processing 
GCF samples were collected using Whatman grade 4 paper strips (2x13 mm) 
(Griffiths et al. 1988). The site being sampled was gently air-dried and any 
supragingival plaque was removed. The area was carefully isolated to prevent 
samples from being contaminated by saliva. The paper strip was inserted into 
the crevice until mild resistance was felt, and left for 30 seconds. Care was 
exercised in order to avoid mechanical injury of the tissues. After GCF 
collection, the paper strip was transferred to the chairside-located Periotron 
6000 (Harco Electronics, Winnipeg, Canada) for the quantification of the fluid 
volume. The jaws of the Periotron were wiped with pure methanol between 
readings. The strips were then placed in individual sterile micro centrifuge
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tubes and stored at -30°C until further processing. Subsequently, the strips 
were eluted into 500 pi of incubation buffer at room temperature using a rotary 
mixer. The strips were then discarded and the eluate aliquoted and stored at -
30°C. These aliquots were subsequently analyzed for the quantification of 
FIB-CL, SL and TIMP.
Calibration of the Periotron 6000
In order to transform the Periotron digital readings for each paper strip into
volumes and also assess the accuracy of instrument, known volumes of
distilled water were delivered to Whatman grade 4 paper strips with a Hamilton
microsyringe in a range of volumes (0.05-1 pi). Each measurement was 
performed 3 times and the mean value for each volume was used in a linear
regression analysis from which the slope and intercept were used to determine
the volumes of GCF collected.
GCF Analysis
FIB-CL, SL and TIMP quantification was performed on the eluates of GCF and 
all constituents were assayed by means of sandwich ELISAs, based on a 
modification of the method of Cooksley e ta l (1990). The 96-well polystyrene 
microplate (Immulon 4 Dynatech Laboratories, Billinghurst, Sussex, U.K) was 
coated with the first antibody, specific to the antigen to be quantified. These 
antibodies were Mac 64 anti-collagenase monoclonal antibody for FIB-CL, Mac 
78 anti-stromelysin monoclonal antibody for SL and Mac 19 anti-TIMP 
monoclonal antibody for TIMP. The eluate of the sample was then added and 
any antigen present was captured by the immobilized antibody. Then the plate
was incubated with a Biotin-conjugated monoclonal second antibody. Finally 
the plate was incubated with Extravidin-Peroxidase (Sigma). These antibodies 
were biotinylated Mac 66 to reveal FIB-CL and biotinylated Mac 15 to reveal 
TIMP. The stromelysin assay differed in that a rabbit polyclonal antibody was 
used as the second antibody followed by Horse Radish Peroxidase (HRP)- 
conjugated anti-rabbit IgG (donkey) (Jackson). The anti-SL monoclonal and 
polyclonal and anti-FIB-CL monoclonals detected both the proenzyme and 
active forms of the fibroblast SL and FIB-CL. Anti-TIMP monoclonals detected 
only free TIMP (Cooksley etal. 1990). All the antibodies were donated by Cell 
Tech. Ltd. Slough, UK. Visualisation was achieved by incubation with TMB 
substrate, and the reaction stopped with 2.5% NaF (sodium fluoride). The 
plate was read at 630 nm, on a Dynatech MR5000 plate reader. Serial 
dilutions of standard antigen were run for each plate and their ODs were used 
in a linear regression analysis from which the slope and intercept were used 
to determine the samples’ levels of FIB-CL, SL and TIMP. FIB-CL and 
stromelysin positive samples were available from ovarian cyst carcinoma fluid 
and rheumatoid arthritis sera (gift from Dr. T. Sorsa) and these confirmed that 
our ELISA techniques were able to detect these proteins. Results were 
expressed as pg/30s sample. Control wells in each plate were included which 
contained no sample or standard antigen in order to calculate background 
binding. The mean OD plus two standard deviations of these wells was taken 
as a cut-off point for detectability (Tijssen, 1985).
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Statistical Analysis
GCF levels of SL and TIMP were markedly skewed and required logarithmic 
transformation (Iog10 (x+1) x=original data value). A repeated measures 
analysis of variance was applied in order to perform within patient comparisons 
of healthy, gingivitis and periodontitis sites. When a significant effect was 
detected by repeated measures analysis of variance, follow up analysis was 
performed using univariate paired t-tests in order to determine the direction 
and location of the differences. A Bonferroni correction was applied and 
significance level for the t-tests was set at 0.05/V3 (3=number of comparisons 
made). In order to identify associations between the clinical indices and the 
levels of SL and TIMP the non-parametric Spearman rank correlation 
coefficients were assessed. Data were analyzed using SPSS statistical 
package on an IBM microcomputer.
Results
One hundred and twenty sites were sampled in total, forty in each clinical 
group. Table 1 presents the average clinical indices and GCF volumes of the 
healthy, gingivitis and periodontitis sites.
The levels (95% confidence intervals) of SL and TIMP are presented in 
Table 2. SL was detected in 75 (62.5%) sites sampled of which 19 (47.5%) 
belonged to the healthy group and 28 (70%) both in the gingivitis and 
periodontitis groups. Multivariate repeated measures analysis of variance
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(MANOVA) demonstrated a significant effect (p=0.006) when healthy, gingivitis 
and periodontitis sites within each patient were compared for their GCF SL 
levels (Table 2). Follow up analysis (Table 2) demonstrated that diseased 
sites (gingivitis and periodontitis) had significantly higher levels of SL than 
healthy sites (p= 0.007 & p=0.002 respectively). However, no significant 
difference could be detected between gingivitis and periodontitis sites 
(p=0.882). TIMP was detected in 108 (90%) sites in total. TIMP was present 
at detectable level in 34 (85%) healthy, 36 (90%) gingivitis and 38 (95%) 
periodontitis sites. Similarly to SL, multivariate repeated measures analysis of 
variance demonstrated a significant effect when healthy, gingivitis and 
periodontitis sites were compared for their GCF TIMP levels (Table 2). Follow- 
up analysis demonstrated that gingivitis and periodontitis sites had significantly 
higher levels of TIMP than healthy sites (p=0.008 & p<0.001) respectively). 
GCF TIMP levels could not however differentiate gingivitis from periodontitis 
sites (p=0.373) (Table 2). FIB-CL was detectable in only 25 (20.8%) out of 
120 sites, of which 7 (17.5%) belonged to the healthy group (mean=193.6 
pg/30s, SD=265.9), 11 (27.5%) sites belonged to the gingivitis group 
(mean=286.3 pg/30s,297.3) and 7 (17.5%) sites belonged the to periodontitis 
group (287.2 pg/30s, SD=271.8). FIB-CL had much higher levels than SL in 
sites where it was detected. In 20 subjects FIB-CL was not detected in any 
site.
The association of SL and TIMP with the clinical indices is shown in 
Table 3. SL and TIMP levels correlated positively and significantly with GCF 
volume, MGI and PD. Overall, TIMP demonstrated higher correlation
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coefficients than SL with clinical indices and GCF volume (Table 3).
Discussion
In the present study we investigated the level of FIB-CL, SL and TIMP in GCF 
samples from healthy, gingivitis and periodontitis sites in the same individuals. 
These fibroblast derived enzymes and inhibitor have never been assessed 
before in GCF. Most of the previous studies in the literature have focused on 
PMN derived enzymes in GCF (Ohlsson etal. 1973; Sorsa etal. 1990; Overall 
etal. 1991). By taking samples from different sites within the same individual 
and using repeated measures MANOVA in order to permit within subjects 
comparisons, the host effect was allowed for. The GCF levels of FIB-CL, SL 
and TIMP are reported as the absolute amount in pg/30s. The rationale for 
expressing GCF biochemical components as absolute amounts with a 
standardised collection time has been discussed in detail by several 
investigators (Lamster et al. 1985; Lamster et al. 1986; Smith & Geegan, 
1991). Our previous reports have reiterated these conclusions, finding that the 
expression of GCF biochemical components by concentration yields results 
which are always in the same direction as the absolute amount analyses but 
have more variability.
The observation that both SL and TIMP were able to differentiate 
between healthy and diseased sites could render these two GCF components 
possible markers of inflammatory periodontal disease. Birkedal-Hansen et al. 
(1993) have also suggested that SL may act as a marker of stromal cell
10
involvement in the process of tissue degradation. Villela et al. (1987), found 
PD to be good indicator of protease activity. However, in the present study 
there was no significant difference between GCF SL and TIMP in gingivitis and 
periodontitis sites in spite of the presence of much shallower pockets in the 
former. In this cross-sectional investigation probing depths were the 
differentiating factor between gingivitis and periodontitis sites. Probing depth 
measurements taken at one point in time are indicative of past history of 
periodontal disease and do not necessarily reflect active periodontal 
destruction. In addition, inflammation present superficially in gingivitis sites 
and at the depth of the pocket (Armitage et al. 1977; Caton et al. 1981) in 
periodontitis sites may obscure the picture. Further longitudinal studies are 
required in order to elucidate whether SL and TIMP levels can be used as 
indicators of active periodontal destruction. The fact that TIMP was higher in 
diseased sites than healthy sites is in agreement with findings of Nomura et 
al. (1993) who found the same results for TIMP mRNA in the periodontal 
tissues. This may be due to the fact that bacterial stimuli initially induce MMP 
expression by host cells causing an increase in tissue self destruction. 
Thereafter, the host cells recognize the ongoing tissue destruction and attempt 
to defend the host by producing tissue inhibitors of metalloproteinases (TIMP). 
However, in contrast to the aforementioned study and the present study, 
Lariv^e and co-workers (1986) concluded that the activity of inhibitors is higher 
in healthy sites than in diseased sites. This discrepancy could be attributed 
to different GCF sampling methodology. They collected GCF by microcapillary 
tubes following a 3 minute GCF sampling by means of paper strips for
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determining GCF flow. Both methods of GCF collection are thought to irritate 
the gingival tissues (Cimasoni, 1983) and could increase the vascular 
permeability in the area, resulting in a dilution of the GCF locally derived 
components. In this study we used a less invasive method of GCF collection 
(paper strips for 30 s). In addition to sampling methodology discrepancies the 
present study reports the amount of enzymes rather than their activity as the 
study of Lariv^e etal. (1986). The distribution of mean SL and TIMP values 
in different disease states varied between individuals. Thus, individuals may 
respond differently and present with different tissue destructive potential in 
response to bacterial stimuli. The observation that FIB-CL was found in only 
18.9% of all the sites and only in 20.8% of periodontitis sites is in agreement 
with the findings of Woolley & Davies (1981). Unemori et al. (1991) in an in 
vitro study demonstrated that stromelysin is able to enhance the collagenase 
activity, although the in vivo validity of this finding has been questioned by 
Woessner (1991). In this study it was found that out of 25 sites with 
detectable collagenase, stromelysin did not reach the detectable level in 9 
sites and of the 75 sites with detectable amounts of stromelysin, 61 sites did 
not express FIB-CL.
In conclusion, this cross-sectional study has shown that although GCF 
SL and TIMP can differentiate healthy and diseased sites these tissue-derived 
components were unable to distinguish gingivitis and periodontitis sites.
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Table 1. Clinical parameters from the three categories of sites in 40 patients.
Site Status MGI PD GCF
Healthy 0.17 ±0.06* 1.41 ±0.06 0.092 ±0.02
Gingivitis 3.00 ±0.07 2.37 ±0.12 0.320 ±0.05
Periodontitis 1.70 ±0.12 5.71 ±0.14 0.380 ±0.06
MGI* modified gingival index
PD « pockBt depth
GCF= gingival crevicular volume
* = mean & SEM
Table 2. Stromelysin and TIMP absolute amounts (pg/30s) in GCF from healthy, 
gingivitis and periodontitis sites in 40 patients. Geometric mean (95% confidence 
intervals) are shown together with repeated measures analysis of variance (MANOVA) 
significance level. Follow up analysis was performed using univariate paired t-test 
and the results are given as footnotes.
Site status Stromelysin* TIMP**
Healthy 3.9 (2.4-6.10) 32.3 (19.4-53.70)
Gingivitis 8.9 (5.5-14.4) 74.0 (44.2-123.8)
Periodontitis 9.4 (5.8-15.3) 93.7 (63.2-138.9)
MANOVA p value 0.006 0.001
*  healthy vs gingivitis: p =0.007, healthy vs periodontitis: p=002, gingivitis vs periodontitis: p=0.882 
** healthy vs gingivitis: p=0.008, healthy vs periodorrtitisp<0.001, gingivitis vs periodontitis: p=0.373
Table 3. Spearman rank correlation coefficient (r) between clinical indices and TIMP 
and SL levels in GCF from 40 patients. Probability levels are shown in parenthesis.
Parameter Stromelysin TIMP
Vol. r=0.283 (p=0.002) r=0.643 (p=0.000)
MGI r=0.228 (p=0.012) r=0.361 (p=0.000)
PD r=0.256 (p=0.005) r=0.308 (p=0.001)
Wot -  GCF volume
MGI= modified gingival index
PD= pocket depth
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Abstract
Fibroblast collagenase (FIB-CL) and stromelysin (SL) are members of a family 
of enzymes which are capable of degrading most of the extracellular matrix 
macromolecules. Extracellular control of these enzymes is performed by 
tissue inhibitor of metalloproteinases (TIMP). During healing, inflammation and 
normal tissue turnover, levels of MMPs and TIMP will change. The effect of 
treatment on the levels of FIB-CL, SL and TIMP as well as their ability, at 
baseline, to predict the outcome of therapy was investigated. 21 patients each 
provided 8 gingival crevicular fluid (GCF) samples from sites with probing 
depths equal or greater than 4mm. Clinical recordings and GCF sampling 
were performed at three time points. Assays for SL, FIB-CL and TIMP were 
performed by a sandwich ELISA. Attachment level changes were detected by 
the '‘tolerance method". The ability of the GCF constituents to predict the 
response to treatment was assessed by comparing pre-treatment levels 
between sites which did or did not show attachment gain after therapy. 
Although no GCF constituents could reliably predict the response to treatment, 
SL reduced significantly (p=0.029) after the hygiene phase of therapy. In 
addition both SL and TIMP’s level showed a highly significant reduction at 
follow-up visit (p=0.003 and p=0.005 respectively). Thus, SL and TIMP !evels 
are reduced by treatment but these GCF proteins do not appear to have an 
ability to predict treatment outcome from baseline.
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INTRODUCTION
Proteinases have long been implicated in the pathogenesis of periodontal 
disease (Ohlsson, Olsson & Tynelius-Bratthall, 1973; Uitto etal. 1978; Heath 
et al. 1982 and Uitto, 1987). The increase proteinases activity/level during 
experimental gingivitis (Kowashi, Jaccard & Cimasoni, 1979) and their 
decrease after periodontal treatment (Lariv&e, Sodek & Ferrier, 1986 and 
Makela et al. 1991) further suggest their involvement in periodontal tissue 
breakdown. Of the different proteinases thought to be involved in periodontal 
connective tissue breakdown the matrix metalloproteinases (MMPs) have 
received much attention and are implicated in other chronic inflammatory 
conditions such as Rheumatoid arthritis (Chin, Murphy & Werb, 1985; MacNaul 
et al. 1990 and Okada et al. 1992). MMPs are capable of degrading a variety 
of extracellular matrix components and this activity is required during tissue 
remodelling (Murphy, Koklitis & Carne, 1989). Tissue inhibitors of 
metalloproteinases (TIMP) inhibit these proteinases (Woessner, 1991), and 
tissue degradation may result from an imbalance between MMPs and TIMP 
(Nomura, Takahashi & Hara, 1993). Analysis of these enzymes, thought to 
mediate degradation of collagen, is a rational approach to diagnosis based on 
the importance of collagen as the major structural component of the 
periodontium (Lee et al., 1991) and the knowledge that it is quickly degraded 
in chronic periodontal inflammation.
The relationship between periodontal treatment and collagenase in GCF
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has been investigated by evaluating the changes in collagenase activity before 
and after treatment in a group of patients with localized juvenile periodontitis 
(Larivde et al., 1986). The enzyme activity for active collagenase showed a 
significant reduction 5 weeks after periodontal surgery, whereas the total 
enzyme activity remained high after surgical treatment (5 weeks) and dropped 
significantly, at the recall visit, 6 months after the last surgery. A further study 
by Villela et al. (1987) indicated that collagenolytic activity in GCF increases 
with the severity of disease in the order: periodontitis > gingivitis > healthy. 
Collagenase and gelatinase activity has also been assessed in mouthrinse 
samples from patients with AP and UP as well as healthy subjects before and 
after periodontal therapy by Gangbar et al. (1990), who reported that both 
collagenase and gelatinase activity reduced following treatment but was only 
significant for active collagenase after scaling and antibiotic therapy in UP 
patients. This suggests that there are differences in host response, reflected 
through MMP levels, which may have a bearing on prognosis and 
susceptibility. However, Birkedal-Hansen et al. (1989) reported no correlation 
between collagenase activity and progression of periodontal disease as was 
evidenced by alveolar bone loss.
Most of the studies have been conducted on polymorphonuclear 
leucocyte derived MMPs which are thought to be carried into the crevice in 
migrating PMNs (Birkedal-Hansen, 1993). It has been shown that one of the 
PMN proteins, lactoferrin, can serve as a marker of PMNs emigrating into the 
crevice (Adonogianaki et al., 1993; Gustafsson et al., 1994). Resident gingival
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cells, including fibroblasts, are other sources of MMPs and TIMP (MacNaul et 
al. 1990). Cawston, McLaughlin and Hazleman, (1987) suggested that TIMP 
is locally produced and its main role is in defending connective tissue 
constituents in the very local area around the cell from which 
metalloproteinases are secreted. TIMP appears to preferentially inhibit FIB-CL 
and SL (Banda et al. 1992). No studies have examined fibroblast derived 
MMPs and TIMP in GCF as predictors of response to treatment. In this 
longitudinal study we have investigated the level of GCF FIB-CL, SL and TIMP 
in sites with advanced periodontal breakdown before and after treatment in an 
attempt to determine: a) the effect of therapy on the enzymes and inhibitor’s 
levels; b) the ability of pre-treatment levels of MMPs and TIMP to predict the 
outcome of treatment; c) the association between clinical and biochemical 
parameters.
MATERIALS AND METHODS
Twenty six individuals, newly referred to the Periodontal Clinic of Glasgow 
Dental Hospital with advanced periodontal disease (pocket depths greater than 
5.5mm in all quadrants) took part in this study. 4 subjects dropped out from 
the study and one individual had to withdraw from the study because of her 
pregnancy. Of 21 patients who remained in this study 11 were female and 10 
were male with a mean age of 43.9 years ranging from 33 to 53 years. These 
individuals had no history of systemic conditions which could influence the 
course of periodontal disease. They were not on any medications that could
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affect the manifestations of periodontal disease, such as chronic antibiotic use,
phenytoin, cyclosporin and calcium channel blockers. A conventional pocket
chart, made at a recruiting appointment using a PC12 periodontal probe, was
used for site selection in this study. Two non-adjacent sites in each quadrant,
(accessible to GCF sampling and attachment level recording) exhibiting
probing depth *4mm on the pocket chart were selected for this study. Mesial 
sites were preferred to distal sites as they are more accessible. On the
maxillary posterior molars, palatal sites were preferred to buccal sites and on
the mandibular teeth buccal/labial sites were preferred to lingual sites as these
sites are less prone to saliva contamination of the GCF sample. All the clinical
recordings and sample collections in this study were carried out at three time
points, i) baseline appointment; ii) reassessment appointment; and iii) follow
up appointment. Prior to the baseline appointment, at the initial recruitment
appointment a medical history form was completed by the patient and the
pocket charting, to be used for site selection, was constructed.
An alginate impression was taken and, from the resulting cast, a soft 
acrylic stent for attachment level measurements was constructed. 
Subsequently, the patient was recalled for the baseline appointment. During 
this appointment and in the following order: a) Pll and MGI recordings were 
taken first; b) GCF samples were then taken from the preselected sites and 
GCF Periotron readings recorded; c) the first set of AL measurements at the 
sites sampled was subsequently made. During this procedure bleeding on
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probing and suppuration were also registered. The stent was then removed; 
d) after changing patient position and reapplying the stent the duplicate set of 
AL measurements was made; e) finally PD was assessed. The same 
procedure was followed at reassessment and follow up appointments.
All patients underwent hygiene phase therapy including oral hygiene 
instruction and scaling and root planing under local anaesthesia. Six weeks 
after the last treatment session (3 months±1 week after baseline examination), 
at the reassessment appointment, the patient was assessed and all the 
procedures in the baseline appointment were repeated. After recording clinical 
parameters and collecting samples a conventional pocket chart was 
constructed. This pocket chart along with the state of bleeding after 
conventional probing was used to assess the overall treatment success and 
determine further treatment needs. At this reassessment session sites were 
assigned to ’no treatment’, ’repeated root planing’ and ’surgery’ treatment 
groups based on the following criteria: a) no treatment; no bleeding on probing; 
PD<3.5mm b) repeated root planing; bleeding on probing; PD>3.5 to 5.5mm 
c) surgery; bleeding on probing; PD>5.5mm. The subjects received further 
treatment according to the above mentioned criteria in different sites. The 
follow-up examination was performed 3 months after reassessment visit (with 
a tolerance of 1 week) in which all the procedures in the baseline and 
reassessment visits were repeated. At this visit a conventional pocket chart 
was constructed in order to evaluate the treatment success in non-study sites. 
One of the study teeth between the baseline and reassessment visits had
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been extracted, thus the number of study sites decreased to 167 at 
reassessment session and all the comparisons between baseline and 
reassessment data were made on 167 sites. Between reassessment and 
follow-up examinations, a further study tooth was lost and one subject had a 
wire splint fitted which excluded another 6 teeth from attachment level 
measurements, thus reducing the number of sites to 160. Two calibrated 
examiners (EA) and (AH) were used throughout this study to record all clinical 
indices. The Modified Gingival Index (MGI) (Lobene etal. 1986) was used to 
assess gingival inflammation. The plaque index (Pll) of Silness and Loe, 
(1964) was used for recording plaque accumulation. The Florida Probe 
(Florida Probe Corporation, Florida, USA) (Gibbs et al.f 1988) was used for 
probing depth and attachment level (AL) recording. This is an electronic 
pressure sensitive probe with a tip diameter of 0.4mm set at 20g. Pocket 
depth and attachment level were recorded to the nearest 0.2mm. Since a 
fixed reference point was required for attachment level measurements, 
individual soft acrylic stents were constructed for both upper and lower arches 
for each patient from a 2mm thick silicone layer using a modification of the 
method described by Isidor, Karring and Attstrom, (1984). Bleeding upon 
probing (BOP) was scored dichotomously using the Florida probe. Scoring 
was performed within 30s of probing. Presence or absence of suppuration 
was recorded after applying gentle pressure on the gingival wall of the pocket 
at an apico-coronal direction using a ball burnisher.
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Gingival Crevicular Fluid (GCF) Sampling and Processing
GCF samples were collected using Whatman grade 4 paper strips (2x13 mm)
(Griffiths, Curtis & Wilton, 1988). The site being sampled was gently air-dried
and any supragingival plaque was removed. The area was carefully isolated
to prevent samples from being contaminated by saliva. The paper strip was
inserted into the crevice until mild resistance was felt or in any event not more
than 1mm, and left for 30 seconds. Care was exercised in order to avoid
mechanical injury of the tissues. After GCF collection, the paper strip was
transferred to the chairside-located Periotron 6000 (Harco Electronics,
Winnipeg, Canada) for the quantification of the fluid volume. The jaws of the
Periotron were wiped with pure methanol between readings. The strips were
then placed in individual sterile microcentrifuge tubes and stored at -30°C until
further processing. Subsequently, the strips were eluted into 500pl of 
incubation buffer at room temperature using a rotary mixer. The strips were
then discarded and the eluate aliquoted and stored at -30°C. These aliquots 
were subsequently analyzed for the quantification of FIB-CL, SL and TIMP.
Calibration of the Periotron 6000
In order to transform the Periotron digital readings for each paper strip into
volumes and also assess the accuracy of the instrument, known volumes of
distilled water were delivered to Whatman grade 4 paper strips with a Hamilton
microsyringe in a range of volumes (0.05-1 pi). Each measurement was 
performed 3 times and the mean value for each volume was used in a linear
regression analysis from which the slope and intercept were used to determine
8
the volumes of GCF collected.
GCF Analysis
FIB-CL, SL and TIMP quantification was performed on the eluates of GCF and 
all constituents were assayed by means of sandwich ELISAs, based on a 
modification of the method of Cooksley etal. (1990). The 96-well polystyrene 
microplate (Immulon 4 Dynatech Laboratories, Billinghurst, Sussex, U.K) was 
coated with the first antibody, specific to the antigen to be quantified. These 
antibodies were Mac 64 anti-collagenase monoclonal antibody for FIB-CL, Mac 
78 anti-stromelysin monoclonal antibody for SL and Mac 19-anti-TIMP 
monoclonal antibody for TIMP. The eluate of the sample was then added and 
any antigen present was captured by the immobilized antibody. Then the plate 
was incubated with a Biotin-conjugated monoclonal second antibody. Finally 
the plate was incubated with Extravidin-Peroxidase (Sigma). These antibodies 
were biotinylated Mac 66 to reveal FIB-CL and biotinylated Mac 15 to reveal 
TIMP. The stromelysin assay differed in that a rabbit polyclonal antibody was 
used as the second antibody followed by Horse Radish Peroxidase (HRP)- 
conjugated anti-rabbit IgG (donkey) (Jackson). The anti-SL monoclonal and 
polyclonal and anti-FIB-CL monoclonals detected both the proenzyme and 
active forms of the SL and FIB-CL. Anti-TIMP monoclonals detected only free 
TIMP (Cooksley et al. 1990). All the antibodies were donated by Cell Tech. 
Ltd. Slough, UK. Visualisation was achieved by incubation with TMB 
substrate, and the reaction stopped with 2.5% NaF (sodium fluoride). The
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plate was read at 630 nm, on a Dynatech MR5000 plate reader. Serial 
dilutions of standard antigen were run for each plate and their ODs were used 
in a linear regression analysis from which the slope and intercept were used 
to determine the samples’ levels of FIB-CL, SL and TIMP. Results were 
expressed as pg/30s sample. Control wells in each plate were included which 
contained no sample or standard antigen in order to calculate background 
binding. The mean OD plus two standard deviations of these wells was taken 
as a cut-off point for detectability and any reading below that was considered 
undetectable (Tijssen, 1985).
Statistical Analysis
Attachment level changes between three appointments were assessed using 
the tolerance method described by Haffajee, Socransky and Goodson (1983b) 
and the differences between duplicate attachment level measurements were 
used to compute the site, subject and population thresholds which had to be 
exceeded in order to declare significant attachment level change. GCF levels 
of SL and TIMP were markedly skewed and required logarithmic 
transformation (Iog10, (x+1) x=original data value). Sites which demonstrated 
attachment gain were compared with their matched controls at baseline for 
their pre-treatment levels of MMPs and TIMP using two-sample t-tests. 
Multivariate repeated measures analysis of variance followed by paired t-tests 
were employed to compare baseline levels of the enzymes and inhibitor with 
their levels at reassessment and follow-up visits. In order to identify
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associations between the clinical indices and the levels of SL and TIMP the 
non-parametric Spearman rank correlation coefficients were used. Data were 
analyzed using Minitab and SPSS statistical packages on an IBM compatible 
computer.
RESULTS
Multivariate repeated measure analysis of variance (MANOVA) (p<0.0001) and 
Friedman test (for non-parametric data) (p<0.0001) followed by pair t-test and 
Sign test revealed a difference in clinical parameters as a result of therapy. 
GCF valume, PD, MGI, BOP and suppuration scores showed a significant 
reduction at both post therapy visits from baseline. However, AL reduced 
significantly only after HPT.
MANOVA demonstrated a highly significant effect (p<0.0001) when all 
the study sites over the three visits were compared for their GCF levels of 
MMPs and TIMP (Table 1). Follow up analysis showed a significant reduction 
in the level of FIB-CL from baseline at both post therapy visits (p=0.025 and 
p<0.001 respectively), however, this reduction was not significant for SL 
(p=0.052) after therapy, but was significant at the follow-up visit (p<0.001). 
TIMP level increased significantly (p<001) after therapy and demonstrated a 
significant reduction at the follow-up visit (p<0.001). Although there was an 
overall improvement in clinical parameters following treatment, in order to 
further elucidate the effects of treatment, sites were grouped for further 
analysis according to their response to therapy assessed by gain in attachment
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level.
a) Reassessment examination
At the reassessment examination, after hygiene phase therapy, 24 (14.4%) 
sites, in 12 subjects, demonstrated significant attachment gain. Clinical and 
biochemical parameters, (except GCF volume) were lower in sites which 
gained attachment (n=24) than those which did not (n=143), however these 
differences did not reach the significance level (Table 4). The percentage of 
sites with detectable amounts of FIB-CL that did and did not gain attachment 
at reassessment were 16.7% and 17.5% respectively. Attempts were made 
to investigate if the mean GCF levels of FIB-CL, SL and TIMP in sites which 
responded to therapy by attachment gain differed from their baseline levels. 
Using MANOVA (p=0.026) followed by paired t-tests, the mean levels of SL 
and TIMP in sites which gained attachment at the reassessment examination 
were compared with their levels at baseline. The mean level of SL decreased 
significantly (p=0.029) at reassessment. The number of sites with detectable 
levels of FIB-CL reduced to half at the reassessment visit (4 sites, (16.7%)). 
The mean pocket depth (paired t-test, p<0.001) as well as the mean gingival 
scores (Sign test, p<0.001) showed a significant reduction at reassessment 
examination (Table 2). The amounts of the proteins in sites which did not 
show attachment gain at reassessment (n=143) were compared with their pre­
treatment levels using MANOVA (p<0.01) followed by paired t-tests. SL level 
showed a reduction at this visit, although it did not reach the significance level
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(p=0.249), whereas TIMP’s level increased significantly (p<0.001). GCF 
volume, PD and gingival scores reduced significantly at reassessment 
examination (p<0.001) (Table 2). The number of sites that expressed FIB-CL 
after therapy, decreased to 25 (17.5%) from 37 (25.9%) at baseline. In order 
to investigate if the baseline levels of FIB-CL, SL and TIMP could differentiate 
between sites which showed attachment gain and those which remained 
unchanged at reassessment visit, each site demonstrating attachment gain 
(n=24) was matched with a site which did not show attachment gain at this 
visit (n=24) for its GCF volume and clinical indices at baseline. Two-sample 
t-test showed no significant difference between the mean baseline levels of the 
enzymes and the inhibitor when the two groups of sites were compared (Table 
3), thus the pre-treatment levels of MMPs and TIMP failed to predict the 
response to treatment.
b) Follow-up examination
According to the follow-up attachment level measurements, 25 sites (15%), in 
11 subjects, had gained attachment from the baseline levels. Sixty percent 
(15) of these sites were among those which gained attachment after therapy. 
However, at this visit 5 (3%) sites within 3 patients showed significant 
attachment loss from baseline. Clinical and biochemical parameters, at the 
follow-up visit, except for GCF volume and the level of TIMP were lower in 
sites which gained attachment (n=25) than those which did not (n=130), 
although these differences did not reach the significance level (Table 4). The
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percentage of sites expressing FIB-CL with or without attachment gain was 4% 
and 13.1 % respectively. The mean levels of SL and TIMP at the follow-up visit 
were compared with their baseline levels in sites that gained attachment 
(MANOVA, p=0.001). Both the enzyme and the inhibitor mean levels showed 
a highly significant reduction at the follow-up examination (paired t-tests, 
p=0.003 for SL and p=0.005 for TIMP). The number of sites expressing 
detectable amounts of FIB-CL reduced from 8 (25%) sites at baseline to 1 
(4%) site at follow-up. Significant reductions were observed in GCF volume 
and pocket depth (paired t-test, p=0.002 and p<0.001 respectively) as well as 
gingival scores (Sign test, p<0.001), in sites with attachment gain, at follow-up 
examination (Table 5). The GCF levels of the enzymes and inhibitor in sites 
which did not gain attachment (n=130) at follow-up visit were compared with 
their baseline levels using MANOVA (p<0.001) followed by paired t-tests. A 
highly significant reduction was observed in SL and TIMP levels at this 
examination (p=0.002 and p<0.001 respectively). GCF volume, PD and 
gingival score showed a significant reduction also (p<0.001) (Table 5). The 
number of sites with detectable amounts of FIB-CL, at this visit decreased to 
17 (13.1%) from 31 (23.8%) sites at baseline. Sites demonstrating attachment 
gain (n=25) were matched with sites which did not gain attachment at this visit 
(25) for their GCF volume and clinical indices at baseline. No significant 
difference was found in the mean baseline levels of FIB-CL, SL and TIMP 
between the sites which gained attachment and their matched controls (two- 
sample t-test) (Table 3), indicating that pre-treatment levels of the enzyme and
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inhibitor are not able to predict the outcome of treatment.
Correlation between clinical and biochemical parameters
In order to illustrate any possible relation between clinical and biochemical 
parameters, the association of SL and TIMP with clinical parameters was 
investigated. Using Spearman rank correlation coefficients, it was found that 
only TIMP had a strong positive correlation with GCF volume at both 
reassessment (r=0.609, p=0.002) and follow-up (r=0.660, p<0.001) visits, 
whereas SL was correlated with GCF volume only at reassessment 
examination (r=0.493, p=0.014). Pocket depths and gingival scores showed 
no significant association with the mean levels of SL and TIMP at both visits. 
As very small number of sites expressed detectable amounts of FIB-CL, no 
attempt was made to correlate its GCF level with the clinical parameters.
DISCUSSION
This paper reports the effect of periodontal treatment on GCF levels of FIB-CL, 
SL and TIMP in a group of patients with advanced periodontal disease as well 
as the ability of pre-treatment levels of these GCF components to predict the 
response to treatment. Longitudinal monitoring of attachment levels is the best 
available tool for evaluating treatment outcome at present. Selection of the 
method for detection of attachment level changes is crucial. Haffajee et al. 
(1983b) compared three different methods namely the linear regression 
analysis, the running median and the tolerance method. In the present study,
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because of its relatively short duration, the "tolerance method" was employed. 
No analysis was performed on sites which showed attachment loss after 
treatment since this might have been merely caused by subgingival 
instrumentation and remodelling of attachment levels during healing (Badersten 
et al., 1987; Vanooteghem etal., 1990). It would be more appropriate if we 
could have analyzed those sites which gained attachment after surgical 
therapy separately. However, this was not possible due to the small number 
of such sites. Since collecting a standard amount of GCF is a prerequisite for 
expressing the results in terms of concentrations (Lamster et al., 1986) and the 
amount of GCF present in different sulci are extremely variable the levels of 
GCF biochemical components were expressed as absolute amounts with a 
standardised collection time as currently recommended (Lamster etal., 1985; 
Lamster etal., 1986; Smith & Geegan, 1991).
The observations that the mean levels of SL, in sites which gained 
attachment, decreased after treatment, at both examinations is in agreement 
with the findings of Larivde et al., (1986), Gangbar et al. (1990), and 
Suomalainen (1992). TIMP’s level increased after therapy in these sites, 
which is consistent with the results of LarivSe et al. (1986). This increase, 
although not significant, may reflect TIMP’s involvement in the healing process. 
At the follow-up visit the mean level of TIMP reduced significantly from 
baseline. This could be explained by the fact that the inflammatory process 
has subsided and the gingival tissues have healed, particularly as more than 
one third of the sites which showed attachment gain at follow-up did not
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receive further treatment after therapy. Further evidence for this speculation 
is the observation that SL’s levels decreased 4.5 times at the follow-up 
examination compared to a 3 times reduction only at the reassessment visit. 
The fact that SL and TIMP followed the same pattern of change after 
treatment in sites which did or did not gain attachment could be explained as 
follows: a) although these sites did not demonstrate significant attachment 
gain, their clinical condition improved significantly after treatment; b) since our 
antibodies detected total enzyme (latent and active) it is possible that the 
active enzyme has been lower in sites which gained attachment over those 
that did not, which is consistent with the studies of Lariv^e et al. (1986) and 
Suomalainen (1992); c) the overall improved clinical condition in an individual, 
may exert an indirect influence on the levels of MMPs and TIMP in sites which 
did not respond to treatment. This is supported by the findings of Ebersole et 
al. (1993) who reported that the levels of PGE, and IL-16 were lower in 
healthy sites from healthy subjects than healthy sites within refractory 
periodontitis patients and gingivitis sites from healthy subjects had lower levels 
of PGEj, than those in adult periodontitis and refractory periodontitis patients. 
Gustafsson et al. (1994) have also reported that elastase activity was higher 
in gingivitis sites from patients with periodontitis than clinically comparable 
gingivitis sites from gingivitis affected individuals. These results are in 
agreement with our recent cross-sectional study in which the GCF levels of 
FIB-CL, SL and TIMP were lower in healthy, gingivitis and periodontitis sites 
in subjects on maintenance care (with only few diseased sites) than in patients
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with advanced periodontal disease (Haerian et al. in press).
Since clinical parameters demonstrated rather poor ability to predict 
disease progression (Haffajee etal., 1983a; Badersten etal. 1985; Jenkins et 
al., 1988; Badersten et al., 1990; Kaldahl et al., 1990), attempts have been 
made to investigate the association between attachment loss and biochemical 
components of GCF in order to predict future disease activity (Offenbacher et 
al., 1986; Lamster et al., 1988; Persson etal., 1990). Prediction of treatment 
outcome, using baseline subjective criteria, has been investigated by 
Vanooteghem etal. (1990) who reported a maximum 30% diagnostic accuracy 
for subjective clinical parameters. Pre-treatment levels of FIB-CL, SL and 
TIMP failed to distinguish between sites that gained attachment and those 
which did not. Sites that gained attachment were carefully matched to their 
controls according to GCF volume and clinical indices at baseline and thus the 
analysis focused on the parameters of interest, namely attachment gain and 
FIB-CL, SL and TIMP. However, within subject matching which is preferable, 
was not possible due to the limited number of sites in each individual. In this 
study, immunochemical analysis of GCF using ELISAs, detected only total 
enzyme (latent and active). Moreover, selection of sites at baseline was made 
by probing depth measurements which are indicative of past history of 
periodontal disease and do not necessarily reflect active periodontal 
destruction. Thus, it could be speculated that different sites in the present 
study, depending on whether they are active or inactive, had different 
proportions of active and latent enzymes at baseline which in turn may
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determine the destructive potential of the inflammatory exudate, the GCF. Lee 
etal. (1991) reported that the frequency of active sites with active collagenase 
was higher than that of inactive sites with comparable pocket depths.
FIB-CL was detected in only 26.8%, 17.4% and 12% of the sites at
baseline, reassessment and follow-up visits respectively which is consistent
with our previous study (Haerian, et al. in press) and the finding of Woolley
and Davies (1981). The rapid binding of a2-macroglobulin (a2-M) to FIB-CL, 
reported by Cawston et al. (1987) could also explain the low detectability of
this enzyme in GCF in the light of the fact that a2-M is present in healthy, 
gingivitis and periodontitis sites (Adonogianaki et al., 1992). It is also
noteworthy that the level of this enzyme, whenever detected, was 1.5 fold
higher than the control wells which contained no sample. However the number
of sites expressing FIB-CL reduced to half after therapy and it was eight times
smaller at follow-up examination in sites with attachment gain.
GCF levels of TIMP showed significant positive correlation with GCF 
volume at both post-treatment visits; the important finding here is that while 
GCF volume and TIMP levels were correlated, their direction of change was 
different after therapy. This is difficult to explain although it may imply local 
production of TIMP. SL showed the same direction of change with GCF 
volume at both post therapy sessions while their relationship was significant 
only at follow-up visit. There is no consensus in the literature regarding 
correlation between clinical parameters and proteinases and their inhibitors in 
gingival tissue/fluid. Kryshtalskyj et al., (1986) reported strong correlation 
between collagenase activity and GCF flow. Villela et al. (1987) have also
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reported positive but rather weak correlation between PD and Gl and 
collagenase activity while Gangbar etal. (1990) and Teng etal., (1992) failed 
to find any correlations between collagenase activity and clinical parameters. 
In our cross-sectional study on GCF MMPs and their inhibitors, there was a 
moderate positive and significant correlation between GCF levels of SL and 
TIMP and clinical parameters when data from healthy, gingivitis and 
periodontitis sites were pooled. When data from different groups of sites were 
separately analyzed the picture changed; so that, there was neither significant 
nor even moderate correlation between clinical and biochemical parameters. 
Different methods of GCF sampling and laboratory techniques as well as 
variations in reporting the results may influence the presence and extent of 
correlation between clinical and biochemical parameters, thus correlations of 
biochemical parameters and clinical indices reported in previous papers should 
be viewed with caution.
REFERENCES
Adonogianaki, E., Mooney, J. & Kinane, D.F. (1992) The ability of 
gingival crevicular fluid acute phase proteins to distinguish healthy, 
g in g iv itis  and perio do ntitis  s ites . Journa l  o f  C l in i ca l  
Periodontology, 19, 98-102.
Adonogianaki, E., Mooney, J. & Kinane, D.F. (1993) Lactoferrin in the 
gingival crevice as a marker of polymorphonuclear leukocytes in 
periodontal disease. Journal of Clinical Periodontology, 20, 26-31.
Badersten, A., Nilveus, R. & Egelberg, J. (1985) Effect of nonsurgical 
periodontal therapy (VII). Bleeding, suppuration and probing depth in 
sites with probing attachment loss. Journal  of Cl inical  
Periodontology, 12, 432-440.
20
Badersten, A., Nilveus, R. & Egelberg, J. (1987) Effect of nonsurgical 
periodontal therapy (VIII). Probing attachment changes related to 
clinical characteristics. Journal of Clinical Periodontology, 14, 425-
432.
Badersten, A., Nilvdus and Egelberg, J. (1990) Scores of plaque, 
bleeding, suppuration and probing depth to predict probing attachment
loss. Journal of Clinical Periodontology, 17, 102-107.
Banda, M.J., Howard, E.W., Scott Herron, G. & Apodaca, G. (1992)
Secreted inhibitors of metalloproteinases (IMPs) that are distinct from 
TIMP. Matrix Supplement, No. 1, 294-298
Birkedal-Hansen, H., Pierson, M., Heaven, T., Jeffcoat, M.& Cogen, R.B.
(1989) Bone loss, GCF collagenase and GCF flow in human periodontitis. 
Journal of Dental Research, 168, 334.
Birkedal-Hansen, H., Moore, W.G.I., Bodden, M.K., Windsor, L.J.,
Birkedal-Hansen, B., DeCarlo, A. & Engler, J.A. (1993) Matrix 
Metalloproteinases: A Review. Critical Review in Oral Biology and
Medicine, 4(2), 197-250.
Birkedal-Hansen, H. (1993) Role of Matrix Metalloproteinases in Human 
Periodontal Diseases. Journal of Periodontology, 64, 474-484.
Cawston, T.E., McLaughlin, P. & Hazleman, B.L. (1987) Paired serum and
synovial fluid values of a2- macroglobulin and TIMP in rheumatoid 
arthritis. British Journal of Rheumatology, 26, 354-358.
Chin, J.R., Murphy, G. & Werb, Z. (1985) Stromelysin, a connective
tissue-degrading metalloendopeptidase secreted by stimulated rabbit 
synovial fibroblasts in parallel with collagenase. The Journal of 
Biological Chemistry, 260, 12367-12376.
Cooksley ,S., Hipkiss, J.B., Tickle, S.P., Holms-levers, E., Docherty, 
AJ.P., Murphy, G. & Lawson, A.D.G. (1990) Immunoassays for the 
detection of human collagenase, stromelysin, tissue inhibitor of 
metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix, 10, 
285-291.
Ebersole, J.L., Singer, R.E., Steffensen, B., Filloon, T. & Kornman,
K.S. (1993) Inflammatory mediators and immunoglobulins in GCF from 
healthy, gingivitis and periodontitis sites. Journal of Periodontal 
Research, 28, 543-546.
Gangbar, S., Overall, C.M., McCulloch, G.A.G., Sodek, J. (1990)
Identification of polymorphonuclear leukocyte collagenase and 
gelatinase activities in mouthrinse samples: correlation with
periodontal disease activity in adult and juvenile periodontitis. 
Journal of Periodontal Research, 25, 257-267.
Gibbs, C.H., Hirschfeld, J.W., Lee, J.G., Low, S.B., Magnusson, I., 
Thousand, R.R., Yemeni, P. & Clark, W.B. (1988) Description and 
clinical evaluation of a new computerized periodontal probe- the 
Florida Probe. Journal of Clinical Periodontology, 15, 137-144.
21
Griffiths, G.S., Curtis, M.A. & Wilton, J.M.A. (1988) Selection of a 
filter paper with optimum properties for the collection of gingival 
crevicular fluid. Journal of Periodontal Research, 23, 33-38.
Gustafsson, A , Asman, B. & Bergstrom, K. (1994) Elastase and
lactoferrin in gingival crevicular fluid; possible indicators of a
granulocyte-associated specific host response. Journal of Periodontal 
Research, 29, 276-282.
Haffajee, AD., Socransky, S.S. & Goodson, J.M. (1983a) Clinical
parameters as predictors of destructive periodontal disease activity.
Journal of Clinical Periodontology, 10, 257-265.
Haffajee, AD., Socransky, S.S. & Goodson, J.M. (1983b) Comparison of
different data analyses for detecting changes in attachment level.
Journal of clinical periodontology, 10, 298-310.
Heath, J.K., Cowen, M., Meikle, M.C. & Reynolds, J.J. (1982) Human 
gingival tissues in culture synthesize three metalloproteinases and a
metalloproteinase inhibitor. Journal of Periodontal Research, 17,
183.190.
Isidor, F., Karring, T. & Attstrom R. (1984) Reproducibility of pocket 
depth and attachment level measurements when using a flexible splint. 
Journal of Clinical Periodontology, 11, 662-668.
Jenkins, W.M.M., MacFarlane, T.W. & Gilmour, W.H. (1988) Longitudinal 
study of untreated periodontitis: (I). Clinical findings. Journal of
Clinical Periodontology, 15, 324-330.
Kowashi, Y., Jaccard, F. & Cimasoni, G. (1979) Increase of free 
collagenase and neutral protease activities in the gingival crevice
during experimental gingivitis in man. Archives of Oral Biology, 24, 
645-650.
Kaldhai, W.B., Kalkwarf, K.L., Patil, K.D. & Molvar, M.P. (1990)
Relationship of gingival bleeding, gingival suppuration, and
supragingivai plaque to attachment loss. Journal of Periodontology, 61, 
347-351.
Kryshtalskyj, E., Sodek, J. and Ferrier, J.M. (1986) Correlation of
Collagenolytic enzymes and inhibitors in gingival crevicular fluid with 
clinical and microscopic changes in experimental periodontitis in the
dog. Archives of Oral Biology, 31, 21 -31.
Lamster, I.B., Hartley, L.J. & Oshrain, R.L. (1985) Evaluation and 
modification of spectrophotometric procedures for analysis of lactate
dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival 
crevicular fluid collected with filter-paper strips. Archives of Oral 
Biology, 30, 235-242.
Lamster, I.B., Oshrain, R.L. & Gordon, J.M. (1986) Enzyme activity in 
human gingival crevicular fluid: considerations in data reporting based
on analysis of individual crevicular sites. Journal of Clinical 
Periodontology, 13, 799-804.
22
Lamster, I.B., Oshrain, R.L, Harper, D.S., Celenti, R.S., Hovliaras, 
C.A. & Gordon, J.M. (1988) Enzyme activity in crevicular fluid for 
detection and prediction of clinical attachment loss in patients with 
chronic adult periodontitis. Six month results. Journal of  
Periodontology, 59, 516-523.
Larivde, L., Sodek, J.& Ferrier, J.M. (1986) Collagenase and 
collagenase inhibitor activities in crevicular fluid of patients 
receiving treatment for localized juvenile periodontitis. Journal of 
Periodontal Research, 21, 702- 715.
Lee, W., Aitken, S., Kulkarni, G., Birek, P., Overall, C.M., Sodek. J. 
& McCulloch, C.A.G. (1991) Collagenase activity in recurrent 
periodontitis: relationship to disease progression and doxycycline
therapy. Journal of Periodontal Research, 26, 497-485.
Lobene, R.R., Weatherford, T., Ross, N.M., Lamm, R.A., & Menaker, L. 
(1986) A modified gingival index for use in clinical trials. Clinical 
Preventive Dentistry, 8, 3-6.
Makela, E., Soderling, E., Paunio, K., Talonpoika, J. & Hyyppa, T. 
(1991) Protein composition of crevicular fluid before and after 
treatment. Scandinavian Journal of Dental Research, 99, 413-423.
MacNaul, K.L., Chartrain, N., Lark, M., Tocci, M.J. & Huthinson, N.I.
(1990) Discoordinate expression of stromelysin, collagenase and tissue 
inhibitor of metalloproteinases-1 in rheumatoid human synovial 
fibroblasts. The Journal of Biological Chemistry, 265, 17238-17245.
Murphy, G., Koklitis, P. & Carne, AF. (1989) Dissociation of tissue 
inhibitor of metalloproteinases from enzyme complexes yields
fully active inhibitor. Biochemistry Journal, 261, 1031-1034.
Nomura, T., Takahashi, T. & Hara, K. (1993) Expression of TIMP-1, TIMP-2 
and collagenase mRNA in periodontitis-affected human gingival tissue. 
Journal of Periodontal Research, 28, 354-362.
Offenbacher, S., Olde, B.M., Van Dyke, T.E. (1986) The use of crevicular 
fluid prostaglandin E2 levels as a predictor of periodontal attachment 
loss. Journal of Periodontal Research, 21, 101-112.
Ohlsson, K., Olsson, I. & Tynelius-Bratthall, G. (1973) Neutrophil 
leucocyte collagenase, elastase and serum protease inhibitors in human 
gingival crevices. Acta Odontologica Scandinavica, 31, 51-59.
Okada, Y., Takeuchi, N., Gonoji, Y., Nakanishi, I., Nagase, H. & 
Hayakawa, T. (1992) Simultaneous production of collagenase, matrix 
metalloproteinase 3 (stromelysin) and tissue inhibitor of 
metalloproteinases by rheumatoid synovial lining cells. Matrix 
Supplement No. 1, 398-399.
Persson, G.R., DeRouen, T.A. & Page, R.C. (1990) Relationship between 
gingival crevicular fluid levels of aspartate aminotransferase and 
active tissue destruction in treated chronic periodontitis patients. 
Journal of Periodontal Research,25,81-7
23
Silness, J. & Loe, H. (1964) Periodontal disease in pregnancy. II.
Correlation between oral hygiene and periodontal condition. Acta 
Odontol Scand, 22, 112-135.
Smith Q. T. & Geegan, S. J. (1991) Repeated measurement of crevicular 
fluid param eters  at di f ferent  sites. Journa l  of  Cl inical  
Periodontology, 18, 171-176.
Suomalainen, K (1992) Relationship of collagenase and cathepsin G 
activity in gingival crevicular fluid. Scandinavian Journal of Dental 
Research, 100, 216-221.
Teng, Y.T., Sodek, J. & McCulloch, C.A.G. (1992) Gingival crevicular 
fluid gelatinase and its relationship to periodontal disease in human
subjects. Journal of Periodontal Research, 27, 544-552.
Tijssen, P. (1985) Practice and theory of enzyme immunoassays. Eds 
Burdon, R.H. & Van Knippenberg, P.H. Amsterdam: Elssevier Science 
Publishers.
Uitto, V.-J., Turto, H. & Sax6n L. (1978) Extraction of collagenase from
human gingiva. Journal of Periodontal Research, 13, 207- 214.
Uitto, V.-J. (1987) Human gingival proteases. I: Extraction and
preliminary characterization of trypsin-like and elastase-like 
enzymes. Journal of Periodontal Research, 22, 58-63.
Vanooteghem, R., Hutchens, L.H., Bowers, G., Kramer, G., Schallhorn, 
R., Kiger, R., Crigger, M. & Egelberg, J. (1990) Subjective criteria and 
probing attachment loss to evaluate the effects of plaque control and 
root debridement. Journal of Clinical Periodontology, 17, 580-587.
Villela, B., Cogen, R.B., Bartolucci, A A  & Birkedal-Hansen, H. (1987)
Collagenolytic activity in crevicular fluid from patients with chronic 
adult periodontitis, juvenile periodontitis and gingivitis, and from 
healthy control subjects. Journal of Periodontal Research, 22, 381- 
389.
Woessner, J.F. (1991) Matrix metalloproteinases and their inhibitors 
in connective tissue remodelling. FASEB Journal, 5, 2145-2154.
Woolley, D.E. & Davies, R.M. (1981) Imuunolocalization of collagenase 
in periodontal disease. Journal of Periodontal Research, 16, 292-297.
24
Table 1. Geometric means and 95% confidence intervals for FIB-CL, SL
and TIMP (pg/30s) at different visits. Number of sites and significance
level (p value) for MANOVA is given.
Protein n Mean 95% C.l.
Fibroblast collagenase
Baseline 166 3.9 2.8-5.6
Reassessment 166 2.3 1.7-3.0
Follow-up 166 1.9 1.4-2.5
Stromelysin
Baseline 166 5.6 4.2-7.4
Reassessment 166 4.0 3.1-5.2
Follow-up 166 2.4 1.9-2.9
TIMP
Baseline 166 228.7 201.8-259.2
Reassessment 166 333.9 291.8-382.8
Follow-up 166 93.30 78.90-110.1
MANOVA p<0.0001
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Table 2. Comparisons of GCF volumes, gingival scores, PD and GCF levels 
of SL and TIMP between baseline and reassessment visits in sites which 
did (AG) or did not demonstrate attachment gain (AU) at the reassessment 
examination (after HPT therapy). Means ±SEM for clinical parameters
and the geometric mean and 95% confidence intervals for the proteins 
(pg/30s) are shown. Significance level (p value) for each paired t-test 
and Sign test (for gingival scores) is given.
Baseline Reassessment
Parameter Mean ±SEM 
(95% cn
Mean ±SEM 
(95% Cl)
P
value
GCF Volume
AG (n=24) 
AU (n=143)
0.397±0.057
0.407±0.025
0.341 ±0.058 
0.295±0.021
0.463
<0.001
Modified Gl
AG (n=24) 3.5±0.104 1.7±0.138 <0.001
AU (n=143) 3.1 ±0.052 1.8±0.067 <0.001
Pocket Depth
AG (n=24)
AU (n=143)
6.5±0.293
5.4±0.104
3.7±0.234 
4.0±0.110
<0.001
<0.001
Stromelysin
AG (n=24) 
AU (n=143)
9.9 (4.6-21.2) 
5.2 (3.8-7.00)
3.1 (1.9-5.6)
4.1 (3.1-5.4)
0.029
0.249
TIMP
AG (n=24) 
AU (n=143)
231.7 (170.2-315-5)
228.7 (199.8-261.9)
291.3 (217.0-391.2) 
343.6 (296.0-398.7)
0.307
<0.001
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Table 3. Prediction of response to treatment according to baseline MMPs 
and TIMP levels. Baseline levels of MMPs and TIMP were compared between 
sites which showed attachment gain and their baseline matched controls 
which did not show attachment gain at the reassessment (n=24) and the 
follow-up (n=25) visits. Geometric mean and 95% confidence intervals 
and p values are shown.
Attachment gain Attachment unchanged
Mean (95% Cl) Mean (95% Cl) P
value
Visit Fibroblast-CL (pg/30s)
Reassessment 5.5 (2.0-15.4) 2.8 (1.2-6.40) 0.296
Follow-up 5.0 (1.9-13.1) 4.3 (1.9-10.4) 0.826
Stromelysin (pg/30s)
Reassessment
Follow-up
9.9 (4.6-21.2) 7.1 (3.3-15.3) 
9.4 (4.4-20.2) 6.5 (3.3-12.8)
0.536
0.446
TIMP (pg/30s)
Reassessment
Follow-up
231.7 (170.2-315.5) 290.8 (217.6-388.7) 
251.4 (192.5-328.4) 229.9 (182.6-289.5)
0.289
0.614
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Table 4. Comparisons of GCF volumes, gingival scores, PD and GCF levels 
of SL and TIMP between sites that gained attachment and those which 
remained unchanged at the reassessment and the follow-up visits. Mean 
±SEM for clinical parameters and the geometric mean and 95% confidence 
intervals for the proteins (pg/30s) are shown. Significance level (p 
value) for each two sample t-test and Mann- Whitney test (for gingival 
scores) is given.
Attachment gain Attachment unchanged
Mean ±SEM Mean ±SEM P
(95% Cl) (95% Cl) value
Visit GCF valume (pi)
Reassessment 0.341 ±0.058 0.295±0.021 0.399
Follow-up 0.220±0.040 0.174±0.013 0.179
Modified Gl
Reassessment 1.7±0.138 1.8±0.067 0.955
Follow-up 1.4±0.151 1.4±0.062 0.805
Pocket Depth (mm)
Reassessment 3.7±0.234 4.0±0.110 0.274
Follow-up 3.0±0.147 3.3±0.115 0.122
Stromelysin (pg/30s)
Reassessment 3.1 4.1
(1.9-5.6) (3.1-5.4) 0.472
Follow-up 2.0 2.5
c\iIU) 001osi 0.275
TIMP (pg/30s)
Reassessment 291.3 343.6
(217.0-391.2) (297.4-398.7) 0.307
Follow-up 115.9 89.3
(71.5-188.0) (73.9-107.91 0.288
28
Table 5. Comparisons of GCF volumes, gingival scores, PD and GCF levels 
of SL and TIMP between baseline and follow-up visits in sites which did 
(AG) or did not demonstrate attachment gain (AU) at the follow-up 
examination. Means ±SEM for clinical parameters and the geometric mean 
and 95% confidence intervals for the proteins (pg/30s) are shown. 
Significance level (p value) for each paired t-test and Sign test (for 
gingival scores) is given.
Baseline Follow-up
Parameter Mean ±SEM Mean ±SEM p value
(95% Cl) f95% cn
GCF Volume
AG (n=25) 0.387±0.051 0.220±0.040 0.002
AU (n=130) 0.408±0.026 0.174±0.013 <0.001
Modified Gf
AG (n=25) 3.4±0.114 1.4±0.151 <0.001
AU (n=130) 3.1 ±0.099 1.4±0.062 <0.001
Pocket Depth
AG (n=25) 6.4±0.289 3.0±0.147 <0.001
AU (n=130) 5.4±0.099 3.3±0.115 <0.001
Stromelysin
AG (n=25) 9.4 2.0
(4.4-20.2) (1.5-2.7) 0.003
AU (n=130) 4.7 4.1
(3.4-6.401 (2.0-3.2) 0.002
TIMP
AG (n=25) 251.4 115.9
(192.5-328.4) (71.5-188.0) 0.005
AU (n=130) 228.0 343.6
(197.3-263.4) (73.9-107.9) <0.001
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